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1 2-Pyrone – a privileged heterocycle and widespread motif in nature 
Nature is an inimitable source of myriad heterocyclic molecules that are involved in all kinds 
of biochemical processes, exhibiting precious biological activities. Research of these natural 
products is one of the cornerstones of medicinal chemistry and plays a vital role in the discovery 
of new drugs. Consequently, the vast majority of drugs marketed over the past 35 years originate 
from various natural products either by consisting directly of naturally occurring compounds or 
are inspired by these entities.1 2-Pyrone (1), an unsaturated six-membered cyclic ester, 
constitutes a renowned representative of naturally occurring heterocycles which can be found 
in all domains of life, e.g., bacteria, fungi, microbes, marine organisms, insects, plants or 
animals (Figure 1).2–4 In these systems, 2-pyrones fulfill important functions as intermediates 
or products in metabolism, as well as signaling molecules or defensive agents against 
predators.3,5 But most importantly, natural 2-pyrones evince an extensive range of biological 
activities with immense therapeutic importance like HIV protease inhibiting, telomerase 
inhibiting, antifungal, anti-inflammatory, antimicrobial, cardiotonic, cytotoxic and neurotoxic 
effects.2–7  
 





Moreover, the privileged heterocyclic structure of 2-pyrones, accommodating the chemical 
behavior of conjugated dienes, lactones and arenes (30−35% resonance energy of benzene7), 
has been widely exploited for the synthesis of value-added products in synthetic organic 
chemistry, polymer chemistry and medicinal chemistry.9,10 Herein, the versatile reactivity of 
pyrones reaches from cycloadditions to ring-opening reactions and cross-coupling reactions 
(Figure 2). Remarkably, functionalized pyrones show also interesting photophysical properties 
that can be delicately tuned by variation of donor-acceptor substituents indicating promising 
applications for organic light-emitting diode (OLED) displays and solid-state lightings.11 
Owing to their exquisite chemical and physical properties, 2-pyrones have attracted 
considerable attention to their synthesis and functionalization over the past decades (Figure 2). 
This review highlights synthetic strategies to the greatest extent divergent from traditional 
methods. Beyond that, the versatile reactivity of 2-pyrones is discussed encompassing their 
application in the synthesis of valuable products.  
 
 






2 Synthesis of 2-pyrones 
2.1 Synthesis from renewable resources 
The growing endeavor of reducing fossil-based feedstocks has encouraged research for 
sustainable strategies to convert renewable resources into valuable chemicals. In 1891, one of 
the first documented syntheses of the 2-pyrone scaffold already utilized malic acid (10) as 
starting material, a renewable resource readily derived from the fermentation of glucose 
(Scheme 1).12 The acid-catalyzed dehydration/decarboxylation of malic acid (10) afforded 
coumalic acid (12) via self-condensation of in situ formed formyl acetic acid (11). Coumalates 
are important platform molecules and until today several big-scale batch conditions13 as well as 
continuous flow processes14 have been developed for the synthesis of coumalic acid (12) from 
malic acid (10).  
 
Scheme 1. Acid-catalyzed synthesis of coumalic acid (12) from malic acid (10).12,13 
Recently, Sebastiano and co-workers reported a sustainable procedure toward the synthesis of 
pyrones starting from various biomass-based C6 sugar acids, also known as aldaric acids 13.15 
Treatment of mucic acid (13, R = H) with acetic anhydride in a buffered medium yielded either 
3-acetoxy-pyrone-6-carboxylic acid or the corresponding sodium salt 15 in good yields 
depending on the employed buffer base (NaOH, pyridine or NaOAc) (Scheme 2). This 
procedure was also verified for the conversion of two salts of glucaric acid (13, R = Ca, K). In 
both cases, the reaction was performed without the presence of a base, since the carboxylate 
anions were able to promote the reaction via intermediate 14 themselves (Scheme 2). Moreover, 
pyrones 15 were quantitatively converted with HCl to 3-hydroxy-2-oxo-2H-pyran-6-carboxylic 
acid (16) which afforded 3-hydroxy-pyrone derivative 17 by subsequent thermal 







Scheme 2. Sustainable synthesis of 2-pyrones 15 and 17 from aldaric acids (13).15 
Likewise, Reiser et al. developed an atom-economic reaction sequence to 6-substituted 
hydroxyalkyl pyrones 26 starting from furfuryl alcohol (18), a renewable resource derived from 
inexpensive agricultural waste products like bran and bagasse (Scheme 3).16 A range of 
hydroxyalkyl substituents were introduced by Baylis-Hillman reaction of enone 22 and various 
aldehydes 23. The thermal rearrangement of epoxides 25, which were utilized as stable 
cyclopentenone epoxide surrogates, constituted the key step of this sequence. Elimination of 
the hydroxy group also enabled the synthesis of naturally occurring 6-alkenyl pyrones 27.  
 






2.2 Transition metal-catalyzed synthesis 
Progresses in transition metal-catalysis paved the way for some elegant and efficient pathways 
towards 2-pyrones, being an attractive extension to traditional methods that often require harsh 
reaction conditions, thus making them unfavorable for the synthesis of sensitive target 
compounds. Particularly, the late transition metals proved to be very efficient catalysts for the 
preparation of 2-pyrone derivatives. 
Conceptually, the synthesis of pyrones via the formation of 7-membered metallacycles 28 has 
moved into the spotlight and a plethora of strategies have been developed to forge these 
intermediates 28 by transition metal-catalyzed annulation that selectively yield the pyrone 
scaffold 29 after reductive elimination (Scheme 4). 
 
Scheme 4. Pyrone synthesis via 7-membered metallacycles 28. 
Nickel-catalyzed [2+2+2]-cycloaddition of diynes 30 and CO2, giving rise to pyrone derivatives 
32, represents one of the oldest transition metal-catalyzed strategies, however, the reaction 
suffered from the employment of high CO2-pressure (Scheme 5).
17 Louie and co-workers 
discovered that application of a N-heterocyclic carbene ligand (IPr-ligand) allows the 
performance of this reaction at atmospheric CO2 pressure with excellent regioselectivity.
18 
Analogously, a rhodium-catalyzed version developed by Tanaka et al. yielded carbocyclic as 
well as heterocyclic fused pyrones under atmospheric CO2 pressure and even at room 
temperature.19 Mechanistically, an initial [2+2]-cycloaddition of CO2 and the sterically less 
hindered alkynyl unit leads to the formation of intermediate 31. Subsequent insertion of the 
second alkyne followed by reductive elimination furnishes pyrones 32 via the intermediacy of 






Scheme 5. Transition metal-catalyzed [2+2+2]-cycloaddition of diynes 30 and CO2.
17–19 
A rare example of a 2-pyrone synthesis via intermolecular [2+2+2]-cycloaddition between two 
terminal alkynes 33 and CO2 at ambient pressure and temperature was reported by Wu and co-
workers.20 An iridium/cobalt dual catalytic system provided access to 4,6-disubstituted pyrones 
35 under irradiation with visible light (Scheme 6). Herein, the photocatalytic system is utilized 
to generate an active CoI species by a visible light-mediated reductive quenching cycle of the 
IrIII-catalyst and i-Pr2NEt. Similarly to the intramolecular [2+2+2]-cycloadditions, the Co
I 
species reacts with CO2 and alkyne 33 to produce the five-membered cobaltacycle intermediate 
34. Insertion of a second alkyne 33 into the cobaltacyle 34 gives rise to pyrones 35 after 
reductive elimination. 
 
Scheme 6. Visible-light mediated [2+2+2]-cycloaddition of alkynes 33 with CO2.
20 
Moreover, homo- and heterodimerization of substituted propiolates 36 proved to be an efficient 
method for the construction of the pyrone skeleton (Scheme 7).21 Ruthenium-catalyzed 
homodimerization of propiolate 36 yielded trisubstituted pyrones 40, whereas disubstituted 





using acetic acid as solvent no homodimerization of the respective propiolates was observed in 
the latter case. Depending on the residue of alkyne 36 either 5-carboxylate- or 6-carboxylate-
substituted pyrones 40-41 are formed regioselectively which can be attributed to selective 
formation of 5-membered metallacycles 38. Aryl substituents coordinate strongly with 
ruthenium thus preferring the formation of 5-carboxylate substituted pyrones 40-41. Selective 
protonation of intermediate 38 again gives rise to a 7-membered metallacycle and followingly 
to pyrones 40-41 by nucleophilic attack of the ester in 39. 
 
Scheme 7. Homo- and heterodimerization of propiolates 36-37.21 
In addition to the processes utilizing only alkynes as starting materials, other approaches 
investigated the formation of pyrone derivatives via 7-membered metallacycles 28 by transition 
metal-catalyzed insertion of α,β-unsaturated acids or esters to alkynes.  
For instance, a range of aryl-, alkyl- and silyl-substituted pyrones 45 were regioselectively 
prepared by Larock and co-workers through palladium-catalyzed annulation of halogen- or 
triflate-containing α,β-unsaturated esters 42 and internal alkynes 43 (Scheme 8).22 The 
regiochemistry of the reaction seems to be controlled by steric factors in the apparent seven-
membered palladacyclic transition product being formed by attack of the carbonyl oxygen on 
the vinylpalladium intermediate 44. Consequently, unsymmetrical alkynes 43 give rise to 






Scheme 8. Palladium-catalyzed annulation of α,β-unsaturated esters 42 and internal alkynes 
43.22 
The development of transition metal-catalyzed reactions proceeding via C-H bond activation 
allowed to circumvent initial halogen- or triflate-functionalization of acrylic acids. Miura and 
co-workers were the first to demonstrate that pyrones 49 can be directly prepared from acrylic 
acid and derivatives 46 by rhodium-catalyzed oxidative coupling/annulation with alkynes 47 
(Scheme 9).23 Key step is the cyclometallation of acrylic acid 46 in 3-position to afford the 5-
membered intermediate 48 that further undergoes insertion into the alkyne 47. Since then, 
several oxidative annulation strategies have been described for the synthesis of 2-pyrones 49 
from readily available acrylic acids 46. Palladium-catalysis enabled the utilization of oxygen as 
oxidant under mild conditions24, whereas cinnamic acid derivatives could be converted into 
multisubstituted pyrones by applying an inexpensive ruthenium-catalyst.25 In addition, Mei and 
co-workers reported the first example of an iridium-catalyzed electrochemical version.26 
Herein, anodic oxidation was necessary to release the pyrone product 49 from a stable, 
coordinatively saturated 18-electron iridium complex. Recently, the combination of acrylic 
acids with 4-hydroxy-2-alkynoates yielded fused heterocyclic pyrone derivatives under 
rhodium-catalysis.27 In all cases, the reaction with unsymmetrical alkynes 47 proceeded 
regioselectively and again large substituents and especially aryl- or heteroaryl groups are 






Scheme 9. Transition metal-catalyzed oxidative annulation of acrylic acids 46 and alkynes 
47.23–27 
Analogous to these oxidative annulations of acrylic acids, decarbonylative- or decarboxylative 
coupling provides an additional elegant route from simple starting materials proceeding also 
via formation of a 5-membered metallacycle 52. Decarbonylative coupling of anhydrides 50 to 
alkynes 47 was first investigated by Matsubara and co-workers using a nickel catalyst in 
association with a Lewis acid cocatalyst.28 Later, the scope of anhydrides 50 and alkynes 47 
was widely extended by applying a rhodium catalytic system, yielding tri- or tetra-substituted 
pyrones 53 regioselectively (Scheme 10).29 However, in both cases coupling of the parent 
maleic anhydride failed and by using terminal alkynes only oligomerization was observed. 
While the first issue could be solved by a modified protocol under ruthenium-catalysis 






Scheme 10. Dercarbonylative coupling of maleic anhydrides 50 and alkynes 47.28–30 
In a similar vein, the decarboxylative coupling of readily available maleic acids 54 with internal 
alkynes 55 furnished aryl-, heteroaryl-, alkyl- and carboxyl-substituted pyrones 58 smoothly 
under rhodium-catalysis with excellent regioselectivity (Scheme 11).31 By using 2-substituted 
maleic acids, the decarboxylation takes place at the C3-position to selectively form metallacycle 
57. 
 
Scheme 11. Decarboxylative coupling of maleic acids 54 and alkynes 55.31 
During the past few decades, the directing-group-assisted C-H activation has become a pivotal 
strategy for the production of diversely substituted molecules. In this context, tunable tandem 
oxidative cyclization of N-tosylacrylamides 59 and diazo compounds 60 furnished either highly 
substituted pyrone derivatives 63 or furans depending on the applied reaction conditions 
(Scheme 12).32 In absence of an external oxidant, the rhodium-catalyzed reaction again takes 





complex 61 can coordinate the diazo compound 60 and after protonation intermediate 62 is 
obtained selectively. Finally, keto-enol tautomerization and lactonization afford pyrone 63 
under C-N cleavage. Aromatic- as well as aliphatic substituents are well tolerated in the 
respective starting materials. 
 
Scheme 12. Oxidative cyclization of acrylamides 59 and diazo compounds 60.32 
A different annulation strategy utilizing sulfoxonium ylides 65 as reliable and practical 
substitutes for diazo compounds has been reported by Jiang and co-workers.33 By application 
of a rhodium-catalyst they observed [3+3]-annulation between cyclopropenones 64 and 
β-ketosulfoxonium ylides 65 having only DMSO as a major byproduct. The proposed catalytic 
cycle involves cyclometallation of cyclopropenone 64 and transmetallation with substrate 65 
delivering a 4-membered rhodacycle intermediate 66. The complex 66 releases DMSO to yield 
the 7-membered metallacyle 67 and ultimately, pyrone 68 by reductive elimination. (Scheme 
13).  
 






A large part of traditional pyrone synthesis relies on carbonyl condensation reactions.6,7 Since 
carbon atoms of a carbonyl compound and an alkyne have the same formal oxidation state, 
alkynes can be used as stable ketone surrogates which can be activated by π-acid catalysts. 
Therefore, π-acid catalysis and particularly gold catalysis has emerged as a powerful tool for a 
systematic exploration of the pyrone estate.  
Gold-catalyzed cycloisomerization of strained β-alkynylpropiolactones 69 triggered by π-acid 
coordination to the alkyne moiety furnished 2-pyrones 71 (Scheme 14).34 In some cases, by-
product formation of acyclic acids was observed as a consequence of simultaneous σ-
coordination of the catalyst to the lactone 69. Noteworthy, derivatives with a substituent 
adjacent to the β-lactone moiety proved far less reactive with a concomitant increase in reaction 
time.  
 
Scheme 14. Gold-catalyzed cycloisomerization of β-alkynylpropiolactones 69.34 
A facile π-acid-catalyzed route towards 2-pyrones was developed by Fürstner and co-workers. 
The ability to manipulate alkynes 72 by the pronounced carbophilicity of [LAu+]-fragments, 
enables the 6-endo-dig attack of a tethered ester carbonyl group onto the transient alkyne-gold 
complex 73 to forge the pyrone ring in a fully regiocontrolled manner. During the total synthesis 
of the marine natural product Neurymenolide A 75 the power of this approach was showcased 






Scheme 15. Synthesis of 4-hydroxy-2-pyrones 74 by gold-π-acid catalysis.35  
A different approach starting from propargyl propiolates 76 was described by Schreiber et al 
(Scheme 16).36 Upon addition of a gold-catalyst, the [3,3]-sigmatropic rearrangement of 
propiolate 76 to enyne allene intermediate 77 is induced. Activation of the alkyne moiety by π-
coordination again instigates a 6-endo-dig cyclization to oxocarbenium intermediate 78, which 
either eliminates a proton to give rise to vinyl pyrones 79 or can be trapped by external 
heteroarene nucleophiles to obtain pyrones 80. Olefinic- as well as aromatic residues are well 
tolerated without interfering with the cascade reaction. Moreover, Schreiber’s strategy has also 
been adapted for the total synthesis of a ring A aromatic congener of urbalactone 81.37 
 
Scheme 16. Gold-catalyzed cascade process for the conversion of propargyl propiolates 76.36,37 
In addition to their earlier work, Schreiber and co-workers investigated the synthesis of 
disubstituted pyrones 85 directly from propiolic acids 82 and terminal alkynes 83 via a cascade 
reaction based on alkyne coupling and subsequent 6-endo cyclization of intermediate 84 





reaction conditions. However, sterically hindered alkynes 83 gave lower yields and 
phenylacetylene reacted only at elevated reaction temperature. 
 
Scheme 17. Synthesis of disubstituted 2-pyrones 85 from propiolic acids 82.38 
Previous examples have shown that π-acid-catalyzed intramolecular 6-endo-dig cyclization can 
provide the 2-pyrone framework in a very reliable way. The enormous value of these 
transformations has been further undergirded by pioneering work in palladium-catalyzed 
methodologies combining cross-coupling and π-acid features of the transition metal and thus, 
enabling the construction of highly functionalized pyrone derivatives. 
Burton and Wang reported the synthesis of 3,4-difluoro-6-substituted pyrones 89 by 
Sonogashira coupling of 2,3-difluoro-3-iodoacrylic acid (86) and terminal alkynes 87 (Scheme 
18).39 The resulting enyoic acid intermediate 88 undergoes further palladium-catalyzed 
cyclization to fluorinated pyrone 89. Aromatic, aliphatic as well as heterocyclic acetylenes 87 
worked well at ambient temperature and the presence of neither an electron-withdrawing nor 
an -donating group on the aromatic rings affected the yield of the products 89. 
 
Scheme 18. Synthesis of 3,4-difluoro-6-substituted pyrones 89.39 
Accordingly, formation of the pyrone scaffold was achieved by tandem Stille coupling and 
selective 6-endo-dig oxacyclization of iodovinylic acids 90 and allenyl-tributyltin reagents 91.40 
By this convenient method, alkyl-, aryl- and silyl-substituted pyrone derivatives 93 were 






Scheme 19. Tandem Stille coupling/oxacyclization of iodovinylic acids 90 and allenyl-
tributyltin reagents 91.40 
A strategy utilizing an opposite chronology of reaction events was developed by Loh and co-
workers. Pd(II)-catalyzed 6-endo-dig cyclization of enynoates 94 in the first step allowed the 
introduction of various substituents in 5-position of pyrones 97 by subsequent cross-coupling 
reactions with alkenes 95 (Scheme 20).41–43 The generality of this method was showcased by 
formation of alkenyl41, alkenone42- or allyl pyrones 97a-c43 employing either electron-deficient 
alkenes 95a or allylic alcohols 95b-c. While pyrones 97a-b are formed by β-hydride elimination 
in the final step, CuCl2 assisted the β-hydroxyl elimination to pyrones 97c. Oxidants like 
Cu(OAc)2, O2 and benzoquinone (BQ) are necessary to regenerate the active Pd(II)-catalyst 
species for a new catalytic cycle. 
 






Besides the pyrone synthesis via annulation and π-acid catalysis, miscellaneous transition 
metal-catalyzed approaches were investigated yielding the pyrone scaffold also in very 
intriguing ways. 
In addition to aforementioned [2+2+2]-cycloaddition strategies, for instance, a ruthenium-
catalyzed carbonylative [3+2+1]-cycloaddition method, using silylacetylenes 98, α,β-
unsaturated ketones 99 and CO as starting materials, was described by Ryu et al. (Scheme 21).44 
Initially, an in situ formed ruthenium hydride reacts with methyl vinyl ketone 99 to yield a 
ruthenium enolate, which undergoes carboruthenation with silylacetylene 98 to a vinyl 
ruthenium complex 100. Following CO insertion, cyclization via acyl ruthenium complex 101 
and β-hydride elimination, the respective tetra-substituted pyrone 102 is obtained  
 
Scheme 21. [3+2+1]-cycloaddition towards silyl-substituted pyrones 102.44 
A synthetic strategy utilizing rather unusual rhenium- or manganese-catalysts was developed 
by Takai et al.45 Mechanistically, the formation of pyrones 107 is divided into two parts. The 
metal complexes are catalyzing the insertion of acetylenes 104 into β-ketoesters 103 leading to 
the formation of δ-keto esters 106 after retro-aldol reaction of 5-membered metallacycle 105 
and subsequent reductive elimination. Finally, the cyclization of δ-keto esters 106 to pyrones 
107 under mild reaction conditions is triggered by TBAF (Scheme 22). Remarkably, the 
sterically demanding substituents of unsymmetrical alkynes 104 are exclusively installed in 4-
position of the pyrone skeleton. In contrast to the rhenium-catalyst, the cheaper manganese-






Scheme 22. Rhenium-and manganese-catalyzed synthesis of pyrones 107.45 
In other approaches, the use of alkynes as starting materials is obviated. Helquist and co-
workers obtained trisubstituted pyrones 111 by a palladium-catalyzed three-component reaction 
in a single-flask (Scheme 23).46 The reaction proceeded via α-arylation of ketone 108 with an 
aryl bromide in the first step. Subsequent α-alkenylation of the resulting intermediate with β-
bromoacrylate 109 gives rise to key enolate 110 that readily cyclizes to pyrone 111 after alkene 
isomerization. Palladium was found to have beneficial roles in all of the key steps. 
 
Scheme 23. Palladium-catalyzed multicomponent synthesis of pyrones 111.46 
Zhou and co-workers developed a synthesis of various 3-aryl pyrones 114 by palladium-
catalyzed cross-coupling of aryl iodides and cyclic vinyldiazo ester 112 that was easily prepared 
from commercially available 3,5-dihydro 2-pyrone (Scheme 24).47 Oxidative addition with aryl 
iodide affords a palladium(II) complex that reacts with diazo compound 112 to carbene 113. 
The aryl group inserts into the carbenic carbon and palladatropic rearrangement to C-5 followed 
by β-hydride elimination furnishes the aryl-substituted pyrone 114. Electron-withdrawing-, 





with the reaction conditions. The preservation of the bromo group in aryl pyrones 114 was 
attributed to the lower reactivity of bromobenzene under these mild reaction conditions. 
 
Scheme 24. Palladium-catalyzed synthesis of 3-aryl pyrones 114.47 
2.3 Transition metal-free synthesis 
Alongside traditional carbonyl condensation-cyclization protocols, a number of novel transition 
metal-free methods have been developed for the construction of 2-pyrones utilizing various 
starting materials and strategies. Some selected examples are listed herein. 
Even before to transition metal-catalyzed approaches, enyoic acids and enynoates 115 served 
as important starting materials in transition metal-free electrophilic 6-endo-dig oxacyclization 
protocols. In 2001, Rossi and co-workers demonstrated that 5-iodo-2-pyrones 118a are readily 
available by iodolactonization of enyoic acids 115 via iodonium ion 116 (Scheme 25).48 
However, butenolides were observed as minor byproducts due to competitive 5-exo-dig 
cyclization of acid 115. The 5-iodo pyrones 118a were further derivatized by Stille coupling 
with organotin compounds. Analogously, electrophilic cyclization of enynoates 115 was 
performed by Larock et al., using different electrophiles like ICl, I2, p-O2NC6H4SCl or 
PhSeCl.49 Also here the reaction suffered from unselective 5-exo-dig cyclization in some cases. 
Furthermore, Blum and co-workers developed a catalyst-free oxyboration of enynoates 115 
with B-chlorocatecholborane (ClBcat) and the resulting 5-borylated 2-pyrones were isolated as 
pincacolboronate esters 118c, providing a variety of bench-stable organoboron building blocks 
for downstream functionalization.50 Equally, oxyindation with indium trihalides furnished 5-
metalated pyrones that enabled easy access to various multi functionalized 2-pyrones 118d by 
subsequent halogenations or cross-coupling reactions.51 In contrast to the first two reports, no 
competitive 5-exo-dig cyclization was observed in the boron- and indium-mediated protocols 






Scheme 25. Electrophilic oxycyclization of enynoates 115.48–51 
Historically, catalytic organic synthesis has been dominated by transition metal catalysis. Since 
its discovery, organocatalysis, however, has grown explosively to become one of the most 
exciting research areas in current organic chemistry. Groundbreaking principles to form 
heterocycles were recognized and among these entities 2-pyrones have been organocatalytic 
target molecules as well.  
In this way, one-step phosphine-catalyzed synthesis of 6-alkyl- or aryl-substituted pyrones 122 
from commercially available aldehydes 119 and ethyl allenoate (120) was achieved by Kwon 
et al. (Scheme 26).52 After addition to the allenoate 120, sterically demanding 
trialkylphosphines are shifting the equilibrium towards the E-isomer of the zwitterionic 
intermediate 121 which is required to form pyrones 122 in further steps by γ-addition of 
vinylphosphonium salt 121 to aldehyde 119 and subsequent lactonization.  
 





An elegant one-pot isothiourea-mediated cascade sequence towards valuable trifluoromethyl 
substituted pyrones 127 including bioactive COX-2 inhibitors was developed by Smith and co-
workers. By addition of pivaloyl chloride and DIPEA, acid 123 is converted in situ to the 
corresponding mixed anhydride. The organocatalyst 125 is acylated by this reactive species and 
a base-mediated Michael-addition to enone 124 leads to the formation of intermediate 126. 
Then, trifluoromethylated pyrone 127 is obtained by lactonization and thiophenol elimination 
(Scheme 27).53 The utilization of alternate Lewis bases than isothiourea-catalyst 125 resulted 
in a poor conversion of the starting materials. 
 
Scheme 27. Isothiourea-catalyzed synthesis of trifluoromethyl substituted pyrones 127.53 
Moreover, N-heterocyclic carbene (NHC) catalysts have developed into a powerful tool for the 
organocatalytic synthesis of pyrone derivatives.54 Ma and co-workers presented a flexible 
protocol for the synthesis of either 2-pyrones 133 or chiral dihydro pyranones from 3-
bromoenals 128 and 1,3-dicarbonyl compounds 129 upon NHC-catalyzed oxidative 
transformation (Scheme 28).55 By addition of an external oxidant, pyrones 133 were selectively 
formed in yields up to 90%, whereas dihydropyrones are obtained in the absence of an oxidant. 
The postulated mechanism explained this observation by generation of an oxidized β-bromo 
Breslow intermediate 131 that is attacked by a deprotonated dicarbonyl compound 129 to 
furnish 1,4-adduct 132. Cyclization of intermediate 132 and bromide elimination yields pyrone 
133 with liberation of the carbene catalyst. Notably, the bigger residues of diketone 129 are 
selectively introduced in 6-position of pyrone 133 which can be attributed to electronic and 






Scheme 28. NHC-catalyzed oxidative transformation of 3-bromoenals 128.55 
A novel thiazolium salt-catalyzed [3+2+1]-cyclization of acetylene dicarboxylates 134 with 
arylglyoxals 135 via umpolung and C-C bond cleavage was reported by Jiang et al. (Scheme 
29).56 According to the proposed mechanism, a whole series of reaction events are leading to 
the formation of trisubstituted pyrone derivatives 140. Starting from arylglyoxal 135 a base-
mediated elimination of water gives an aldehyde that is attacked by carbene-catalyst 136. After 
an umpolung process to intermediate 137, nucleophilic attack to alkyne 134 furnishes the 
zwitterionic intermediate 138. Aldol-type reaction between zwitterion 138 and a second in situ 
prepared aldehyde of arylglyoxal 135 yields intermediate 139 by following proton transfer and 
elimination of an aryl acid. Finally, 139 is converted into pyrone 140 through a continuous 
intramolecular nucleophilic addition/elimination and dehydration sequence. Herein, the 
arylglyoxals 135 played dual roles in the formation of trisubstituted pyrones 140. Besides 
serving as a ring component, glyoxal derivatives 135 possessed additional importance as a 






Scheme 29. Thiazolium salt-catalyzed [3+2+1]-cyclization.56 
Due to their rich chemical reactivity, cyclopropanes have been demonstrated to be useful 
synthetic building blocks in organic chemistry. Especially, the ring-opening reaction of 
activated cyclopropanes via 1,3-dipoles provides versatile access to a plethora of cyclic and 
acyclic compounds.  
In line with this, donor-acceptor cyclopropanes 141 underwent sequential ring-opening, 
fragmentation, recombination and lactonization into highly substituted pyrones 144 upon 
treatment with AlCl3 (Scheme 30).
57 Since no cross-over products were observed by having 
different cyclopropanes 141 in the reaction mixture, the fragmentation/recombination-step of 
zwitterion 142 to 143 was assigned to be intramolecular in nature. Alternatively, by switching 
the Lewis acid to TiCl4, substituted 1-indanones were obtained.  
 
Scheme 30. Lewis acid-mediated transformation of donor-acceptor cyclopropanes 141.57 
Starting from 2-acyl-1-chloro cyclopropane carboxylates 145 and aliphatic amines, a base-





the chlorine in cyclopropane 145 instantly triggers ring-opening of the resulting donor-acceptor 
cyclopropane to iminium intermediate 146. Deprotonation and lactonization gives 3-amine 
substituted pyrones 148 in up to excellent yields. Several compounds that were obtained by this 
simple and transition metal-free method exhibited interesting photophysical properties.  
 
Scheme 31. Base-promoted domino reaction of cyclopropanes 145 and amines.58 
Another base-mediated synthesis has been accomplished by direct conjugate addition of imino 
esters 150 to β-chlorovinyl ketones 149.59 Remarkably, only substoichiometric amounts of a 
hard base are required since an in situ generated species 151 is acting in an autocatalytic way 
to convert the imino esters 150 to its corresponding enolates. The resulting neutral addition 
product of 151 readily eliminates HCl and MeOH to give pyrone 152 with the help of molecular 
sieves. Thereby, a broad range of 2-imino-pyranones 152 were obtained in good to excellent 
yields (Scheme 32). 
 
Scheme 32. Conjugate addition approach to 2-imino-pyrones 152.59 
With respect to the concept of Green Chemistry, the utilization of abundant reagents like CO2 
and O2 plays a vital role in modern synthetic chemistry. Consequently, a base-mediated 
approach utilizing CO2 as abundant, non-toxic and renewable C1 building block was developed 
by Lu and co-workers.60 The carboxylative cyclization of propenyl ketones 153 with CO2 





revealed that only one oxygen atom of pyrone 155 comes from CO2. Therefore, the cyclization 
of 154 presumably proceeds via an intramolecular attack of carbonyl oxygen into the 
carboxylate group. 
 
Scheme 33. Carboxylative cyclization of propenyl ketones 153 and CO2.
60 
Likewise, a catalyst- and additive-free Baeyer-Villiger-type oxidation of α-
iodocyclopentenones 156 to pyrones 158 using air as a green oxidant was reported by Rao et 
al. (Scheme 34).61 This reaction exhibits an excellent functional group tolerance and the 
synthetic utility was demonstrated by a large-scale synthesis of a pyrone derivative 158. Control 
experiments indicated that the role of molecular oxygen as the oxidant is crucial for the success 
of the Baeyer-Villiger-type oxidation. On the basis of these experiments, it was proposed that 
cyclopentenone 156 undergoes thermally driven homolysis of C-I and the resulting radical is 
trapped by oxygen. Intramolecular attack on the carbonyl gives intermediate 157 that rearranges 
to the 6-membered lactone scaffold.  
 






3 Reactivity of 2-pyrones 
3.1 Ring-opening 
In common with other lactones, 2-pyrones can be easily hydrolyzed or opened to the 
corresponding acyclic products by nucleophilic attack of aqueous alkali- or Grignard reagents 
at the C-2 carbon.62 However, due to the inherent unsaturated lactone structure, ring-opened 
products can also be obtained by nucleophilic attack at the C-6 position. The nucleophilic 
ring--opening of 2-pyrone (1) by 1,6-addition of cyanide was already discovered by Vogel in 
1965 (Scheme 35).63 After attack of the nucleophile, resonance-stabilized intermediate 159 is 
formed, subsequently collapsing to acid 160 by 6-π electrocyclic ring-opening.  
 
Scheme 35. Nucleophilic ring opening of 2-pyrone (1).63 
Fürstner and co-workers were able to supersede the conventional reactivity mode of Grignard 
reagents by iron-catalysis.64 In presence of an iron-catalyst, pyrones 161 underwent formal 
cross-coupling reactions at C-6 in which the lactone moiety gained a new role as a 
nontraditional leaving group (Scheme 36). The unconventional reactivity mode can be assigned 
to the formation of a complex 162 in which 2-pyrone 161 serves as an η4-bound diene ligand. 
Critical delivery of the nucleophile occurs by an inner-sphere mechanism. This method opened 
access to di-unsaturated acid derivatives 163 or 164 with high functional group tolerance and 
the stereochemistry (2E,4E 163 vs. 2Z,4E 164) being easily controlled by variation of the 
temperature before work-up. Interestingly, the power of this transformation has been illustrated 
in the synthesis of several diene containing natural products. The total synthesis of cytotoxic 
Granulatamide B (165) was accomplished in two steps from pyrone 161, which was readily 
available in multigram amounts by condensation of cheap 3-methyl-crotonate and octanoyl 
chloride. Moreover, the 2-pyrone ring-opening proved to be very efficient in late-stage 
incorporation of dienoates (Scheme 36, red) into a macrocyclic core. Thus, macrodiolides 





cytotoxic and in vivo anticancer activities, were synthesized by the same working-group 
unveiling the dienoate motif just before macrocyclization.65,66  
 
Scheme 36. Iron-catalyzed ring-opening reaction.64–66 
An uncatalyzed ring-opening of methyl coumalate (167) through 1,6-addition of Grignard 
reagents was reported by Dechoux et al. yielding 2Z,4Z or 2Z,4E dienoics acids 169 with high 
chemo- and stereoselectivity (Scheme 37).67 In this case, the presence of an ester in 5-position 
on the pyrone modified the regioselectivity of the nucleophile addition. The nature of the 
Grignard reagent played a key role on the outcome of the reaction. While alkenyl-, alkynyl- and 
aromatic reagents mainly furnished dienoic acids 169, the additional formation of unsaturated 
lactones 170 was observed using alkyl Grignards. The selective formation of conjugated acids 
169 using alkenyl-, alkynyl- and aromatic reagents can be easily rationalized by invoking the 






Scheme 37. Synthesis of dienoic acids 169 by nucleophilic ring-opening of methyl coumalate 
167.67 
Later, the same working-group described a sequential double 1,6-addition of Grignard reagents 
to methyl coumalate (167) to afford β,γ-unsaturated acids 173 in a highly regio-, chemo- and 
stereoselective manner (Scheme 38).68 The excellent stereoselectivity of the reaction can be 
explained by formation of a chair-like bicyclic transition state 172 after addition of the second 
Grignard reagent via complex 171. 
 
Scheme 38. Sequential double 1,6-addition to methyl coumalate (167).68 
Differently, Tunge et al. engaged pyrone 174 in an unique palladium-catalyzed double-
decarboxylative addition of allyl carbonates and carbamates 175, forming valuable dienoic 
esters 177 (Scheme 39).69 In contrast to previous strategies, ring-opening proceeds through 
allylation of pyrone 174 at C-3 by a π-allyl-Pd complex in a first step to form intermediate 176. 







Scheme 39. Palladium-catalyzed double-decarboxylative addition to pyrone 174.69 
3.2  [2+2]-Cycloaddition 
Examples of inter- and intramolecular [2+2]-cycloadditions of pyrones with alkenes are quite 
rare in literature and especially the intermolecular reactions are facing grave regio- and 
chemoselectivity issues making, these transformations unattractive for applications in synthetic 
chemistry.70 However, the intramolecular [2+2]-cycloaddition of the 2-pyrone scaffold itself 
has attracted considerable attention in organic chemistry. Already in 1964, Corey et al. 
discovered that UV-light irradiation of 2-pyrone 178 furnishes cyclobutene lactones 179 in 
almost quantitative yield (Figure 3).71 Lately, the working-groups of Kappe and Maulide 
demonstrated in collaboration the first continuous flow synthesis of lactone 179, achieving a 
roughly ten-fold productivity increase compared to batch conditions.72 Maulide et al. also 
recognized the enormous potential of bicyclic lactones 179 as versatile building blocks resulting 
in intriguing synthetic approaches for cyclobutene and diene derivatives. Palladium-catalyzed 
allylic alkylation of 179 enabled rapid access to functionalized cyclobutenes 180 or 181 with 
high and unusual diastereo- and enantioselectivities (Figure 3).73,74 Besides stabilized 
nucleophiles like malonates and azlactones, nonstabilized allylpinacaol boronates were 
employed to afford cyclobutene derivatives 182.75 Simple alkyl- 183 or halogen-substituted 
cyclobutene derivatives 184 were obtained by reaction with organocopper reagents76 or alkali 
halide salts.77 Noteworthy, these cyclobutenes can be further opened by 4π-electrocyclic 
ring-opening reactions giving rise to various diene frameworks, which themselves were 
extensively exploited for the synthesis of polyenic natural products, e.g. the southeastern 





photoisomerization of pyrones has been utilized in the total synthesis of natural products by 
other working groups as well.79 
 
Figure 3. Synthesis and versatile chemistry of cyclobutene lactones 179.71,73–78 
3.3 [4+2]-Cycloaddition 
The [4+2]-cycloaddition of a conjugated diene and a dienophile (an alkene or alkyne) – 
commonly known as the Diels-Alder reaction – is an exceptionally reliable and atom-economic 
pericyclic reaction for the construction of complex structures in a regio- and stereoselective 
fashion. Interestingly, 2-pyrones can act as both diene and dienophile in Diels-Alder reactions. 
However, just a few examples for the latter are reported in literature.80,81 Generally, electron-
withdrawing substituents in 5-position are necessary, as demonstrated in the reaction of methyl 
coumalate (167) and electron-rich dienes 188 (Scheme 40) – the first example for the usage of 
2-pyrone as dienophile.81 
 
Scheme 40. Pyrone 167 as dienophile in Diels-Alder reactions.81 
Classically, pyrones take part as dienes in [4+2]-cycloadditions with alkenes and alkynes 





through a normal- or inverse electron-demand Diels-Alder (IEDDA) reaction. The 
[4+2]-cycloaddition with alkynes 190 gives rise to highly strained bicyclooctadiene 
intermediates 191, which readily form aromatic products 192 after extrusion of CO2. In contrast, 
cycloaddition with alkenes 193 yields isolable adducts 194, representing useful synthetic 
intermediates due to their structural and stereochemical inimitability.82  
 
Scheme 41. 2-Pyrone (1) as diene in Diels-Alder reactions.82  
Since Diels and Alder published in 1931 that 2-pyrones could function as a diene component 
in [4+2]-cycloadditions83, this strategy has emerged as a powerful tool for the synthesis of 
aromatics, heteroaromatics and natural products.82 Especially, the ability to form aromatic 
products from pyrones has been widely exploited. For instance, Garg et al. demonstrated, that 
an additional benzene ring can be easily introduced to oxygen-or nitrogen-containing strained 
alkynes 196 (Scheme 42).84,85  
 
Scheme 42. [4+2]-cycloaddition of strained alkynes 196 and 2-pyrone (1).84,85 
A substrate-directed cycloaddition of pyrones 198 and alkynyl boronates 199 was developed 
by Harrity and co-workers.86 By activation of pyrone 198 with a Lewis acid the cycloaddition 
proceeded smoothly under mild reaction conditions and various synthetically useful motifs such 





this reaction the boronated products 201 were further functionalized by C-O, C-C and C-N 
bond-forming reactions (Scheme 43).  
 
Scheme 43. Substrate-directed cycloaddition of pyrones 198 and alkynyl boronates 199.86 
Additionally, heteroaromatic compounds like phosphinines 203 – the higher homologs of 
pyridines – can be easily prepared by Diels-Alder reaction of 2-pyrone (1) with phosphoalkynes 
202 (Scheme 44).87,88 The silyl-phosphinine product 203 has been utilized for the preparation 
of a Cu(I)- and the first crystallographically characterized phosphinine-Ag(I) complex.  
 
Scheme 44. Synthesis of phosphinines 203.87 
Although 2-pyrones were regarded as challenging dienes in asymmetric Diels-Alder reactions 
due to their inherent electron-deficient properties of aromatic character, some examples have 
been reported for the reaction with alkenes. In 2007, Deng et al. explored cinchona alkaloid-
based bifunctional organic catalysts 206 for the asymmetric [4+2]-cycloaddition of 
3-hydroxy pyrones 204 and electron-deficient alkenes 205.89 Thereby, valuable bicyclic 
adducts 208 were obtained with high enantio- and diastereoselectivity (Scheme 45). Herein, the 
cinchona alkaloid catalyst 206 simultaneously raises the energy of the HOMO of pyrone 204 
and lowers the energy of the LUMO of the dienophile 205 by H-bonding interactions while 






Scheme 45. Asymmetric Diels-Alder reaction of 3-hydroxy pyrones 204.89 
Besides further organocatalyzed methods employing chinchona alkaloid90,91- or Jørgensen-
Hayashi-type catalysts92, also some Lewis acid-catalyzed asymmetric IEDDA reaction of 
2-pyrones have been developed.93 Recently, an ytterbium-catalyzed IEDDA reaction of pyrones 
209 with 2,2-dimethyl-1,3-dioxole (210) enabled the total synthesis of bioactive natural product 
(+)-MK7607 (213) in total three steps (Scheme 46).94 By coordination to both carbonyls of 
pyrone 209, the chiral catalyst is forcing the alkene 210 to a stereoselective cycloaddition due 
to steric shielding. 
 
Scheme 46. Ytterbium-catalyzed asymmetric IEDDA reaction of pyrones 209.94 
Likewise, intramolecular [4+2]-cycloaddition of pyrones has been established as a reliable 





even in late stages.91,95,96 By combining the diene and dienophile moiety in one molecule, the 
cycloadditions can proceed regioselectively without employing catalysts due to the predefined 
coordination of the reactants. Snyder and co-workers, for instance, demonstrated the simple and 
elegant route to hydroindolines 215 which underwent subsequent hydrolysis to compounds 216, 
a widespread motif in natural products (Scheme 47).97 As an illustration of the power of this 
strategy, natural products Δ7-Mesembrenone (217) and Gracilamine (218) have been obtained 
either formally or by total synthesis. 
 
Scheme 47. Intramolecular Diels-Alder reaction to hydroindolines 215.97 
3.4 Other cycloadditions 
The versatility of pyrones is also reflected in their ability to serve as a substrate in other 
cycloaddition reactions, e.g. [3+2]-98 or [4+3]-cycloadditions99, to give rise to otherwise elusive 
medium-sized ring systems. Guo et al. reported an enantioselective synthesis of medium-sized 
bicyclic compounds 222 via tandem [3+2]-cycloaddition of vinyl ethylene carbonates 219 and 
pyrones bearing electron-withdrawing substituents in 5-position 220 followed by Cope 
rearrangement of intermediate 221 (Scheme 48).100 Noteworthy, the presence of aryl and at 
least vinyl-substituted substituents on carbonates 219 is necessary for a successful reaction. 
Based on control experiments and detailed computational studies product formation via direct 






Scheme 48. Tandem [3+2]-cycloaddition/Cope rearrangement of pyrones 220.100 
In contrast, [4+3]-cycloaddition of 5-substituted pyrones 223 and imine esters 224 furnished 
functionalized azepine derivatives 226 after decarboxylation of bicyclic intermediate 225 and 
[1,5]-H-shift (Scheme 49).101 The tandem reaction only requires NEt3 as a mild base to provide 
biologically important azepine derivatives. However, again only pyrones with electron-
withdrawing substituents worked in this reaction type, whereas no conversion of unsubstituted 
2-pyrone was observed.  
 
Scheme 49. [4+3]-cycloaddition of pyrones 223 and imine esters 224.101 
A quite unusual [10+4]-cycloaddition strategy for the synthesis of azulenes 231 has been 
investigated by Jørgensen and co-workers.102 Application of a bifunctional thiourea catalyst 
229 allowed the performance of the [10+4]-cycloaddtion of indene-2-carbaldehydes 227 and 
ethyl coumalate (228) under mild reaction conditions (Scheme 50). Herein, the 10π-reactant, 
which undergoes cycloaddition with pyrone 228, is formed in situ by condensation of 
carbaldehyde 227 and catalyst 229. Deprotonation of the resulting intermediate 230 
concomitantly releases the catalyst and CO2. The introduction of additional substituents to 






Scheme 50. Organocatalyzed [10+4]-cycloaddition.102 
3.5 Lactamization 
The structural motif of 2-pyridinone 232 is ubiquitous in nature and a wide range of 
2-pyridinone derivatives exhibit important bioactivities (Figure 4).103–109 Similarly to pyrones, 
pyridinones are useful starting materials in organic and medicinal chemistry possess interesting 
properties like dimer formation of the two existing tautomers of 2-pyridinone 232 and 233 
(Figure 4).110,111 
 
Figure 4. Dimerization of 2-pyridinone tautomers 232-233 and bioactive derivatives 234-
237.103–111 
2-pyrones are easily converted into the corresponding lactams via 1,6-addition of amines. 
Reaction with ammonia yields N-unsubstituted 2-pyridinones, whereas N-substituted 
derivatives are obtained by reaction with primary amines.112 The transfer of 2-pyrones to 2-





synthetic sequence to triazolo pyridines 241 enclosing the lactamization of methyl coumalate 
(167) to dihydrazide intermediate 240 as key step (Scheme 51).113 
 
Scheme 51. Synthesis of triazolo pyridines 241 by lactamization of pyrone 167.113 
A different lactamization approach for the synthesis of bicyclic 2-pyridinones 245 was lately 
investigated by Disadee et al. (Scheme 52).114 The novel double cyclization of 2-pyrones 242 
bearing a tethered, homochiral α-amino acid proceeded through deprotection, enamine 243 
formation, decarboxylation and lactamization of 244 with retention of the chirality. This 
strategy required no special reagents for the multichemical transformations. Only ethylene 
glycol was added to improve the solubility of pyrones 242 in water. 
 
Scheme 52. Synthesis of bicyclic 2-pyridinones 245.114 
3.6 Conjugate addition 
The α,β-unsaturated carbonyl structure present in 2-pyrones offers the opportunity for 
1,4-nucleophilic additions resulting in synthetic valuable 3,4-dihydro-2-pyrones or allowing the 
introduction of additional substituents into the 2-pyrone ring system.115,116 During the formal 
synthesis of antibacterial agent Lasalocid A 249, Ireland et al. found that Grignard reagent 246 
effectively underwent conjugate addition to pyrone 174, while organocuprates surprisingly 





attributed to the stabilization of the carbanion generated at 3-position by the methoxycarbonyl 
group. 
 
Scheme 53. Conjugate addition of pyrone 174 with Grignard reagent 246.117 
However, the reactivity of 2-pyrones 250 towards organocopper reagents could be increased by 
silylation with tert-butyldimethylsilyl triflate (TBDMSOTf) forming the corresponding 
pyrylium salt 251.115 After silylation, several substituents were introduced by conjugate 
addition, whereby a selective attack at 4-position was especially preferred by soft and bulky 
organocuprates. Moreover, lithium diorganocuprates reacted more efficiently than the cuprates 
prepared from Grignard reagents. Finally, hydrolysis of silylated adducts 252 afforded 
substituted dihydro pyrones 253 (Scheme 54).  
 
Scheme 54. Conjugate addition of organocuprates.115 
Due to the increased electron delocalization compared to acyclic unsaturated esters, the 
stereoselective addition to pyrones is quite challenging. However, an efficient copper-catalyzed 
asymmetric conjugate addition of Grignard reagents to unsubstituted 2-pyrone (1) has been 
developed by Feringa and co-workers.116 In the presence of a chiral ferrocenyl-based 
diphosphine ligand 254, various 3,4-dihydro-pyrones 255 were obtained with excellent 
enantioselectivity (Scheme 55). Further transformations of these products 255 allowed to access 






Scheme 55. Asymmetric conjugate addition to 2-pyrone (1).116 
The development of organocatalytic conjugate-addition protocols plays also a pivotal role in 
the functionalization of pyrones. The first example of a sequential Mukaiyama-
Michael/Mukaiyama aldol reaction of pyrones 256 with silicon enolate 257 and acetone 258 
was published by Yanai and Matsumoto in 2016 (Scheme 56).118 Moreover, the strong acid 
catalyst was able to promote a second Mukaiyama-Michael reaction to dihydropyrone 262 by 
adding a further Michael-acceptor 259 to the reaction mixture without overreacting to 
polymeric byproducts.  
 
Scheme 56. Subsequential Mukaiyama-Michael/Mukaiyama aldol reaction of pyrones 256.118 
As previous illustrations of ring-opening reactions showed, conjugate additions can also take 
place at the 6-position of 2-pyrones. Consequently, Zu et al. reported an organocatalyzed 
enantioselective Rauhut-Currier reaction of methyl coumalate (167) with α,β-unsaturated 
aldehydes 263.119 The enals 263 were activated by iminium catalysis to serve as 
Michael-acceptors, while 1,6-addition of a nucleophile to pyrone 167 generated the latent 
enolate. The latter is also facilitated by activation of pyrone 167 by the organocatalyst 264. 
Ultimately, elimination of the nucleophile in intermediate 265 furnished 3-substituted pyrones 






Scheme 57. Enantioselective Rauhut-Currier reaction of methyl coumalate (167).119 
In conformity with this approach, Dechoux and co-workers demonstrated the functionalization 
of methyl coumalate (167) with various aldehydes or imines 267 by an organocatalyzed 
Morita-Baylis-Hillman reaction (Scheme 58).120 In contrast to common Baylis-Hillman 
reactions, the transformation occurs via an unprecedented 1,6-conjugate addition of the Lewis 
base to pyrone 167. 
 
Scheme 58. Morita-Baylis-Hillman reaction of methyl coumalate (167).120 
3.7 Cross-coupling reactions 
Cross-coupling reactions constitute an important tool for the premeditated derivatization of 
pyrones in the total synthesis of natural products and biologically active compounds.96,121–123 
Owing to the merging aromatic and alkenic character, the pyrone scaffold can be used as the 
organometallic component as well as the organic halide/pseudohalide component in several 
renowned coupling reactions.  
Meinwald et al. investigated the synthesis of the core structure of steroidal pyrone substrates 





5-stannyl pyrone 270a was easily prepared from 5-bromo pyrone (Scheme 59) and this concept 
was also applicable to the synthesis of 3-substituted pyrones and 3-substituted 5-bromo-
pyrones.125 The analogous conversion of 5-bromo pyrone into 5-boronate ester 270b and 
subsequent Suzuki coupling with a range of aryl- and heteroaryl halides and triflates was 
reported by Jones and co-workers (Scheme 59)126. Similarly, a facile route to 5,6-disubstituted 
pyrones via Negishi coupling of 5-iodozinc pyrones 270c with organic electrophiles was 
developed by Rossi et al. (Scheme 59).127 The required iodo pyrones 270c can be obtained by 
iodolactonization as discussed earlier (Scheme 25).48  
 
Scheme 59. Cross-coupling of 5-metallated pyrones 270a-c.124,126,127 
Although the conversion of halogenated pyrones into organometallic compounds proved to be 
successful, the direct engagement of halogenated- or pseudohalogenated pyrones in cross-
couplings has been established as a more efficient strategy. In 2002, Cho et al. demonstrated 
the regioselective palladium-catalyzed Sonogashira coupling of 3,5-dibromo-2-pyrone (272) 
with alkynes 273 to give rise to 3-alkynyl-5-bromo-2-pyrones 274 (Scheme 60).128 Later, the 
same strategy found application in the formal synthesis of the steroidal tricyclic lactone (+)-






Scheme 60. Regioselective Sonogashira coupling of dibromo pyrone 272.96,128 
The same working-group found that dibromo pyrone 272 undergoes Stille coupling with 
stannanes regioselectively at either C-3 or C-5, depending on the employed reaction conditions 
(Scheme 61).129 Usually, cross-couplings proceed preferred at the 3-position of dibromo pyrone 
272 due to the lower electron density at C3. However, conducting the reaction in DMF a switch 
in regioselectivity was observed, which could not be explained with the level of current 
mechanistic understanding. Moreover, in DMF the ratio of 278 to 277 increases in proportion 
to the equivalents of CuI. Sarpong and co-workers exploited this strategy for an one-pot 
sequential Stille-Stille coupling in the total synthesis of Delavatine A (279).121 
 
Scheme 61. Regioselective Stille coupling of dibromo pyrone 272.121,129 
Along these lines, Suzuki coupling of pyrones has established as a reliable functionalization 
method.130 Recently, a synthetic pathway to natural products 283 isolated from fungus Phellinus 
igniarius has been developed by Ohyoshi et al. enclosing Suzuki couplings of 3-brominated 






Scheme 62. Suzuki coupling pyrone 280 with boronate 281.123 
A novel intramolecular direct arylation of 3-bromo 2-pyrones 284 was developed by 
McGlacken and co-workers (Scheme 63).131 Herein, intramolecular coupling was achieved by 
C-H activation of the phenoxy substituent and subsequent cross-coupling reaction. Both 
electron-donating and withdrawing substituents were tolerated on the aryl moiety. Surprisingly, 
the employment of iodo-substituted pyrone derivatives failed and no conversion of these 
substrates was observed. 
 
Scheme 63. Intramolecular direct arylation of 3-bromo 2-pyrones 284.131  
3.8 C-H activation 
Direct coupling methods, involving at least one C-H activation step, offer several advantages 
over traditional cross-couplings. In general, the production of waste is reduced by avoiding 
suitable prefunctionalization of substrates with activating groups and ideally, both coupling 
partners are unactivated. Generally, pyrones have higher electron-density at their 3- or 5-





for a C-H functionalization of 2-pyrones was described by Fairlamb and co-workers.132 Pyrones 
287 were regioselectively activated at the 3-position to yield fused products 289 (Scheme 64). 
Control experiments revealed the oxidative addition of palladium to the aryl substituent to be 
the first step in the reaction events. The reaction worked with iodo- and bromo-substituted aryls 
and the yield decreased significantly by employing substrates that bear electron-withdrawing 
substituents on the aryl moiety. 
 
Scheme 64. Palladium-catalyzed C-H functionalization of pyrones 287.132 
In collaboration with McGlacken, the same working group also extended the scope to six-
membered fused cycles 292 by varying the length of the tethered side-chain.133 However, the 
formation of C-5 activated byproducts was observed in some cases. Later, regioselective 
functionalization at C-3 has been optimized by McGlacken and co-workers (Scheme 65).134 
The use of pivalic acid was proved to be necessary for a successful reaction since a concerted 
metalation-deprotonation via intermediate 291 was determined as a crucial key step. 
 
Scheme 65. Regioselective C-H functionalization at C-3.134 
In addition, McGlacken and co-workers were able to circumvent the preferential reactivity at 
the 3-position and developed a direct arylation protocol for the intramolecular coupling at C-5 
by blocking C-3 with an unreactive chlorine atom.135 The retained chlorine atom at C-3 in 






Scheme 66. Regioselective C-H functionalization at C-5. 
As part of their pioneering work in this research field, McGlacken et al. also investigated the 
aryl-heteroaryl coupling via double C-H activation of compound 295, thus avoiding the 
preinstallation of any activating group (Scheme 67). Based on mechanistic studies, the excellent 
regioselectivity towards cyclized products 297 was rationalized by initial C-H activation of the 
2-pyrone skeleton at C-3.136 Equally, double C-H activations of 4-aniline137 or 4-thioaryl138 
substituted pyrones led to the formation of indole- or benzothiophene fused products, 
respectively.  
 
Scheme 67. Double C-H activation of pyrone 295.136 
A heretofore unprecedented intermolecular C-H activation approach was developed by Yusuf 
and co-workers (Scheme 68).139 The palladium-catalyzed ligand-free alkenylation of pyrones 
298 with various alkenes 299 proceeded smoothly under mild reaction conditions with high 
regioselectivity. Besides hydroxy or methoxy groups, also chlorine was tolerated as substituent 
in 4-position furnishing valuable pyrone derivatives 301 without forming classical Heck-type 
products. Moreover, styrenes 299 with both electron-donating, electron-withdrawing groups 
and halogen-substituents reacted efficiently to generate the corresponding alkenylated products 
301. The excellent chemo- and regioselectivity again can be explained by C-H activation of 






Scheme 68. Palladium-catalyzed direct alkenylation of pyrones 298.139  
3.9 2-Pyrone ligands 
The multifaceted nature of 2-pyrones appears not only in their versatile reactivity but also in 
their vein to complex various metals. The preparation of new complexes is an important 
research field in catalysis. Alternatively, coordination of organic molecules to metal fragments 
can have pronounced effects on their reactivity as observed in the iron-catalyzed ring-opening 
reactions of 2-pyrones 161 (Scheme 36).64 Pyrone complexes with various metals, e.g. Fe140,141, 
Os142, Co143, Re144, Mo145,146 or Ir26, have been reported in which the 2-pyrone unit is bound 
either in a η4-diene- or η1-like fashion (Figure 5).  
 
Figure 5. 2-Pyrone complexes.140,144,146 
Furthermore, pyrone complexes like 302 and 304 show interesting CO-releasing properties.146–
148 Those CO-releasing molecules are capable of delivering controlled amounts of CO within a 
cellular environment having potential therapeutic applications. Herein, the intrinsic stability of 
the complexes, which can be controlled by appropriate substituents on the pyrone scaffold, 
influences the extent and rate of the CO release.147 
In conclusion, 2-pyrones are a privileged class of heterocycles exhibiting an extensive range of 
biological activities with immense therapeutic importance, which attracted considerable 
attention in recent years for the synthesis of this specific molecular scaffold by either transition 





exert a vast potential to generate molecular complexity being showcased in the synthesis of 
numerous natural or pharmacologically active products. Moreover, the ability to form metal 
complexes could enable the development of new catalytic systems and CO-releasing molecules, 
whose intrinsic stability can be delicately tuned by a plethora of diverse substitution patterns 
located on the pyrone moiety. Therefore, the development of novel strategies for the synthesis 






B Main part 
1 Sustainable synthesis of 2-pyrones 
1.1 Introduction 
Processes for the production of carbon-based chemicals are nowadays predominantly based on 
non-renewable feedstocks like oil, natural gas and coal (Figure 6).149 However, the predictable 
depletion of fossil raw materials as well as the increasing environmental awareness of society 
are progressively forcing the chemical industry to replace fossil-based chemicals by 
commodities that can be derived from renewable resources. With advances in its conversion 
technologies, biomass has become the most promising renewable carbon source.150 All organic 
materials, that are assigned to biomass, are originally produced by biological photosynthesis 
using CO2, water and light and therefore, abundant carbon-neutral renewable resources.
151 
Accordingly, research is especially focused on the development of new synthetic strategies for 
the production of valuable products based on biomass. Among these, fine chemicals, which 
demonstrate a variety of reactivities and thus enabling access to value-added molecules are of 
particular interest.  
 

















2-pyrones, for instance, are versatile starting materials in synthetic organic chemistry and 
several methods have been developed over the years to access this class of substrates (see 
introduction A2). Recently, Reiser et al.16 reported the synthesis of 6-hydroxyalkyl 2-pyrones 
26 starting from renewable resources (Scheme 69). The key step of this synthetic sequence is 
the thermal rearrangement of cyclopentenone epoxide 307 through a 6π-electrocyclic reaction 
via the intermediacy of a vinyl ketene 308 (Scheme 69).153  
 
Scheme 69. Synthesis of 6-hydroxyalkyl 2-pyrones 26 from renewable resources via thermal 
rearrangement of epoxide 307.16  
Since cyclopentenone epoxides cannot be directly obtained from cyclopentadienones due to the 
high tendency of the latter to dimerize, enone 22 was envisioned as a suitable 
cyclopentadienone precursor154 for the synthesis of hydroxyalkyl 2-pyrone derivatives 26. 
Enone 22 was readily available by a reaction sequence starting from furfuryl alcohol (18) 
(Scheme 70) which itself can be prepared by catalytic reduction of furfural (310) on ton scale 
(Scheme 71). 
 
Scheme 70. Synthesis of enone 22 from renewable resources.16 
Furfural (310) is the most frequent chemical derived from hemicellulosic biomass in industry 
and used as an important platform chemical for the production of biofuels, solvents and other 
valuable products.155,156 Hemicellulose, a polysaccharide of different sugar monomers, 
e.g. xylose, arabinose, mannose and galactose, is an abundant and inexpensive renewable 





hemicellulose with acids gives rise to xylose (309), the major component of this polysaccharide 
and by further dehydration furfural (310) is obtained (Scheme 71). 
 
Scheme 71. Synthesis of furfuryl alcohol (18) starting from renewable resources. 
The ready availability of furfuryl alcohol (18) by the aforementioned process and its versatile 
reactivity158 offer outstanding opportunities for the production of valuable chemicals and drugs. 
In the synthesis of 6-hydroxyalkyl pyrones 26, the acid-catalyzed Piancatelli rearrangement of 
alcohol 18159 was used to get access to 4-hydroxy-2-cyclopentenone (19), a precursor for key 
compound enone 22 (Scheme 70). In 2010, Reiser et al.160 were successful in transferring this 
rearrangement to a continuous flow setup making a large scale synthesis and high yields 
possible (Figure 7).  
 
Figure 7. Continuous flow setup for the Piancatelli rearrangement of furfuryl alcohol (18).160,161 
A solution of furfuryl alcohol (18) in toluene and water (pH = 4) are separately injected via a 
high-pressure pump and mixed with a blender. After passing the mixture through an oven at 
240 °C and 34 bar in less than 1 min two layers are obtained, with 4-hydroxy-2-cyclopentenone 
(19) dissolved in the aqueous phase and polymeric byproducts in the organic layer. Water is 





strategy allowed the synthesis of key compound enone 22 (Scheme 70) and therefore, of 2-
pyrone derivatives 26 from readily available renewable resources (Scheme 69).  
Based on this previous work of Reiser et al.16,161 the first part of the present thesis constitutes 
the development of a sustainable big-scale process towards unsubstituted 2-pyrone (1) from 
furfuryl alcohol (18). Additionally, the synthesis of 6-alkyl pyrones was investigated which 
could enable access to natural products. The utility of biobased pyrone compounds should be 
showcased in various follow-up transformations. 
1.2 Big-scale synthesis of unsubstituted 2-pyronea 
Unsubstituted 2-pyrone (1) is a versatile starting material in organic chemistry and has been 
used for the synthesis of a variety of natural products and pharmacologically active substances 
e.g. (-)-Leodomycin D (311) or Rosiglitazone (312) (Scheme 72).10,76 Nevertheless, only few 
methods for the synthesis of pyrone 1 have been reported in literature to date162 which is 
associated with quite high prices at commercial suppliers for this valuable chemical.  
 
Scheme 72. Examples of substances derived from 2-pyrone (1).10,76 
Targeting the synthesis of unsubstituted 2-pyrone (1) on a big-scale the thermal rearrangement 
of epoxide 313 should provide an exceptional atom economic and efficient route (Scheme 73). 
Due to aforementioned processes, acetate 20 can be obtained on a large scale from inexpensive, 
biomass-based furfuryl alcohol (18).16 However, upscaling of the following Diels-Alder 
reaction to enone 22 and thermal rearrangement to pyrone 1 created some issues. 
 
a This chapter includes parts from a manuscript which has been prepared in collaboration with D. Dobler 






Scheme 73. Envisioned retrosynthetic strategy towards 2-pyrone (1). 
In literature, the Diels-Alder/elimination reaction of acetate 20 with cyclopentadiene 21 is 
generally performed by using superstoichiometric amounts of ZnCl2 as Lewis acid and dry 
benzene or toluene as solvent making these conditions unfavorable for a multigram synthesis 
of enone 22 (Table 1, entry 1 and 2).16,163 In addition, significant amounts of inorganic waste 
are formed herein leading to a quite challenging reaction work-up. Therefore, different 
cycloaddition conditions were investigated to obviate the usage of stoichiometric amounts of 
reagents and toxic solvents in this synthetic step (Table 1). 
Table 1. [4+2]-cycloaddition of acetate 20 with cyclopentadiene 21. 
 
entry[a] Lewis acid equiv LA solvent T t [h] yield [%] 
1 ZnCl2 3.0 benzene rt 17 89 (95)
163 
2 ZnCl2 3.0 toluene rt 18 86 (87)
16 
3 ZnCl2 1.0 Et2O rt 18 86 
4 ZnCl2 0.25 Et2O rt 18 70 
5 BF3∙OEt2 0.10 Et2O 0 °C 18 72 
6[b] BF3∙OEt2 0.10 Et2O 0 °C 18 82 
[a] conditions: acetate 20 (10.0 mmol, 1.0 equiv), cyclopentadiene 21 (3.0 equiv) in solvent (65 mL); [b] 
conditions: acetate 20 (200 mmol, 1.0 equiv), cyclopentadiene 21 (2.0 equiv) in Et2O (650 mL). 
Comparable yields to those obtained under literature conditions (Table 1, entry 1 and 2) could 
be achieved by switching the solvent to Et2O allowing a better solubility and thus equimolar 
amounts of the used Lewis acid (86%, Table 1, entry 3). A further decrease of Lewis acid led 
to a significantly lower yield of 70% after 18 h (entry 4). Additional [4+2]-cycloaddition of the 





the reaction furnished enone 22 in 72% yield (entry 5). In this case, the OAc-elimination of the 
primarily Diels-Alder intermediate is already partially catalyzed by the Lewis acid. This issue 
was overcome by lowering the equivalents of cyclopentadiene 21 in the reaction mixture and 
enone 22 was obtained in very good yields of 82% (Table 1, entry 6). Notably, by using this 
method the reaction workup is substantially facilitated and pure enone 22, itself a valuable 
starting material in organic synthesis164, is readily available in multigram scale and very good 
yields just by recrystallization. 
In the following, the Diels-Alder adduct 22 was epoxidized with hydrogen peroxide to yield 
epoxide 313 in 84% yield (Scheme 74). The retro-Diels-Alder reaction of epoxide 313 and 
subsequent rearrangement to unsubstituted 2-pyrone (1), the key step of the synthetic sequence, 
was performed by using a flash vacuum thermolysis (FVT) setup (Figure 8). The apparatus of 
the FVT consists of a quartz tube containing the starting material on one end, an oven in the 
middle and a cooling trap on the other end. The starting material is usually evaporated and then 
sucked through the high-temperature area of the oven by a vacuum (0.02 mbar). The following 
transformation towards the respective product is induced by thermal excitation occurring 
mainly by molecule-wall collisions. The high-temperature exposure periods are only very short 
(ca. 10-3−1 s) and therefore, very high temperatures between 400 and 1100 °C can be used 
without destroying the compounds. In this way, products can be obtained by unique 
transformations that are not accessible by other strategies.165,166  
 
Figure 8. Flash vacuum thermolysis setup.161 
Although, the FVT is an elegant and atom-economic method for the rearrangement of epoxide 
313 towards 2-pyrone (1), upscaling remained a big challenge because there are several issues 
to face. The steady-state concentration, the concentration of the substrate 313 in the hot 





reactions.166 Additionally, the temperature of the cooling trap features prominently in the big-
scale pyrolysis. Too low temperatures could lead to freezing of the product 1 and thus blocking 
of the quartz tube and the vacuum. Whereas, product loss could be observed by an insufficient 
trapping temperature. Several conditions for the FVT of epoxide 313 were examined to make 
this process reliable for a big-scale synthesis of pyrone 1 (Table 2). 
Table 2. Upscaling of the flash vacuum thermolysis setup. 
 


















3 Kugelrohr oven 130 0.02 water 88 product loss 






5[b] Kugelrohr oven 130 0.02 ice/water  96 
perfect 
conditions 
[a] conditions: epoxide 313 (15 mmol) was used; [b] conditions: epoxide 313 (123 mmol) was used. 
Incomplete conversion of epoxide 313, caused by a too high steady-state concentration, was 
observed when the flask with starting material was directly heated in the pyrolysis oven at 
650 °C and pyrone 1 was obtained in moderate yield of 60% (Table 2, entry 1). To control the 
steady-state concentration, the sublimation temperature of epoxide 313 was ascertained at first. 
The experiment revealed that the amount of starting material 313 in the high-temperature zone 
may be controlled by slowly sublimating the compound at 110 °C and 0.02 mbar pressure. 
Indeed, complete conversion and excellent yield of pyrone 1 was achieved by extern heating at 
130 °C using an upstream Kugelrohr distillation oven (98%, entry 2). However, freezing of the 
product 1 at the cooling trap filled with liquid nitrogen was observed in this case. On the 
opposite, using only water cooling led to a product loss (88%, entry 3) and by connecting the 





only frozen 2-pyrone (1) was obtained (entry 4). The freezing of the product finally could be 
circumvented at a cooling trap temperature of 0 °C (entry 5). With this optimized condition in 
hand, a big-scale pyrolysis of epoxide 313 (20.0 g, 123 mmol) was performed yielding the 
desired product 1 in excellent 96% yield and >99% purity (GC-analysis) without any further 
purification (Figure 9). This FVT setup would allow running even bigger scales and is only 
limited to the size of the used extern heater and cooling trap. In addition, dicyclopentadiene, 
which is formed after the extrusion of cyclopentadiene 21 by the retro-Diels-Alder reaction, is 
collected at the cooling trap of the high vacuum pump and can be reused for a new reaction 
cycle of pyrone synthesis.  
 
Figure 9. Big-scale FVT setup (Kugelrohr oven left, high-temperature oven in the middle and 
cooling trap right). 
Remarkably, the multigram synthesis of unsubstituted pyrone 1 is achieved without any 
chromatographic workup step during the sequence. Hydroxy cyclopentenone 19 and acetate 20 
were distilled, enone 22 was recrystallized and epoxide 313 was extracted after completion of 






Scheme 74. Big-scale synthesis of 2-pyrone (1) from renewable resources. 
The novel big-scale FVT setup is not only applicable for the multigram synthesis of 
unsubstituted pyrone (1) but also 6-(1-hydroxyethyl)-2H-pyran-2-one (26a)16 was obtained in 
excellent yield by slow distillation of epoxide 25a (3.1 g, 15 mmol) at 170 °C extern oven 
temperature (Scheme 75).  
 
Scheme 75. Synthesis of hydroxyalkyl pyrone 26a by the established FVT setup. 
1.3 Synthesis of naturally occurring 6-alkyl 2-pyronesb 
The established synthetic strategy towards 2-pyrones starting from furfuryl alcohol (18) should 
also be adopted for the introduction of further substituents into the pyrone skeleton. Herein, the 
introduction of alkyl substituents in 6-position is from particular interest. This structural motif 
is present in many naturally occurring 2-pyrone derivatives, e.g. 6-n-propyl, -n-pentyl or 
n-heptyl 2-pyrone 2a-c, which were isolated from strains of Trichoderma viride and possess 
fragrant aromas (Scheme 76).8,167  
 
b This chapter includes parts from a manuscript which has been prepared in collaboration with D. Dobler 






Scheme 76. 2-Pyrone natural products 2a-c isolated from Trichoderma viride.8 
The synthesis of the desired pyrones 2a-c should be accomplished from furfuryl alcohol 
derivatives 314a-c. The required alkyl substituents can be easily introduced by a Grignard 
reaction with furfural (310) and the reaction of the respective Grignard reagents yielded the 
furfuryl alcohol derivatives 314a-c in excellent yields (92-98%, Scheme 77). Piancatelli 
rearrangement to 5-substituted 4-hydroxy cyclopentenone derivatives 315a-c was performed 
under microwave conditions in a water/acetone mixture (40-75%, Scheme 77). In case of the 
heptyl derivative 315c, considerable amounts of polymeric byproduct were formed and the 
yield dropped drastically to 45%. A continuous flow setup as for the synthesis of unsubstituted 
4-hydroxy-cyclopentenone 19 might be also beneficial for this synthetic step. The subsequent 
acetylation gave the corresponding acetates 316a-c again in excellent yields (89-94%, Scheme 
77). 
 
Scheme 77. Synthesis of 5-substituted acetates 316a-c from furfural (310). 
Analogously to the synthesis of unsubstituted 2-pyrone (1) the Diels-Alder/elimination step of 






Table 3. Diels-Alder/elimination reaction of 5-substituted acetates 316a-c. 
 
entry[a] R Lewis acid equiv LA equiv 21 yield [%] 
1 n-Pr ZnCl2 1.0 3.0 79 
2 n-Pr BF3∙OEt2 0.10 2.0 70 
3 n-Pr BF3∙OEt2 0.10 3.0 82 
4 n-Pr BF3∙OEt2 0.20 3.0 94 
5 n-Pr BF3∙OEt2 0.20 1.5 76 
6 n-Pent BF3∙OEt2 0.20 3.0 95 
7 n-Hept BF3∙OEt2 0.20 3.0 94 
[a] conditions: acetate 316a-c (10 mmol, 1.0 equiv) in Et2O (30 mL). 
Reaction of propyl acetate 316a using stoichiometric amounts of ZnCl2 as Lewis acid furnished 
the Diels-Alder adduct 317a in 79% yield (Table 3, entry 1). Applying previously optimized 
conditions for the synthesis of unsubstituted enone 22 slightly decreased the yield to 70% (entry 
2). The yield of desired product 317a could be improved by increasing the equivalents of 
cyclopentadiene 21 in a following experiment (82%, entry 3). Finally, an excellent yield of 94% 
could be achieved by using 20 mol% of BF3∙OEt2 as Lewis acid and 3.0 equivalents of 
cyclopentadiene 21 (Table 3, entry 4), whereas lower equivalents of cyclopentadiene 21 again 
dropped the yield to 76% (entry 5). Under the optimized conditions also the n-pentyl- and n-
heptyl substituted derivatives 317b-c were obtained in excellent yields (94-95%, entry 6 and 
7). The sterically demanding alkyl substituents prevent further cycloaddition with 
cyclopentadiene as it is observed with unsubstituted acetate 20 (Table 1).  
In the last steps, enones 317a-c were epoxidized (97-98%) and subjected to FVT to yield the 






Scheme 78. Synthesis of naturally occurring 6-alkyl 2-pyrones 2a-c. 
1.4 Investigations towards the synthesis of 6-alkyl-4-methoxy-2-pyrones 
The 6-alkyl-4-methoxy-2-pyrone structure is present in many natural products with interesting 
biological properties. Among them, the kavalactones 8 (Figure 10) isolated from the kava-kava 
plant (piper methysticum) are the most prominent representatives and especially known for their 
anxiolytic, sedative and antidepressant effects.168,169  
 
Figure 10. Naturally occurring kavalactones 8.169 
Having previously shown that 6-hydroxyalkyl16 26 or 6-alkyl pyrones161 2 are easily accessible 
from renewable resources the further introduction of a methoxy group in 4-position could give 
rise to such interesting compounds. With consideration of the retrosynthesis, the additional 
alkoxy/hydroxy-group has to be introduced at the γ-position to the carbonyl group, between the 
6- and 5-membered ring of enone 317 (Scheme 79). 
 
Scheme 79. Envisioned retrosynthesis of 4-alkoxy-6-alkyl 2-pyrones (319). 
For this purpose, allylic oxidation was intended as the preferred strategy. The allylic oxidation 





oxidant. Unfortunately, under conventional heating as well as microwave conditions no 
conversion of the starting material 317a was observed, which could be ascribed to steric 
hindrance of substrate and oxidant (Scheme 80). 
 
Scheme 80. Investigation of the Riley oxidation of enone 317a. 
Consequently, a different approach had to be pursued. Zwanenburg et al. demonstrated that the 
γ-bromo enone compound 322 can be transformed into the methoxy derivative 324 within few 
minutes (Scheme 81).170 Interestingly, the reaction is reported to take place via elimination of 
the bromide to dienone 323 and subsequent conjugate addition of a methoxide. 
 
Scheme 81. Introduction of methoxy group according to Zwanenburg et al.170 
The introduction of a bromine in γ-position of enone 317a is quite impossible by standard 
methods. Therefore, we questioned if bromination of the enone 317a in δ-position would allow 
for the same transformation by the intermediacy of a dienone 323. 
The methylation of enones 317 in δ-position, for instance, can be achieved by using LDA as 
base to generate the enolate and MeI as electrophile.161 Accordingly, these reaction conditions 






Table 4. Attempts for the introduction of an α-bromo atom. 
 
entry reagents T t [h] yield [%] 
1 LDA, NBS −78 °C 1 decomposition 
2 
1) LDA, TMSCl 
2) NBS, NaOAc 
−78 °C to 0 °C 2 decomposition 
3 TMSOTf, NBS rt 24 --- 
 
However, similar conditions as for the methylation but using NBS as electrophile led only to 
decomposition (Table 4, entry 1). This might be due to further elimination of the initially 
introduced bromo-atom by the strong base. In an attempt to avoid elimination by protecting the 
enolate in the first step and brominating in the second step also decomposition was observed 
(Table 4, entry 2). By applying more gentle conditions using TMSOTf the starting material 
317a was completely recovered after one day (Table 4, entry 3). Since all attempts for the 
synthesis of 4-methoxy 2-pyrones 319 failed, the next focus of this thesis was placed on the 
application and functionalization of biobased 2-pyrone derivatives.  
In summary, a multigram synthesis of unsubstituted 2-pyrone (1) was achieved in high yields 
and excellent purity from biobased and inexpensive furfuryl alcohol (18). The Diels-Alder 
reaction of acetate 20, a key step of the synthetic strategy, could be performed with catalytic 
amounts of Lewis acid without using toxic solvents. Furthermore, a FVT setup was developed 
that enabled us to run the thermal rearrangement of epoxide 313 on every scale and with various 
substrates. Naturally occurring 6-alkyl 2-pyrones 2a-c were also synthesized from renewable 
resources by this strategy, whereas the introduction of a hydroxy/methoxy group in 4-position 





2 Application of 2-pyrones derived from renewable resources 
2.1 Synthesis of 3-substituted phthalides 
2.1.1 Introduction 
The structure of 3H-isobenzofuran-1-ones, also called phthalides, is characterized by the fusion 
of a benzene- and γ-lactone-ring. This framework is present in a large number of natural 
products displaying a broad range of bioactivities like anticonvulsant, anesthesia, anti-HIV, 
antibacterial and antibiotic effects (Figure 11).171,172 Most of the naturally occurring and 
pharmacologically active compounds belong to the group of 3-substituted phthalides. 
3-Butylphthalide (326b) is the best-known representative of this class and, despite its structural 
simplicity, possesses interesting physiological properties. The major constituent of celery oil 
can be used as an antiplatelet drug for ischemia-cerebral apoplexy and has been approved as an 
anti-ischemic stroke drug by the China Food and Drug Administration (CFDA).171,173 Besides 
their interesting biological activities, phthalides are also used as versatile building blocks in 
organic and medical chemistry.171,174 
 
Figure 11. Selected examples of naturally occurring 3-substituted phthalides.171 
Over the years, various methods have been developed for the racemic and asymmetric synthesis 
of 3-substituted phthalide derivatives.171 Most of them rely on a lactone formation on the 
benzene ring. One of the simplest strategies for an enantiomeric pure synthesis of phthalides is 
the catalytic reduction/lactonization of 2-acylarylcarboxylates 329.174,175 In 2017, Zhang 
co-workers reported a general method for the stereoselective synthesis of various 3-substituted 






Scheme 82. Stereoselective reduction/lactonization approach by Zhang et al.176 
In addition, progress in transition metal-catalyzed C-H bond functionalization paved the way 
for a rhodium-catalyzed intramolecular hydroacylation of 2-ketobenzaldehydes 331 developed 
by Dong et al. (Scheme 83).177 By appropriate choice of the counterion of AgX the 
enantioselectivity could be controlled for each substrate.  
 
Scheme 83. Intramolecular hydroacylation by Dong et al.177 
Transition metal-catalyzed [2+2+2]-cycloadditions of ester-linked diynes 333 with 
monoalkynes 334 have also been described for the synthesis of 3-substituted phthalide 
derivatives 335. In presence of a chiral phosphine ligand a one-pot transesterification and 
cycloaddition process gave rise to enantioenriched tricyclic 3,3-disubstituted derivatives 335 
(Scheme 84).178 
 
Scheme 84. Transesterification/[2+2+2]-cycloaddition of diynes 333 with tertiary propargylic 
alcohols 334.178  
The only method that was developed starting from renewable resources is based on a [4+2]-
cycloaddition of furfuryl alcohol (18) and dimethyl acetylenedicarboxylate (DMAD D) 
followed by a ring-opening/aromatization with IrCl3 (Scheme 85).
179
  However, no substituents 






Scheme 85. Synthesis of 3-unsubstituted phthalide 336 from renewable resource.179 
Hence, the utilization of starting materials that were derived from renewable resources would 
be a heretofore unprecedented strategy for the synthesis of 3-substituted phthalides.  
2.1.2 Synthesis of 3-substituted phthalides by Diels-Alder reaction of pyrones 
2-pyrones are well known to undergo [4+2]-cycloadditions with various alkenes and alkynes. 
Depending on the substitution pattern of the pyrones the cycloaddition can proceed through a 
normal or inverse electron demand Diels-Alder (IEDDA) reaction.180 The latter is usually 
evoked by electron-withdrawing substituents on the pyrone moiety. Generally, the 
cycloaddition of pyrones with alkynes gives rise to benzene derivatives after extrusion of CO2 
due to instability of the highly strained bicyclooctadiene intermediate 338. Therefore, the 
aforementioned 6-hydroxyalkyl 2-pyrones 26, reported by Reiser et al.16, seem to be suitable 
precursors for the synthesis of phthalide derivatives 340. It was envisioned, that the electron-
rich pyrones 26 undergo normal Diels-Alder reaction with electron-poor acetylenecarboxylate 
derivatives 337 and after extrusion of CO2 a transesterification in intermediate 339 should lead 
to the lactone ring formation (Scheme 86).  
 
Scheme 86. Envisioned transformation of 6-hydroxyalkyl pyrones 26 towards 3-substituted 
phthalides 340. 
Initially, the reaction was investigated using a symmetrical alkyne ester 341 to prevent the 






Table 5. Investigation of the synthesis of 3-substituted phthalide derivative 342a by Diels-





solvent c [M] T [°C] t [h] yield [%] 
1 Δ xylene 1.0 200 24 58 
2 Δ xylene 2.0 200 24 74 
3 Δ neat - 200 24 56 
4 MW xylene 2.0 150 7 64 
5 MW neat - 150 7 80 
[a] conditions: pyrone 26a (1.00 mmol, 1.0 equiv), dienophile 341 (1.4 equiv). 
Indeed, the reaction of 6-hydroxyethyl 2-pyrone (26a) with diethyl acetylenedicarboxylate 
(341) afforded the phthalide derivative 342a in fair yield by conventional heating (58%, Table 
5, entry 1). In 2004, Loupy et al. demonstrated, that the yields and selectivities of pyrone 
cycloadditions can be improved by using more concentrated reaction conditions and/or 
microwave irradiation.181 In case of conventional heating, a higher concentration led to 
increased yield of product 342a (74%, entry 2), whereas under neat conditions a drop in the 
yield to 56% was observed (entry 3). Microwave irradiation in the presence of a solvent slightly 
decreased the yield (64%, entry 4) compared to conventional heating. This could be rationalized 
by the poor excitability of xylene by microwave irradiation.182 Consequently, microwave 
activation under neat conditions gave the best result with 80% yield of phthalide 342a and 
additionally, shorter reaction times than under conventional heating could be achieved (Table 
5, entry 5).  
With the optimized conditions in hand, other 2-pyrone derivatives 26b-c and one 
enantiomerically pure substrate (S)-26a (99% ee)16 were subjected to the cycloaddition 
reactions with alkyne 341 (Scheme 87). As expected, no change of enantiomeric excess was 
observed during the cycloaddition/lactonization approach and enantiomerically pure phthalide 
(S)-342a is easily accessible in very good yield (81%, 99% ee). Furthermore, a derivative 342b 





the inferior solubility of the phenyl substituted pyrone 26c in alkyne 341 the yield dropped 
drastically and the corresponding phthalide 342c was obtained in fair yield (50%, Scheme 87).  
  
Scheme 87. Synthesis of 3-substituted phthalide derivatives 342a-c. 
It was demonstrated that chiral phthalide derivatives 342 can be synthesized from enantiomeric 
pure pyrones 26 by this strategy. Nevertheless, another methodology starting directly from 
racemic pyrones 26 should be investigated as well. In 2005, a catalytic enantioselective 
Diels-Alder reaction of 2,4-hexadienol (343) with methyl acrylate (344) was developed 
(Scheme 88).183 Chirality was induced by applying a binuclear Lewis-acid template derived 
from (R)-BINOL.  
 
Scheme 88. Enantioselective cycloaddition of 2,4-hexadienol (343) and methyl acrylate 
(344).183 
By possessing the same dienol structure 2-pyrones 26 appeared to be convenient substrates for 
a similar transformation. Herein, a kind of kinetic resolution should give the enantiomerically 






Table 6. Investigation of the stereoselective synthesis of 347a. 
 
entry[a] solvent T [°C] t [h] yield [%] 
1 DCM rt 48 --- 
2 DCM 70 48 --- 
3 toluene 150 48 --- 
[a] conditions: Pyrone 26a (0.5 mmol, 1.0 equiv), dienophile D (1.4 equiv), catalyst (1.0 equiv).  
However, by investigating different solvents and temperatures no conversion was observed and 
the starting material was recovered (Table 6). This could be attributed to the presence of the 
lactone moiety in pyrone 26a which also can be coordinated by the Lewis acid, thus preventing 
coordination of the dienophile D or creating an electronical mismatch. 
Considering the significance of simple 3-substituted phthalides 326 as versatile substrates in 
organic chemistry as well as important drugs like 3-butylphthalide (326b) for instance, the 
cycloaddition approach was also examined for the synthesis of phthalides 326 bearing no 
substituents on the benzene moiety (Table 7).  










1 Δ xylene 0.5 200 24 30 33 
2 Δ xylene 2.0 200 24 27 51 
3[b] Δ xylene 2.0 200 48 --- --- 
4 MW neat - 150 7 20 59 





Intermolecular Diels-Alder reaction with ethyl propiolate (37) was performed to afford the 
desired phthalide 326a, but utilization of an asymmetric alkyne furnished two different 
regioisomers 326a (30%) and 348a (33%) in almost equal yields (Table 7, entry 1). A higher 
concentrated reaction mixture favored the formation of the benzene derivative 348a (51%, 
entry 2) compared to phthalide 326a (27%), which could be explained by steric repulsion of the 
hydroxyalkyl and ester group. Additionally, a larger orbital coefficient of the HOMO of pyrone 
26a in 6-position than in 3-position due to the electron-donating substituent and smaller orbital 
coefficient in the LUMO at the β-position of alkyne 37 could prefer product 348a. The attempt 
to control the ratio by adding a Lewis acid failed and starting material 26a was completely 
recovered after 48 h (entry 3). The previously optimized neat microwave condition also rather 
promoted the synthesis of 348a (59%, Table 7, entry 4) than of phthalide 326a (20%). 
Therefore, a different approach for the selective synthesis of phthalides 326 had to be examined. 
Intramolecular cycloaddition should prevent the formation of regioisomers due to the 
predefined orientation of the dienophile and diene. For this purpose, hydroxyalkyl 2-pyrones 
26 had to be coupled with propiolic acid (349). Screening revealed that the solvent had a big 
impact on the outcome of the respective reaction (Table 8).  
Table 8. Coupling of pyrones 26a-c with propiolic acid (349). 
 
entry[a] R solvent yield [%] 
1 Me THF 24 
2 Me Et2O 42 
3 Me DCM 56 
4 n-Bu DCM 62 
5 Ph DCM 54 
[a] conditions: Pyrone 26a-c (1.0 equiv), propiolic acid (349) (2.0 equiv), DCC (1.13 equiv), DMAP (7 mol%). 
The reaction in Et2O and especially THF provided the ester 350a in poor yields of 24% and 
42%, respectively (Table 8, entry 1 and 2). The use of DCM proved to be beneficial and the 





when the reaction was conducted with the n-butyl (62%) or phenyl (54%) substituted 2-pyrone 
derivative 26b and 26c (Table 8, entry 4 and 5). 
Subsequently, the intramolecular Diels-Alder reaction of the methyl derivative 350a was 
initially investigated under conventional heating conditions (Table 9).  





c [M] t [h] yield [%] 
1 Me Δ 0.025 20 82 
2 Me MW 0.025 3 >99 
3 Me MW 0.10 5 >99 
4[a] n-Bu MW 0.10 5 >99, 74% ee[b] 
5 Ph MW 0.10 5 >99 
[a] starting from enantioenriched 2-pyrone 26b (74% ee); [b] determined by chiral HPLC analysis of the isolated 
product. 
The reaction provided phthalide 326a in a very good yield of 82% after 24 h (Table 9, entry 1). 
Satisfyingly, microwave activation again was superior to conventional heating and furnished 
product 326a quantitatively (>99%) in much shorter reaction time (entry 2). Furthermore, the 
concentration could be increased at least four times without observing byproducts by 
intermolecular cycloaddition (entry 3). Likewise, n-butyl and phenyl derivative 326b and 326c 
were obtained in quantitative yield (>99%, entry 4 and 5). Additionally, starting from 
enantioenriched butyl 2-pyrone (R)-26b (74% ee16) the enantiomeric excess remained 
unchanged over the two synthetic steps giving rise to enantioenriched naturally occurring 
3-butylphthalide (R)-326b (>99%, 74% ee, entry 4). 
After validating the inter- and intramolecular cycloaddition as an atom-economic synthetic 
strategy towards phthalides, the research was concentrated on the synthesis of 
7-hydroxy 3-substituted phthalides 327. This structural motif can be found in many naturally 





(327c) and chrycolide (327d) (Figure 11). During the total synthesis of 8-deshydroxyajudazol 
B, Rizzacasa and co-workers184 made use of Buchwald’s condition185 for the borylation of aryl 
halides 351 and after subsequent oxidation/hydrolysis the corresponding phenol derivative 352 
was obtained (Scheme 89).  
 
Scheme 89. Borylation/oxidation of 351 to alcohol 352 by Rizzacasa et al.184 
Thus, an analogous transformation should give rise to the aforementioned natural products 
using 7-bromo substituted phthalides 354. However, the introduction of bromine in 7-position 
by intermolecular Diels-Alder reaction with ethyl 3-bromopropiolate (353) was unsuccessful 
and only starting material 26a was recovered (Scheme 90).  
 
Scheme 90. Attempted intermolecular cycloaddition of pyrone 26a with ethyl 
3-bromopropiolate (353). 
In contrast, bromination of the terminal alkyne 350a using NBS and AgNO3 followed by 
intramolecular [4+2]-cycloaddition furnished the bromo phthalide 354 in excellent yield over 
two steps. Unfortunately, the borylation and oxidation step afforded mainly unsubstituted 






Scheme 91. Investigation of the synthesis of 7-hydroxy phthalide 327 via intramolecular 
cycloaddition. 
Although there are still some methods described in literature that could allow converting the 
bromo-phthalide 354 into the hydroxy derivative 327, further investigations could not be 
conducted due to limited time left in the lab.  
2.2  [4+2]-Cycloaddition of 6-acetyl 2-pyrone with alkenes 
As stated above (B.2.1.2), 2-pyrones can also undergo cycloaddition reactions with alkenes 
leading generally to isolable bicycloadducts 359. These structurally and stereochemically rich 
compounds 359 are useful synthetic intermediates, for instance, in the stereoselective synthesis 
of cyclohexane derivatives 360 (Scheme 92).180,186  
 
Scheme 92. Diels-Alder reaction of pyrones with alkenes.  
Accordingly, bicycloadducts 363 derived from cycloadditions with pyrone 361 would possess 
valuable functional groups enabling their further elaboration towards value-added products. 
6-Hydroxyalkyl pyrones 26 have been previously demonstrated to participate in normal 
Diel-Alder reactions with electron-poor alkynes. Consequently, pyrone 361 bearing an 
α-carbonyl group in 6-position was considered as an electron-poor diene due to the electron-





oxidation of the respective α-hydroxy pyrone 26a161, was investigated in an inverse electron 
demand Diels-Alder reaction using ethyl vinyl ether (362) as dienophile (Table 10). 
Table 10. Investigation of the IEDDA of α-carbonyl pyrone 361. 
 
entry[a] Lewis acid yield 363a [%] yield 363b [%] 
1 - --- --- 
2 ZnCl2 --- --- 
3 BF3∙OEt2 --- --- 
[a] conditions: pyrone 361 (1.0 mmol, 1.0 equiv), ethyl vinyl ether (362) (2.0 equiv), toluene (2.0 M). 
Surprisingly, pyrone 361 did not react with the electron-rich dienophile 362 upon heating at 
150 °C for 48 h (Table 10, entry 1). Also, activation of the pyrone 361 with a Lewis acid did 
not lead to a successful conversion of the starting material (Table 10, entry 2 and 3). 
These results indicated, that pyrone 361, despite the electron-withdrawing substituent, is a 
rather electron-rich diene and hence the cycloaddition had to be performed with an electron-



















1 - 2.0 toluene 150 24 complex mixture 
2 - 1.0 toluene 150 24 complex mixture 
3 - 1.0 DCM 60 48 --- 
4 ZnCl2 1.0 DCM 60 48 --- 
5 BF3∙OEt2 1.0 DCM 60 48 --- 
[a] conditions: pyrone 361 (1.0 mmol, 1.0 equiv), Lewis acid (1.0 equiv) in solvent (2.0 M). 
In fact, pyrone 361 underwent facile cycloaddition with methyl acrylate (344), but 
bicycloadducts 364 could not be isolated in any case. Under the thermal conditions extrusion 
of CO2 in adducts 364 and further cycloaddition of the corresponding cyclohexadiene 
intermediates with methyl acrylate (344) occurred leading to a complex mixture of various 
products (Table 11, entry 1). The attempt to isolate the initial cyclohexadiene intermediates by 
lowering the amount of alkene 344 (entry 2) was unsuccessful since the second cycloaddition 
was more favored than in the first step with pyrone 361. In order to circumvent the thermal 
extrusion of CO2 in bicycloadducts 364, the reaction was also performed at a lower reaction 
temperature (entry 3). However, this experiment showed that higher temperatures are necessary 
for an uncatalyzed Diels-Alder reaction and only starting material 361 was recovered. Upon 
addition of Lewis acids for the preactivation of dienophile 344 also no conversion was observed 
(Table 11, entry 4 and 5). Herein, again an electronic mismatch due to simultaneous 
coordination of both reagents to the Lewis acid could be the major reason. Thus, the selectivity 
issues of the reaction could not be solved with the given materials and therefore, other 
applications for the biomass-derived pyrones were investigated. 
To sum up, a heretofore unprecedented transition metal-free synthetic strategy towards 3-
substituted phthalides 326 and derivatives 342 was developed starting from pyrones 26 derived 





enantiomeric excess was observed and enantioenriched products were obtained. In addition, the 
capability to introduce a bromine atom in 7-position of the phthalide by this method could pave 
the way to some natural products in future work. In contrast, desired bicycloadducts 364 could 
not be isolated by cycloaddition of 6-substituted pyrone 361 with alkenes. 
2.3 Visible light-mediated [4+2]-cycloaddition of 2-pyrones 
The eclectic photochemistry of 2-pyrone (1) has been discovered early and these photoinduced 
transformations provide appealing entities that are elusive by other methods (Scheme 93). In 
1964, Corey71 reported that direct irradiation of 2-pyrone (1) in diethyl ether furnished bicyclic 
lactone 365 by 4π-photocyclization, while an acyclic ester 366 was obtained by irradiation in 
methanol.187 In contrast, by addition of acetophenone as sensitizer the formation of two 
[4+2]-cycloadducts 367a and 367b was observed, which constitutes a rare example of 
photochemical [4+2]-cycloaddition.187 Whereas the latter reaction seems to arise via the triplet 
2-pyrone excited state (T1, Figure 12), the cyclobutene lactone 365 and acyclic ester 366 are 
formed via the singlet excited state (S1, Figure 12).  
 
Scheme 93. Versatile photochemistry of 2-pyrone (1). 
As discussed earlier in the introduction (see chapter A3.2 and A3.3) lactone 365 and structurally 
rich cycloadducts like 367a and 367b are very potent building blocks. However, established 
synthetic protocols still make use of UV-mediated processes entailing some drawbacks. 
UV-light requires a high input of energy and specialized equipment for its safe generation. The 
concentration of substrates has to be kept low in order to allow efficient light penetration and 
prevent undesired intermolecular reactions. Moreover, up-scaling of UV-mediated reactions is 
a big challenge. Concerning a more sustainable process, the UV-light source should be replaced 
by an environmentally friendly visible light-emitting diode (LED).  
Transformations proceeding via singlet excited transition states (S1) can not be accomplished 
by direct irradiation with visible light in this case. Therefore, the focus was placed on the triplet-





molecule (sensitizer) can be applied to generate the first triplet state of a substrate (T1), from 
which the reaction takes place (Figure 12). 
 
Figure 12. Energy transfer of a sensitizer to a substrate.  
Over the years, several transition metal catalysts have been developed that absorb in the visible 
region of light promoting various chemical processes either by photoredox or energy transfer 
mechanisms. In 2019, Reiser et al. developed a visible light-mediated, intramolecular [2+2]-
photocycloaddition of amide linked dienes catalyzed by [Ir(dtb-bpy)(dF(CF3)ppy)2]PF6 as 
triplet sensitizer.188  
Encouraged by this work, an iridium-sensitized protocol was considered as a promising strategy 



























455 0.50 rt 0.5 46 46 
3 - - 0.50 150 48 --- 
4 - 455 0.50 rt 48 --- 
5 Cu(dap)2Cl 530 0.50 rt 48 --- 
6 Ru(bpy)3Cl2 455 0.50 rt 48 --- 
[a] conditions: pyrone 1 (1.0 mmol, 1.0 equiv), catalyst (1.0 mol%). 
Gratifyingly, the iridium-catalyzed reaction furnished both regioisomers 367a and 367b in 
equal amounts after 3 h (Table 12, entry 1). The reaction took place in a complete 
diastereoselective fashion and for both products only the exo-diastereomer was obtained. In 
contrast to the earlier report187, structures of 367a and 367b could be unambiguously 
characterized by spectroscopic and single-crystal X-ray analysis (Figure 13). Moreover, the 
reaction time could be reduced by tenfold concentrated reaction conditions and cycloadducts 
367a and 367b were formed in an excellent overall yield of 92% (entry 2). In order to exclude 
the transformation to proceed through thermal (entry 3) or light-induced (entry 4) excitation, 
the conditions were examined in further experiments, but pyrone 1 was recovered in both cases. 






     
Figure 13. Crystal structure of 367a and 367b (50% thermal probability). 
Having identified excellent conditions for a visible light-catalyzed [4+2]-cycloaddition of 2-
pyrone (1) it was examined if an additional substituent could prevent the formation of one 
regioisomer. Hence, pyrones 2a and 26a were employed having an alkyl or hydroxyalkyl 
substituent, which might induce selectivity by steric reasons or additionally through H-bond 
interactions. But the reactions of alkyl pyrone 2a and hydroxyalkyl pyrone 26a provided a 
complex reaction mixture of different products that were not separable by standard column 
chromatography. NMR- and mass-analysis of the crude reaction mixture revealed the formation 
of [4+2]-cycloadducts and their corresponding products after elimination of the 
CO2-bridgehead. (Scheme 94). In addition, [2+2]-cycloaddition products of two pyrone 
molecules were observed, as well. 
 
Scheme 94. Triplett sensitized reaction of alky pyrone 2a and hydroxyalkyl pyrone 26a. 
All in all, the UV-mediated [4+2]-cycloaddition of 2-pyrone (1) was successfully replaced by 
a visible light catalyzed process giving rise to structurally and stereochemically rich 
cycloadducts 367a and 367b in a diastereoselective manner. The structures of both 
cycloadducts were unambiguously characterized by X-ray analysis. By introduction of 
substituents no selectivity of this reaction type could be obtained and only a complex mixture 






2.4 Cyclopropanation of 2-pyrone and 2-pyridinone and follow-up transformation 
2.4.1 Cyclopropanation of 2-pyrone and 2-pyridinone 
In general, 2-pyrones represent valuable starting materials in synthetic organic chemistry, 
however, besides versatile reactivities, that have been reported in recent literature, 
enantioselective functionalization of pyrones is still a remaining challenge. So far, only few 
methods have been developed in this field, e.g. asymmetric conjugate addition of Grignard 
reagents116 or enantioselective hydrogenation of pyrone derivatives189 accessing chiral 3,4- or 
5,6-dihydro 2-pyrone derivatives – again precious synthetic building blocks.190 Among the 
various known catalytic processes, transition metal-catalyzed cyclopropanation deems to be a 
promising strategy for stereoselective functionalization of 2-pyrones. Cyclopropanation 
reactions have already been established for the stereoselective elaboration of heterocycles like 
furan, pyrrole and indole191,192 and the utility of these transformations have been showcased 
through the synthesis of many biologically relevant compounds (Figure 14).193–198  
 
Figure 14. Selected examples of synthetic applications out of cyclopropanated heterocycles 
368.193,194,196,198 
Commonly, cyclopropanation of olefinic compounds proceeds via copper or rhodium 
carbenoids as key reaction intermediates readily generated by metal-catalyzed decomposition 
of diazoacetates. In contrast to free carbenes, metal carbenoids provide higher stability and 
tunable reactivity/selectivity dependent on the carbenoid structure. The letter can be categorized 
in three classes – acceptor/acceptor- 373, acceptor- 374 and donor/acceptor-carbenoids 375 
(Figure 15). Due to their electrophilic character, the reactivity of carbenoids can be increased 
by acceptor substituents, while at the same time selectivity gets decreased. Introduction of 






Figure 15. Classification and reactivity pattern of metal carbenoids. 
Although transition metal-catalyzed cyclopropanation has been already applied to a number of 
heterocycles, to the best of our knowledge 2-pyrones have not been investigated as substrates 
in literature so far. Considering the electrophilic character of metal carbenoids, 
functionalization should occur on the more electron-rich double bond in 5,6-position next to 
the ring oxygen of pyrone 1 remaining an interesting α,β-unsaturated lactone moiety. Thus, the 
enantioselective formation of cyclopropanated pyrones would enable further follow-up 
transformations to access value-added compounds under high stereochemical control. 
Consequently, unsubstituted 2-pyrone (1) was at first investigated in racemic cyclopropanation 






Table 13. Racemic cyclopropanation of 2-pyrone (1) with diazoacetate 376. 
 
entry[a] solvent cat. [mol%] equiv 376 T t [h] yield [%] 
1 toluene 5.0 3.0 rt 1.5 74 
2 toluene 1.0 3.0 rt 1.5 49 
3[b} toluene 2.5 3.0 rt 1.5 75 
4 toluene 2.5 1.5 rt 1.5 55 
5 toluene 2.5 3.0 60 °C 1.5 66 
6 toluene 2.5 3.0 rt 3.0 72 
7 DCM 2.5 3.0 rt 1.5 59 
8 hexanes 2.5 3.0 rt 1.5 24 
9 trifluorotoluene 2.5 3.0 rt 1.5 67 
10[c] DCM - 0.2 rt 24 --- 
[a] conditions: to a solution of pyrone 1 (1.00 mmol, 1.0 equiv) and catalyst in solvent (0.5 M) was added dropwise 
a solution of diazoacetate 376 in solvent (1.1 M) over the indicated time; [b] pyrone 1 (5.00 mmol, 1.0 equiv) was 
used; [c] pyrone 1 (1.00 mmol) and diazoacetate 376 in DCM (0.5 M) were stirred under irradiation with a blue 
LED (λ = 455 nm) for 24 h. 
Encouragingly, in a first experiment, using 5.0 mol% of Rh2(OAc)4, the expected reactivity 
could be confirmed and 2-pyrone (1) was regioselectively cyclopropanated in 5,6-position in 
good yields of 74% (Table 13, entry 1). Remarkably, no additional double cyclopropanated 
product was observed though the aromatic character of pyrone 1 is broken. In addition, 
cyclopropanation furnished only one diastereomer 377a whose structure was unambiguously 
characterized by single-crystal X-ray analysis (Figure 16). This promising result initiated 
further research to optimize the reaction conditions. Screening of the amount of catalyst 
revealed that a catalyst loading of at least 2.5 mol% is necessary to achieve good yields of 75% 
(Table 13, entry 3), while a lower catalyst loading of 1.0 mol% significantly decreased the yield 
to 49% (entry 2). Likewise, reduction of the equivalents of diazoacetate 376 led to a drop in 





time of 376 (entry 6) did not improve the yield. Next, solvents commonly used in 
cyclopropanation reactions were screened. DCM (59%, entry 7) and hexanes (24%, entry 8) 
had adverse effects on the outcome of the reaction. In some cases, toluene, bearing a benzylic 
CH bond, shows unwanted side reactions with metal carbenoids and therefore, inert 
trifluorotoluene was also tested as solvent (Table 13, entry 9). However, utilization of 
trifluorotoluene slightly decreased the yield of 377a to 67% indicating that the aforementioned 
side reactivity is no issue in this case. In 2018, Davies et al. reported that aryldiazoacetates 376 
undergo photolysis by irradiation with blue light enabling cyclopropanation with a variety of 
substrates.199 Irradiation of diazoacetate 376 with a blue LED (λ = 455 nm) in presence of 
pyrone 1 only gave dimers of 376 and 2-pyrone (1) was completely recovered (entry 10).  
 
Figure 16. Crystal structure of 377a (50% thermal probability). 
Having identified the optimized conditions for a racemic cyclopropanation of unsubstituted 
2-pyrone (1), next, the scope of this transformation should be investigated using 2-pyridinone 
derivative 378 as substrate (Table 14), which is readily available by a reaction of 






Table 14. Racemic cyclopropanation of 2-pyridinone 378 with diazoacetate 376. 
 
entry[a] cat. [mol%] equiv 376 yield [%] 
1 2.5 3.0 97 
2 2.5 1.5 89 
3 1.0 3.0 96 
4 1.0 2.0 95 
[a] conditions: to a solution of pyridinone 378 (5.0 mmol, 1.0 equiv) and catalyst in toluene (0.5 M) was added 
dropwise a solution of diazoacetate 376 in toluene (1.1 M) over 1.5 h. 
Interestingly, under previously determined reaction conditions, cyclopropanated pyridinone 
377b was isolated in almost quantitative yield of 97% (Table 14, entry 1). On the analogy of 
2-pyrone (1), only one diastereomer was formed and the structure of the α,β-unsaturated lactam 
377b could be characterized by X-ray analysis (Figure 17). Further experiments showed, that 
the catalyst loading could be even reduced to 1.0 mol% and 2.0 equivalents of diazoacetate 376 
were still sufficient to furnish 377b in excellent yields of 95% (entry 4). The increased reactivity 
of pyridinone 378 compared to 2-pyrone (1) could be assigned to the powerful 
electron-donating ability of the nitrogen lone-pair leading to a more electron-rich heterocycle.  
   
Figure 17. Crystal structure of 377b (50% thermal probability). 
After proving pyrone 1 and pyridinone 378 as suitable substrates in transition metal-catalyzed 
cyclopropanations, the focus was then turned to the asymmetric transformation. A variety of 
chiral dirhodium catalysts have been developed for the reactions with donor/acceptor carbenes 





heterocycles.193–195,198,201 Therefore, a short catalyst screening using 2-pyrone (1) as model 
substrate and DCM as solvent was conducted at the beginning (Table 15). 
Table 15. Catalyst screening for the enantioselective cyclopropanation of 2-pyrone (1). 
 
entry[a] Rh(II) catalyst yield [%] ee [%][b] [𝜶]𝑫
𝟐𝟎 
1 Rh2(S-TCPTTL)4 52 50 −165 
2 Rh2(R-p-BrTPCP)4 46 57 −190 
3 Rh2(S-PTAD)4 94 87 281 
[a] conditions: to a solution of pyrone 1 (0.5 mmol, 1.0 equiv) and catalyst (1.0 mol%) in DCM (0.5 M) was added 
dropwise a solution of 376 (3.0 equiv) in DCM (1.1 M) over 1.5 h at room temperature; [b] determined by chiral 
HPLC analysis of the isolated product. 
The initially tested phthalimido catalyst Rh2(S-TCPTTL)4 gave the cyclopropanated pyrone 
377a in moderate yield (52%) and low enantiomeric excess (50% ee, Table 15, entry 1). 
Utilization of the triarylcyclopropane carboxylate catalyst Rh2(R-p-BrTPCP)4 furnished 377a 
in even lower yield (46%) but slightly increased ee (58% ee, entry 2). The Rh2(S-PTAD)4 
catalyst proved to be very efficient and 377a was isolated in an excellent yield of 94% with a 
high level of enantioselectivity (87% ee, entry 3).  
   
Figure 18. Structures of chiral rhodium catalysts used. 
Encouraged by the satisfying performance of Rh2(S-PTAD)4, further screening of the reaction 
conditions was conducted in collaboration with Jiantao Fu, a member of the research group of 
Professor Huw M. L. Davies at the Emory University in Atlanta. For this purpose, trichloroethyl 





Table 16. Screening of reaction conditions for the enantioselective cyclopropanation of pyrone 
1. 
 
entry[a] starting material equiv 379 T yield [%] ee [%][b] 
1 X = O 0.5 rt 33 90 
2 X = O 0.5 40 °C 60 86 
3 X = O 2.0 rt 98 90 
4 X = O 2.0 0 °C 98 93 
5 X = NTs 2.0 0 °C 99 95 
[a] conditions: to a solution of pyrone 1 or pyridinone 378 (0.5 mmol, 1.0 equiv) and Rh2(S-PTAD)4 (0.5 mol%) 
in DCM (0.5 M) was added dropwise a solution of 379 in DCM (1.1 M) over 1.5 h at the indicated temperature; 
[b] determined by chiral HPLC analysis of the isolated product. 
Using a twofold excess of pyrone 1, like it is reported for chiral cyclopropanations of furans 
and pyrroles193,194, gave cycloproduct 380a in poor yield of 33% but with excellent ee of 90% 
(Table 16, entry 1). Under reflux conditions (40 °C) the yield could be increased to 60%, 
however, a marginally decrease in enantioselectivity (86% ee) was observed (entry 2). A much 
better result was obtained, when diazoacetate 379 was added in excess (entry 3 and 4). Reaction 
at room temperature furnished 380a in almost quantitative yield (98%) with an excellent ee of 
90% (Table 16, entry 3). Enantioselectivity could be even slightly increased (93% ee) by 
performing the reaction at 0 °C (entry 4). Notably, lowering the catalyst loading to 0.5 mol% is 
still sufficient to achieve chiral functionalization with great results. In addition, pyridinone 378 
was cyclopropanated under the same conditions in almost quantitative yield of 99% and with 
excellent enantiomeric excess of 95% (entry 5). With optimized conditions in hand, the scope 
of pyrones 381, pyridinones 382 and aryl diazoacetates 383 is currently investigated in 






Scheme 95. Planned scope of enantioselective cyclopropanation of pyrones 381, pyridinones 
382 and diazoacetates 383. 
Besides donor/acceptor-carbenes, acceptor-diazoacetate 385 should also be employed for a 
cyclopropanation of pyrone 1 (Table 17). Routinely, reactions of acceptor-only carbenes under 
dirhodium tetracarboxylate catalysis give poor results in terms of selectivity and 
reactivity.193,202 Hence, metal carbenoids derived from copper salts or copper(I)-bis(oxazoline) 
complexes are used for cyclopropanation reactions.196,203  
Table 17. Attempts towards cyclopropanation of pyrone 1 with diazoacetate 385. 
 
entry[a] Cu catalyst ligand yield [%] 
1 Cu(OTf)2 - --- 
2 Cu(OTf)2 i-Pr-Box --- 
3 Cu(acac)2 - --- 
4 Cu(acac)2 i-Pr-Box --- 
[a] conditions: pyrone 1 (1.00 mmol, 1.0 equiv), catalyst (10.0 mol%), ligand (20.0 mol%), 
PhNHNH2 (10.0 mol%), diazoacetate 385 (3.0 equiv). 
Disappointingly, under several conditions tested, no conversion of pyrone 1 was observed and 
only dimers of diazoacetate 385 were obtained (Table 17, entry 1-4). Upon addition of i-Pr-
bis(oxazoline) ligand, usually increasing the reactivity of copper carbenoids, also only 
dimerization was observed in both cases (entry 2 and 4). The inefficient reactivity of 1 with 
these types of electrophilic carbenoids in contrast to heterocycles like furan and pyrrole could 
be attributed to the less electron-rich character of pyrone heterocycles, thus creating an 





diazoacetate 385 were unsuccessful, the focus was then turned to the follow-up transformations 
of cyclopropanated pyrone 377a. 
2.4.2 Follow-up transformations of cyclopropanated pyrone 
As already mentioned in the previous chapter (B.2.4.1), cyclopropanated 2-pyrone 377a 
contains an α,β-unsaturated lactone moiety clearly offering the possibility for further 
stereoselective transformations. The same structural motif can be found in 5,6-dihydro pyrones 
387 displaying versatile reactivities in synthetic organic chemistry, e.g. in cycloadditions204, 
1,4-additions118,205, Baylis-Hillman reactions206, and hence, presenting a powerful tool for 
building up molecular complexity (Figure 19).  
 
Figure 19. Reactivity of 5,6-dihydro 2-pyrones 387.207,208,209 
Lately, the research of our working group was focused on the stereoselective synthesis of 
6-membered heterocycles by endocyclic ring-opening of cyclopropanated pyrones and furans, 
which is much more challenging than the well-known exocyclic ring-opening reaction.210 
Besides selective cleavage of the non-activated endocyclic C-C bond through palladium-
catalyzed Heck coupling211, introduction of a good leaving group (e.g. OMs) next to the 
cyclopropane moiety provided these valuable products after trapping of the resulting cation 
with a nucleophile (Scheme 96).c  
 







Scheme 96. Endocyclic ring expansion of cyclopropanated heterocycles by introduction of a 
leaving group.  
Inspired by this work, the question arose whether an endocyclic ring expansion of 
cyclopropanated pyrone 377a could enable access to 7-membered heterocycles, whose selective 
construction is still an important and challenging task in organic synthesis.212 Therefore, the 
aforementioned reactivity of unsaturated lactones in Baylis-Hillman reactions should be 
utilized for the in situ introduction of a leaving group next to the cyclopropane ring. Generally, 
Baylis-Hillman reactions proceed via 1,4-addition of a Lewis base (LB) forming enolate 392. 
Consequently, an aldol reaction gives rise to intermediate 393 and after proton abstraction, 
which is the rate-determining step (rds), product 395 is formed and the Lewis base catalyst is 
recovered (Scheme 97).  
 
Scheme 97. General mechanism of a Baylis-Hillman reaction. 
Following this mechanism, it was envisioned that 1,4-addition of a Lewis base could lead to in 
situ introduction of a valuable leaving group next to the cyclopropane moiety of unsaturated 
lactone 377a. Hence, after endocyclic ring-opening, the corresponding cation 397 could be 
trapped by a nucleophile accessing 7-membered ring systems 398 (Scheme 98). 
 





Lewis base-catalyzed ring-opening of cyclopropanes via Michael-addition has already been 
applied by Zhang et al. for the construction of 2,3-dihydrofurans 401 (Scheme 99).213 Herein, 
DABCO provides both the electron source as well as the electron sink. 
 
Scheme 99. Synthesis of 2,3-dihydrofurans 401 by Lewis-base-catalyzed ring-opening.213  
In a first experiment, the reaction was performed using DABCO as Lewis base and a polar 
protic solvent (MeOH) to stabilize anionic intermediates by H-bond interactions and 
simultaneously acting as the nucleophile (Table 18, entry 1).  
Table 18. Attempts to a Lewis base mediated endocyclic ring-opening of 377a.  
 
entry[a] Lewis base electrophile T t [h] yield [%] 
1 DABCO - rt to 80 °C 48 decomposition 
2 Bu3P - rt 24 decomposition 
3 DABCO benzaldehyde rt to 80 °C 48 decomposition 
4 Bu3P benzaldehyde rt 24 traces, decomposition 
[a] conditions: cyclopropanated pyrone 377a (1.00 mmol, 1.0 equiv), Lewis base (40 mol%), 
electrophile (1.5 equiv) in MeOH (0.2 M).  
However, when running the reaction at room temperature, no conversion of the starting material 
377a was observed. Hence, the reaction temperature was increased to 80 °C, but under reflux 
condition the starting material 377a decomposed (Table 18, entry 1). The same trend was 
observable for tributylphosphine as Lewis base (entry 2). In order to stabilize the potential 
enolate intermediate 396 by an aldol reaction, benzaldehyde was added as an electrophile in 
further reactions (Table 18, entry 3 and 4). Again, no starting material 377a was converted at 
room temperature using DABCO and upon heating decomposition was observed (entry 3). In 





with cyclopropanated pyrone 377a (entry 4). Mass spectrometry of the crude product revealed 
some formation of 402 besides mainly decomposition, but the ring expansion product 402 could 
not be isolated after column chromatography. 
A further attempt to achieve Lewis base mediated ring-expansion was conducted by adding 
trimethylsilyl azide to trap the possible enolate intermediate 396 as silyl ether. Additionally, 
azide should act as the nucleophile. Unfortunately, decomposition of 377a was also observed 
in this case (Scheme 100).  
 
Scheme 100. Investigation of the ring expansion of 377a by addition of TMSN3. 
This led to the decision to pursue a different strategy for the ring-opening of bicyclic lactone 
377a. A variety of reaction conditions have been developed for the epoxidation of unsaturated 
δ-lactone systems. After epoxidation of cyclopropanated pyrone 377a, the corresponding 
epoxide 404 should be investigated in a Brønsted- or Lewis acid-catalyzed ring-extension via 
cationic intermediate 405. (Scheme 101). This concept was already successfully applied to 
cyclopropanated piperidine substrates in our research group.d  
 
Scheme 101. Envisioned strategy for a ring-opening of pyrone 377a by epoxidation. 
In the following, cyclopropanated substrate 377a was investigated in different epoxidation 
reactions (Table 19).  
  
 






Table 19. Investigation of the epoxidation of cyclopropanated pyrone 377a. 
 
entry reagent solvent T t [h] yield [%] 
1 H2O2/NaOH DCM/MeOH rt 24 decomposition 
2 DMDO acetone/H2O 0 °C to 80 °C 72 --- 




DCM rt to 40 °C 24 --- 
5 t-BuOOH, DBU DCM rt 24 decomposition 
 
Due to the electron-deficient character of the targeted double bond in 377a, a nucleophilic 
epoxidation as for the synthesis of 2-pyrones was performed at first (Table 19, entry 1). Under 
basic reaction conditions, starting material 377a completely decomposed, which could be 
rationalized by a lactone opening leading to further unselective reactions. Consequently, rather 
neutral conditions were tested (entry 2-4). However, the electrophilic epoxidation reagents 
DMDO and mCPBA did not convert 377a even under reflux conditions (entry 2-4). 
DBU-catalyzed conjugated addition of tert-butyl-hydroperoxide, specifically developed for the 
epoxidation of base sensitive α,β-unsaturated lactones by Kapoor and co-workers209, again 
showed decomposition of cyclopropanated pyrone 377a. Like reported for other base sensitive 
lactones, the electron-withdrawing cyclopropane ring seems to facilitate opening of the lactone 
ring thus prevent selective epoxide formation.208,209  
The unsuccessful epoxidation of pyrone 377a ultimately led to the end of the endocyclic ring-
opening efforts. Nevertheless, the previously observed tendency of cyclopropanated pyrone 
377a to undergo easily lactone opening should be exploited for another kind of transformation. 
The presence of a vinylcyclopropane moiety in cyclopropanated pyrone 377a provides further 
opportunities for its application as chiral building blocks. Vinylcyclopropanes can undergo 
several rearrangements that have been used for the synthesis of valuable complex 





derivatives has been studied in detail.215,216 For instance, Davies et al. showed Et2AlCl catalyzed 
1,3-sigmatropic rearrangement of vinylcyclopropane 407 exhibiting excellent stereoselectivity 
(Scheme 102).  
 
Scheme 102. Et2AlCl catalyzed 1,3-sigmatropic rearrangement of vinylcyclopropane 407.
216 
Applying this reaction pattern on cyclopropanated pyrone 377a, may give rise to derivatives of 
hydroxymethyl cyclopentenol 409 with high stereocontrol. This important substrate and the 
corresponding dihydroxymethyl derivatives have found application in the synthesis of valuable 
natural occurring substances and drugs, e.g. entecavir (410), hexacyclinol or (+)-ophiobolin 
A.217,218 Entecavir (410) is a nucleoside analog and has been approved by the U.S. FDA for the 
treatment of hepatitis B virus (HBV) infected patients, thus being listed on WHO’s list of 
essential medicines. It was first discovered and synthesized by chemists from Bristol-Myers 
Squibb starting from enantiomerical pure (1S,2R)-2-(hydroxymethyl)cyclopent-3-en-1-ol (409) 
(Scheme 103). 
 
Scheme 103. Synthesis of entecavir (410) according to Bristol-Myers Squibb.217 
Lactone opening of cyclopropanated pyrone 377a should provide an acyclic vinylcyclopropane 
undergoing a further sigmatropic rearrangement towards cyclopentenol derivative 411. 
Moreover, ring-opening by applying reductive conditions could lead to the simultaneous 
formation of a hydroxymethyl substituent next to the secondary alcohol. Therefore, DIBAL-H 






Scheme 104. Synthesis of cyclopentenol 411 by reductive ring-opening/rearrangement of 377a. 
Pleasingly, first attempts under reductive conditions furnished cyclopentenol derivative 411 in 
63% yield. Further optimization of the aforementioned reaction remains to be determined. 
Therefore, increasing the amount of DIBAL-H or varying the reduction agent seems to be a 
promising starting point since a not complete reduced aldehyde derivative of 411 was observed 
as a side-product. Noteworthy, the reductive ring-opening/rearrangement of 377a proceeded 
with excellent stereoselectivity and only one diastereomer of 411 was obtained. On closer 
consideration of the mechanism (Scheme 105), the excellent stereocontrol can be explained by 
the suprafacial 1,3-sigmatropic rearrangement of intermediate 412 leading to a retention of the 
configuration.216  
 
Scheme 105. Proposed mechanism for the ring-opening/rearrangement of 377a. 
Starting from enantiopure cyclopropanated pyrone 377a this process enables access to chiral 
hydroxymethyl cyclopentenol derivatives 411 being a valuable precursor for the synthesis of 
highly biologically active products like entecavir derivatives. Additionally, the same 
transformation of cyclopropanated pyridinone 377b could give rise to chiral derivatives of 
hydroxymethyl cyclopentene amines 414 which have been proved as important intermediates 
in organic synthesis (Figure 20).219,220 Reaction optimization, scope investigation and 







Figure 20. Selected samples of valuable products derived from hydroxymethyl cyclopentene 
amine 414.219,220 
In conclusion, 2-pyrone (1) and pyridinone 378 were successfully functionalized by transition 
metal-catalyzed cyclopropanation using donor/acceptor-carbenoids. Moreover, catalyst 
screening revealed that chiral Rh2(S-PTAD)4 proved to be an efficient catalyst giving rise to 
cyclopropanated pyrone 380a and pyridinone 380b in excellent yields and enantiomeric excess. 
The scope of substrates and diazoacetates is currently investigated by Jiantao Fu, a member of 
the research group of Professor Huw Davies in Atlanta. Unfortunately, attempts to use acceptor-
carbenoids were unsuccessful. The following endocyclic ring expansion of cyclopropanated 
pyrone 377a to 7-membered heterocycles failed under applied strategies. In contrast, the 
development of a reductive lactone ring-opening/rearrangement strategy enabled access to a 
cyclopentenol derivative 411 that could find application in the synthesis of precious compounds 
like, e.g., entecavir derivatives. Further investigations on this project and additional follow-up 







3 Atypical reactivity of anthracene derivativese 
3.1 Diels-Alder reaction with atypical regioselectivity 
3.1.1 Diels-Alder reaction of anthracene derivatives 
The [4+2]-cycloaddition of a conjugated diene with 4 π-electrons and a dienophile (an alkene 
or alkyne) with 2 π-electrons – commonly known as the Diels-Alder reaction – is one of the 
most emblematic pericyclic reactions. It is deservedly celebrated due to its synthetic reliability 
and atom-economic approach for the facile construction of complex 6-membered ring systems 
in a regio- and stereoselective fashion. Being an easily available conjugated π-electron-rich 
carbocyclic system, anthracene (419a) has been widely exploited as a classic diene for 
Diels-Alder reactions wherein its chemical reactivity and transformational effectiveness are 
subsidized by the partial loss of aromaticity. Extensive synthetic and mechanistic studies reveal 
that the natural preference for [4+2]-cycloadditions of unsubstituted anthracene (419a) is at its 
9,10-positions (red, Figure 21).221 The selectivity is governed by thermodynamic factors given 
that the twofold stabilization energy of benzene (2 × 35 = 70 kcal/mol) is greater compared to 
that of the naphthalene moiety (50 kcal/mol) as well as kinetic factors for having the largest 
frontier molecular orbital coefficients at the 9,10-positions (red sphere, Figure 21) in the 
Highest Occupied Molecular Orbitals (HOMO) of 419a (Figure 21).222  
 
Figure 21. Inherent reactivity mode of anthracene (419a) with dienophiles.222 
Considering the significance of the transformation, tuning the regioselectivity of the Diels-
Alder reaction of anthracenes is an attractive problem. However, until today, only very few 
approaches have been successful to indirectly circumvent the inherent 9,10-preference of 
anthracenes in [4+2]-cycloaddition reactions and almost all of these studies relied on 
premeditated engagement of the 9,10-positions either sterically or electronically. Installation of 
 
e This chapter includes parts from a manuscript which has been prepared in collaboration with V. Ngoc, A. 
Bhattacharyya, P. Kreimeier, P. Sarkrausky, J. Rehbein and O. Reiser. Experimental results obtained from the 





voluminous and/or electron-withdrawing substituents at the 9- and 10-positions indirectly 
deactivates the central B-ring for steric and electronic reasons, thereby allowing the formation 
of the corresponding cycloadducts with the terminal A-ring (Figure 22).  
 
Figure 22. Previous approaches for 1,4-selective [4+2]-cycloadditions by electronic and steric 
maneuvers at the 9,10-positions.223–228 
For example, 9,10-dicyanoanthracene in the reaction with benzyne furnishes a 1:1 mixture of 
the corresponding 1,4- and 9,10- adducts, albeit only in low yield (8%).223 Moreover, in the 
total synthesis of molecular gyroscopes with triptycyl frames, Garcia-Garibay et al. observed 
the formation of 1,4-cycloadducts as byproducts (maximal ratio 9,10/1,4 = 1:1) during the 
Diels-Alder reaction of anthracenes bearing alkyne groups in 9-position with benzynes.224 
Likewise, sterically more demanding 9,10-diphenyl- or 9,10-diferrocenyl-substituted 
anthracenes were found to yield exclusively the corresponding A-ring adducts with DMAD in 
50% and 38% yield, respectively.225,226 More recently, a 1,4-selective cycloaddition with 
sterically bulky N-2,6-difluorophenylmaleimide227 or with N-substituted maleimides activated 
by superstoichiometric amounts of AlCl3
228 was reported with anthracene derivatives. 
However, yet again blocking of both, the 9- and / or the 10-position by ester, halide and/or 
phenyl groups was necessary.  
The only example so far that is reported to be exclusively 1,4-selective with an anthracene 
moiety unsubstituted at the 9,10-positions is the reaction between anthracene (419a) itself and 
N-cyclohexylmaleimide confined as an inclusion complex of a supramolecular octahedral 
organopalladium host.229 It was assumed that the unusual regioselectivity stemmed from an 
external topochemical control by the way the substrate bind to the host which made it 






Figure 23. 1,4-Selective [4+2]-cycloaddition of anthracene (419a) by external topochemical 
control.229 
More recently, an anthracene derivative with fused carbocyclic moieties in 2,3- and 6,7-
positions was found to undergo a cycloaddition at both 9,10- and 1,4-positions 
(ratio 9,10/1,4 = 1:2) with 4,5-dimethoxybenzyne in 33% yield.230 The unusual reactivity was 
explained by electronic activation of the outer rings that outweighs the steric hindrance.  
Motivated by this literature void, the question was asked whether the A-ring of the anthracene 
could be sufficiently electronically enriched by placing donor substituents on it so that 
corresponding 1,4-cycloadducts would directly form with electron-deficient dienophiles 
without the necessity of blocking the 9,10-positions (Figure 24).  
 
Figure 24. Direct electronic activation of the A-ring with unblocked 9,10-sites. 
In order to assess the validity of the hypothesis, 1,5-disubstituted anthracenes 419b-d were 
synthesized from readily available anthraquinones 426-428 (Scheme 106)231,232 and employed 






Scheme 106. Synthesis of 1,5-disubstituted anthracenes 419b-d.231,232 
A range of electron-deficient alkene dienophiles such as dimethyl fumarate (A), maleic 






Table 20. Diels-Alder reactions of disubstituted anthracenes 419b-d and dienophiles A-C. 
 






















[a] conditions: anthracene (419b-d, 1.0 equiv) and dienophile (A-C, 1.1 equiv) in toluene (0.5 M) in a sealed tube 
at 150 °C (for details on reaction times see experimental part); [b] isolated yield.  
However, only the formation of 9,10-cycloadducts 430A-C was observed in 68-99% yield 
(Table 20), even in the case of substrates 419c (entry 2, 5 and 8) and 419d (entry 3, 6 and 9) 
with increased π-electron density. Notably, the reaction of dimethoxy anthracene 419b and 
dimethyl fumarate (A) furnished selectively the syn-cycloadduct 430bA (Table 20, entry 1), 
because steric effects are negligible for 419b and the electronic secondary orbital interactions 
predominate in every reaction. Next, the attention was turned to evaluate alkyne dienophiles 
(Table 21) such as dimethylacetylene dicarboxylate (DMAD, D)233 which are also known for 





Table 21. Diels-Alder between 1,5-disubstituted anthracenes 419a-d and alkynes D-F. 
 
entry[a] R1 dienophile product[b] 430 : 431[c] 
1233 H 
  




















>99 : 1 
[a] conditions: anthracene (419a-d, 1.0 equiv) and dienophile (D-E, 1.1 equiv; F 5.0 equiv) in toluene (0.5 M) in 
a sealed tube at 150 °C (for details on reaction times see experimental part); [b] isolated yield; [c] determined by 
1H NMR. 
When 419b was reacted with D under thermal reaction conditions, the first indication of the 





cycloadduct 431bD formed alongside the formation of the usual 9,10-cycloadduct 430bD 
(73%, Table 21, entry 2). Subsequently, when dimethylamino-group bearing 1,5-disubstituted 
anthracene 419c was subjected to the [4+2]-cycloaddition with DMAD (D), the corresponding 
1,4-cycloadduct 431cD turned out to be the major product (58% yield) dominating over the 
usual 9,10-cycloadduct 430cD which was obtained in only 20% yield (Table 21, entry 3). 
Inspired by the observation that the donor strength of the substitutions on the A-ring indeed 
affected the regioselectivity of [4+2]-cycloaddition reactions of anthracene derivatives, the 
dipyrrolidino 1,5-disubstituted anthracene 419d was next investigated, following the lead of 
Zipse et al.235 who demonstrated that a pyrrolidine substituted pyridine is more nucleophilic 
than dimethylaminopyridine (DMAP). When 419d was engaged in the thermal 
[4+2]-cycloaddition with D, gratifyingly, the reaction yielded the 1,4-adduct 431dD exclusively 
in 78% yield (Table 21, entry 4), representing the first example for a 1,4-selective 
[4+2]-cycloaddition of an anthracene derivative in which the 9,10-positions are not blocked 
with substituents or shielded by any other means. Interestingly, when methyl propiolate (E) 
bearing a single ester group on the alkyne functionality was employed as the dienophile and 
reacted with 419d, a drop in regioselectivity was observed and the corresponding 
1,4-cycloadduct 431dE as a single isomer was obtained in 56% yield along with the formation 
of the corresponding 9,10-cycloadduct 430dE in 14 % yield (entry 5). The regioselectivity was 
again found to be entirely reversed when methyl phenylpropiolate (F) was reacted with 419d 
and the 9,10-cycloadduct 430dF formed exclusively, albeit with poor yield even after 72 h 
(23%, Table 21, entry 6). 
After establishing a definite relationship between the donor strength of the substituents at the 
1,5-positions and the regioselective outcomes of the [4+2]-cycloadditions of anthracenes with 
alkene and alkyne dienophiles, the extent of the electron-donating effect on the regioselectivity 
of the transformations should be investigated next. Accordingly, monosubstituted pyrrolidino 
anthracene derivative 419e was synthesized (Scheme 107).236  
 
Scheme 107. Synthesis of 1-pyrrolidine anthracene (419e).236 
The monosubstituted anthracene derivative 419e was also investigated in a series of 





Table 22. Diels-Alder reaction of pyrrolidine anthracene 419e and dienophiles A-G. 
 


































[a] conditions: anthracene (419e, 1.0 equiv) and dienophile (A-E, 1.1 equiv; F-G 5.0 equiv) in toluene (0.5 M) in 
a sealed tube at 150 °C (for details on reaction times see experimental part); [b] isolated yield; [c] determined by 
1H NMR; [d] conditions: anthracene (419e, 1.0 equiv), dienophile (C, 1.1 equiv) and AlCl3 (3.0 equiv) in CHCl3 
(0.08 M) in a sealed tube at room temperature for 3 h. 
Analogous to the disubstituted anthracenes 419b-d, when 419e was employed in the thermal 
[4+2]-cycloaddition with alkene dienophiles A-C, the respective 9,10-cycloadducts 430eA-C 
exclusively formed in every case in 95-99% yields (Table 22, entry 1-3). On the contrary, 
activation of dienophile C by a Lewis acid (AlCl3) furnished Friedel-Crafts type product 434 
exclusively in para-position of the pyrrolidine substituent (62%, Table 22, entry 4). The 
reaction seems to take place through a Michael-addition in the first step. Subsequent 
rearomatization of the zwitterionic intermediate by proton abstraction proceeds faster than ring 
closure to the corresponding cycloadduct. Satisfyingly, when DMAD (D) was used as 
dienophile, the selective formation of the 1,4-cycloadduct 431eD was observed in excellent 
yield (90%, entry 5). Likewise, methyl propiolate (E) yielded preferentially the corresponding 
1,4-cycloadduct 431eE as a single regioisomer in 72% yield along with the formation of the 
corresponding 9,10-cycloadducts 430eE as a syn/anti (syn/anti = 55:45) isomeric mixture 
(25%, entry 6). In contrast, methyl phenylpropiolate (F) did not undergo any cycloaddition 
reaction with 419e (entry 7). The reaction of 419e with in situ prepared benzyne (G), a reagent 
that has been studied in 1,4-cycloadditions with anthracene derivatives223,224,230, led only to 
decomposition of the starting material (Table 22, entry 8). The structure of 1,4-cycloadduct 
431eD was unambiguously assigned by NMR spectroscopy and was confirmed by 
single-crystal X-ray diffraction analysis (Figure 25). It is noteworthy to mention that all 1,4- 
and 9,10-cycloadducts were examined at high-temperature conditions (reflux, 24 h, 160 °C), 






Figure 25. Crystal structure of 431eD (50% thermal probability). 
3.1.2 Computational studies 
With a view to completely comprehending the atypical regioselectivity demonstrated by the 
anthracenes 419b-e in aforementioned [4+2]-cycloadditions with alkyne dienophiles D-E, 
extensive theoretical calculations were performed in cooperation with Prof. J. Rehbein. The 
theoretical calculations were conducted by Patrick Sakrausky (Ph.D. student of AK Rehbein). 
The fundamental question arose, what governs the 9,10- vs. 1,4-selectivity in the reaction of 
the various dienophile and anthracene combinations. The two dienophiles maleic anhydride (B) 
and DMAD (D) were picked as they show a stark contrast in their position-selectivity in the 
reaction with the dienes 419a-e. Whereas D followed a smooth trend from 9,10- to 
1,4-selectivity with the variation of the electronics of the dienes, B apparently was insensitive 
to this and showed expected 9,10-selectivity only.  
The analyses went beyond the simple comparison of calculated activation barriers (ΔG≠) and 
driving forces (ΔRG) to achieve a fundamental understanding of the variation in product 
selectivities. On the same note, the concepts by Fukui (frontier molecular orbital analysis, 
FMO) and Bell-Evans-Polanyi (BEP) that are commonly used to predict relative reactivities, 
i.e. selectivities in Diels-Alder reactions, were re-evaluated in their applicability for the 
observed peculiar position-selectivities. 
A judgment about the minimum energy pathway (MEP, concerted vs. stepwise) was based on 
the intrinsic reaction coordinate (IRC) calculations and analysis of the root mean square (RMS) 
gradient. In a subsequent step, Marcus theory was employed to differentiate the kinetic 
(intrinsic barrier) and thermodynamic contributions to the overall activation barrier (ΔG≠). To 
understand why the intrinsic barriers of the (first) σ-bond formation govern the product ratios, 
the electronics of the starting materials and transition state structures were analyzed by natural 
bond orbital (NBO) analysis. The calculations have been run with the Gaussian09.E01 suite of 
programs using the B3LYP-D3/6-31G** level of theory. For further details and citations see 





The combination of dienophile DMAD (D) with five different anthracenes (419a-e, R = H, 
OMe, NMe2, bis-pyrrolidine, mono-pyrrolidine) was used to establish the choice of the level of 
theory (LOT). The calculated activation barriers reproduced the experimentally observed trend 
of 9,10- to 1,4-cycloaddition selectivity as a function of the electron donor substituent (EDG) 
at the diene (Table 23). Therefore, this LOT was used for a more detailed analysis. 
Table 23. Summary of calculated vs experimental selectivities of the reaction between 





9,10 : 1,4 
experimental selectivity 
9,10 : 1,4 
419a (R = H) ‒6.2 9,10 only >99 : 1 
419b (R = OMe) ‒1.4 10 : 1 9 : 1 
419c (R = NMe2) 0 1 : 1 1 : 2.5 
419d (R = bis-
(N(CH2)4) 
1.5 1 : 13 1 : >99 
419e (R = mono-
(N(CH2)4) 
6 quant. 1,4  1 : >99 
 
To determine the extent of concertedness, the transition state (TS) structures were analyzed 
with respect to the extent of bond reorganization (Figure 26) and most importantly the minimum 
energy pathway (MEP) of the respective transformations were scanned by IRC calculations and 
the RMS gradient was analyzed (for details see IRC plots in experimental part E5.6 and E5.7).  
  
Figure 26. Bond orders (BOs) according to Pauling characterizing the mechanisms in the 





Interestingly, in the cycloaddition of D even with the parent anthracene (419a) the TS structures 
of the 9,10-additions, as well as the 1,4-addition, are asynchronous, with the 1,4-addition 
slightly more so (Figure 26A). This is contrary to the TS structures with maleic anhydride 
(B, Figure 26B) that remained insensitive to changes in the electronics for the 9,10-additions 
and only showed asynchronicity for the 1,4-additions process. Adding electron donor groups 
(EDGs) in 1-and/or 5-position of the anthracenes a trend towards higher asynchronicity is 
consistently observed for reactions with D. Based on the analysis of the RMS gradient along 
with the calculated IRC a stepwise mechanism was identified to be in operation for the 
1,4-additions of D with 419d and B with 419b-d. And for the 9,10-addition in case of D with 
419d (for details see IRC plots in experimental part E5.6 and E5.7). With the help of this energy 
and force related differentiation of concerted vs. two-step mechanism in the reactions of D also 
a geometric parameter of the transition state structures was defined as an indicator for a change 
in mechanism: A difference in bond orders (ΔBO237) of the two-forming σ-bonds of ΔBO ≥ 
0.63 is characteristic for the stepwise pathway. 
Based on the MEP-analysis the comparison of the Gibbs free activation barriers of the 9,10- vs. 
1,4-addition were conducted with respect to either the concerted pathways or the first σ-bond 
formation step that is occurring. In case of the addition reaction with D, the 1,4-addition is 
consistently facilitated by increasingly electron-donating substituents, whereas the 
9,10-addition barrier is significantly less sensitive to changes in the diene electronic (Table 24) 
and in addition, shows no consistent correlation.  
Table 24. Thermodynamic data for the reaction of anthracenes 419a-e with DMAD D. 
anthracene 
9,10-addition 1,4-addition 
ΔG≠[a] ΔH≠[a]  ΔRG
[a] ΔRH
[a] ΔG≠[a] ΔH≠[a] ΔRG
[a] ΔRH
[a] 
419a 25.7 13.5 ‒24.6 ‒39.6 31.9 19.5 ‒12.4 ‒27.2 
419b 26.7 13.6 ‒22.7 ‒38.0 28.1 14.3 ‒6.9 ‒22.7 
419c 25.0 11.9 ‒25.6 ‒41.4 25.0 10.2 ‒5.1 ‒21.7 
419d 24.4 8.2 ‒26.8 ‒42.9 21.6 5.4 ‒5.0 ‒21.0 
419e[b] 29.1 14.8 ‒24.8 ‒40.9 23.1 7.0 ‒19.7 ‒2.3 
[a] values in [kcal/mol], [b] values in [kcal/mol] for 5,8-addition: ΔG≠ = 36.1 ; ΔH≠ = 22.0 ; ΔRG = −10.8 ; ΔRH = 






The relative thermodynamic contributions (ΔRG) to the activation barrier of the reaction with 
D based on the Marcus analysis238 do not explain the observed product selectivities. On the 
contrary, the 1,4-addition product is thermodynamically significantly less stable than the 
9,10-addition product and moreover, the driving force for the 1,4-product formation decreases 
with increasing strength of the electron donor (EDG, see Figure 27, Table 25).  
 
Figure 27. Summary of the experimental results and their computational rational based on 
FMO-analysis, activation barriers, mechanism (concerted vs. stepwise) and thermodynamics.  
Clearly, there is no linear free energy relationship in operation. In addition, analysis of intrinsic 
activation barriers ΔG≠° according to Marcus confirmed this conclusion: the observed product 


















∆G≠ representing the activation barrier, ∆G≠° representing the intrinsic barrier and ∆RG 








419a 25.7 ‒24.6 37.0 31.9 ‒12.4 37.9 
419b 26.7 ‒22.7 37.2 28.1 ‒6.9 31.5 
419c 25.0 ‒25.6 35.7 25.0 ‒5.1 27.5 
419d 23.1 ‒26.8 36.6 21.6 ‒5.0 24.0 
419e[b] 29.1 ‒24.8 40.6 23.1 ‒2.3 24.2 
[a]values in [kcal/mol]; [b] values in [kcal/mol] for 5,8 position: ΔG≠5,8 = 36.1 ;  ΔRG5,8 = ‒10.8, ΔG≠°5,8 = 41.3; 
for details on calculations of intrinsic barriers for maleic anhydride (B) see Table S11 + S12 in the experimental 
part (E5.3). 
Kinetic control of the product formation may be rationalized by a maximal orbital overlap in 
the rate-determining step. Therefore, the analysis was focused on the understanding of how the 
amino substituents change the electronic (FMO) and nuclear structure of the transition states 
(TSs) and the dienes in favor of the 1,4-addition process. This analysis is based on the frontier 
molecular orbitals (FMOs), and the natural bond orbital (NBO) analysis (partial charges). 
Although the 1,4-addition pathway is shifting from a concerted to a stepwise bond 
reorganization in the series of 419a to 419d the FMO analysis of the anthracenes turned out to 
correctly predict the position selectivity in the reactions with D. The relative size of the orbital 
coefficients in the anthracenes provided a mean for a quick estimate where the first bonding 
interaction will take place (Figure 27). On the other hand, the HOMO-LUMO gap Δε of the 
reactants reflects the increased ease of the 1,4-addition in the series R = H to N(CH2)4 
surprisingly well (Table 26). Whereas, there is no correlation between the activation barriers of 
the 9,10-addition and Δε. This observation can be read in support of the results obtained by the 







Table 26. FMO analysis for anthracenes 419a-e and DMAD (D). 
anthracene 


















419b −4.82 3.33 −1.27 6.62 
419c −4.81 3.32 −1.40 6.49 
419d −4.37 2.88 −1.12 6.77 
419e −4.68 3.19 −1.38 6.51 
For details on FMO analysis for maleic anhydride (B) see Table S14 in the experimental part (E5.4). 
Since the bond reorganization is approaching the stepwise limit in the reaction of D and 419d-e 
charge separation and its stabilization by the substituents is deemed to be the second important 
player in the kinetically controlled Diels-Alder reaction in anthracene derivatives 419b-e. With 
an increasing asymmetry, one would expect a built-up of a partial positive charge at C1 and a 
partial negative charge at CA (see Figure 26 for nomenclature). Indeed, significant charge 
separation in the TS structures was confirmed by NBO analysis (Table 27). 
Table 27. Partial charges at the reaction centers for the reaction with DMAD (D). 
anthr. 
1,4-addition 9,10-addition 
CA CB C1 C4 CA CB C9 C10 
419a −0.023 −0.130 0.049 0.076 −0.132 −0.013 0.074 0.102 
419b −0.025 −0.153 0.410 0.005 −0.130 −0.022 0.083 0.119 
419c −0.060 −0.131 0.269 −0.012 −0.103 −0.052 0.077 0.091 
419d −0.058 −0.148 0.283 −0.022 −0.173 −0.047 0.019 0.125 
419e[a] −0.103 −0.138 0.282 −0.032 −0.123 −0.086 0.068 0.096 
[a]  Values for 5,8-addition: CA = −0.106, CB = −0.110, C5 = 0.074, C8 = 0.056; for details on NBO analysis for 
maleic anhydride (B) see Table S16 + S17 in the experimental part (E5.5). 
The comparison of the aforementioned parameters also provided a clue for the apparent 
insensitivity of maleic anhydride (B) to the electronic changes in 419a-e. The computed 





dienes, the 1,4-addition is still kinetically favored, but the transformation is thermodynamically 
inhibited (endergonic, Figure 28), Hence, the 9,10-adduct is predicted to be the only product 
being formed in case of B independent of the electronic situation in the diene (Figure 28, for 
more details see computational details experimental part E5). 
 
Figure 28. Summary of the experimental results and their computational rational based on 
FMO-analysis, activation barriers, mechanism (concerted vs. stepwise) and thermodynamics. 
3.2 Atypical regioselectivity in electrophilic aromatic substitution reactions 
The effect of the pronounced electronic perturbations exerted by the amine substitution in 1-
and/or 5-position favoring their terminal ring functionalization in Diels-Alder reaction with 
electron-deficient alkynes was also investigated for the reactions with various electrophiles. 
Analogous to the cycloaddition reactions, electrophilic aromatic substitution of anthracenes 
generally takes place in the central B ring as a consequence of maximizing the aromatic 
stabilization energies in the transition state and by harboring the largest orbital coefficients of 
the HOMO at the 9,10-positions.239 Therefore, mono-pyrrolidine substituted anthracene 419e 
was examined in a bromination reaction (Table 28) that is also reported to be 9,10-selective for 






Table 28. Investigation of the bromination of anthracene 419e. 
 









MeCN rt 1 14 4 
3 1.0 - DCM 0 °C 5 18 10 








DCM 0 °C 5 - 58 
[a] conditions: to anthracene 419e (1.0 equiv) dissolved in solvent (0.08 M) was added NBS. 
When 419e was reacted with NBS in a polar solvent, usually promoting bromination reactions, 
only decomposition was observed (Table 28, entry 1). It was demonstrated that the addition of 
NH4OAc had advantageous impacts in the bromination of phenol and aniline derivatives 
leading to excellent yields in short reaction times.241 Similar reaction conditions furnished 
ortho-brominated anthracene 435 together with ortho/para-brominated product 436 albeit in 
low yield (14% and 4%, entry 2). The same products were obtained in slightly increased yields 
(18% and 10%) when 419e was reacted with NBS in DCM at 0 °C (entry 3). Hence, in a further 
attempt, the synthesis of only ortho/para-product 436 should be achieved exclusively by adding 
more equivalents of NBS (entry 4). However, decomposition was also observed in this case. 
During NMR-analysis it was observed that brominated products 435 and 436 are sensitive to 
traces of acids and decomposition occurred in deuterated CHCl3. Therefore, NEt3 was added as 
an acid scavenger to the reaction mixture to prevent the decomposition of products by HBr and 
to facilitate deprotonation of the initially brominated intermediate. Indeed, yields of 435 and 
436 could be significantly improved to 30% and 41% respectively (entry 5). Moreover, by 





could be synthesized in 58% yield (entry 6). Satisfyingly, in every reaction no 9- and/or 
10-brominated product was observed indicating that the electronic perturbation also directs the 
selectivity of electrophilic aromatic substitutions towards the outer A-ring system.  
In addition to the bromination, 4-methyl-1,2,4-triazoline-3,5-dione (MTAD, 437) was 
employed in the reaction with 419e (Table 29). MTAD (437) has been reported to react with 
anthracene (419a) in the dark to produce the corresponding 9,10-cycloadduct within three 
minutes quantitatively, while under acid catalysis also the formation of a Friedel-Crafts type 
product in 9-position was observed.242  
Table 29. Reaction of anthracene 419e with MTAD (437). 
 
entry[a] equiv 437 hν  solvent T t [h] yield [%] 
1 1.0 dark CHCl3 rt 24 --- 
2 1.1 dark HFIP rt 2 polymerization 
3 0.5 530 nm acetone −78 °C 5 42% 
4 1.0 530 nm acetone −78 °C 5 34% 
5 3.0 530 nm acetone −78 °C 5 decomposition 
6[a] 0.5 530 nm acetone −78 °C 5 60 
[a] conditions: anthracene 419e (1.0 mmol, 1.0 equiv) was dissolved in solvent (0.2 M) and MTAD (437) was 
added; [b] NEt3 (4.0 equiv) was added to the reaction mixture. 
Under the same reaction conditions, no conversion of 419e was observed even after 24 h (Table 
29, entry 1). In 2017, Crousse et al. found that hexafluoro-2-propanol (HFIP) effectively 
promotes the para-selective C-H amination of various anilines with azodicarboxylate 
derivatives such as MTAD (437).243 However, the reaction of 419e and MTAD (437) in HFIP 
led to the formation of a polymeric product that was not dissolvable in any solvent (entry 2). 
Hence, the ability of MTAD (437) to undergo a [4+2]-cycloaddition with benzene and 





naphthalene derivatives, the activation of MTAD by irradiation with a green LED (λ = 530 nm) 
and subsequent reaction with 419e furnished a para-Friedel-Crafts type product 438 in 42% 
yield wherein again the terminal ring was functionalized exclusively (Table 29, entry 3). In 
order to improve the yield of 438 further reactions with increased amounts of MTAD (437) 
were conducted but in course of this the yield decreased (entry 4) or only decomposition was 
observed (entry 5). As in the bromination reactions, the product 438 was very sensitive towards 
acids. By addition of NEt3, the yield of 438 could be increased to 60% (Table 29, entry 6). 
Mechanistically, as observed in the Lewis acid-mediated reaction of anthracene 419e and 
N-phenylmaleimide (C, Table 22, entry 4), again a kind of Michael-addition to the electrophile 
437 leads to the formation of a zwitterionic intermediate that performs proton abstraction faster 
than the respective ring-closing furnishing a Friedel-Crafts type product 438. In conclusion, it 
was demonstrated that the selectivity of electrophilic aromatic substitution reactions switched 
from the inner ring system to the outer A-ring by installing electron donating-substituents in 
1-position enabling further interesting transformations in future work. 
3.3 Investigation of the photodimerization of pyrrolidine substituted anthracenes 
The photodimerization of anthracenes is one of the oldest known photochemical reactions and 
can be considered as a (4π + 4π)-photocycloaddition (Scheme 108). Generally, the dimerization 
of anthracene (419a) occurs across the 9,10-positions and the resulting photodimer 439 reverts 
to the monomers by photochemical (wavelengths <300 nm) or thermal dissociation. By 
irradiation, an anthracene molecule is excited to its singlet excited state 1419a* and combines 
with a nonexcited molecule to form an excimer [419a ∙ 419a]*. Excimer decay via 
cycloaddition affords the photodimer 439.245 Cross-dimerization of two different anthracene 
derivatives is only efficient, in case if one anthracene molecule can be excited separately at a 
distinguished wavelength, however, itself has to be inert towards homodimerization due to 
steric constraints for instance.246 
 
Scheme 108. Photodimerization of anthracene (419a). 
Although anthracenes are prone to dimerize across the 9,10-position, again guided by relative 
aromatic stabilization energies and orbital coefficients of the HOMO, a few dissymmetrical 





9,10/1,4-positions have been observed for 2,6-bis(didecyloxy)anthracene247, 
1-acetylanthracene and methyl anthracene-1-carboxylate248, but always as mixtures with the 
respective 9,10/9,10-dimers. 
As the computational studies revealed pyrrolidine anthracenes 419d and 419e harbor the largest 
orbital coefficients in the HOMO at the 4-positions and therefore, it was envisioned that these 
anthracene derivatives might undergo selective (4π + 4π)-photocycloaddition across the 
unusual 9,10/1,4-positions (product 440, Table 30) or even 1,4/1,4-positions (product 441, 
Table 30). Initially, the UV/Vis spectra of anthracene (419a) and pyrrolidine substituted 
derivatives 419d-e were measured to determine the appropriate wavelengths for their irradiation 
(Figure 29). Compared to anthracene (419a, blue) the absorption maxima of the pyrrolidine 
derivatives (419d, red and 419e, green) are significantly bathocromically shifted, ranging 
widely into the visible region of light. 
 
Figure 29. UV/Vis spectra of anthracene (419a, blue), 1,5-diyprrolidine anthracene (419d, red) 
and 1-pyrrolidine anthracene (419e, green). 
In the following, the pyrrolidine substituted derivatives were investigated in a series of 
photodimerization reactions using LEDs for irradiation at 403 nm or 455 nm wavelength, 






















Table 30. Investigation of the photodimerization of anthracene 419d and 419e. 
 
entry[a] anthracene additional reactant  hν [nm] yield [%] 
1 419d - 403 --- 
2 419d - 455 --- 
3 419d anthracene (419a) 403 --- 
4 419d anthracene (419a) 455 --- 
5 419e - 403 --- 
6 419e anthracene (419a) 403 --- 
[a] conditions: anthracene (419d-e, 1.0 equiv) and additional reactant (419a, 2.0 equiv) in degassed DCM 
(0.0125 M) were stirred under irradiation with a LED for 24 h at room temperature. 
The pyrrolidine anthracenes 419d-e showed no homodimerization by irradiation at the 
respective wavelengths (Table 30, entry 1,2 and 5) and the starting materials were completely 
recovered. Since no homodimerization was observed, the anthracene derivatives were also 
examined in a cross-dimerization reaction with anthracene (419a). However, again no 
conversion of the pyrrolidine anthracenes 419d (entry 4-5) and 419e (entry 6) was observed. 
Obviously, the (4π + 4π)-photocycloadditions of pyrrolidine substituted anthracenes 419d-e are 
prevented by steric repulsion. Therefore, no further attempts for photodimerizations of 419d 
and 419e were performed.  
To conclude a longstanding problem in controlling and accessing atypical regioselectivity in 
the Diels-Alder reaction of anthracenes has been addressed by a simple yet highly effective 
electronic manipulation of the terminal rings by installing substituents of varying electron-
donating abilities at the 1- or 1,5-positions. This synthetic approach obviates any premeditated 
engagement of the 9,10-positions with either any sterically bulky or electron-withdrawing 
substituents. Consequently, a functionally diverse range of 1,4-cycloadducts could be obtained 





observed in aromatic substitution reactions with various electrophiles. The computational 
studies revealed the origin of the atypical regioselectivity to be of kinetic nature, being reflected 
by the largest orbital coefficient in the HOMO at the 4-position imposed by the electron-
donating ability of the substituents in the terminal rings and the highly asynchronous transition 







The first chapter of the present thesis deals with the synthesis of 2-pyrones starting from 
renewable resources (Scheme 109). The synthetic sequences started from furfuryl alcohol (18) 
and its corresponding derivatives 314, which were readily available from inexpensive furfural 
(310) – a platform chemical that is derived from agricultural waste products. Initially, the big-
scale synthesis of unsubstituted 2-pyrone (1) was described. Key step was the development of 
a FVT setup that allowed to perform the thermal rearrangement of epoxide 313 on a multigram 
scale. Herein, 20 g (123 mmol) of epoxide 313 were converted to the desired pyrone 1. 
Similarly, a reaction sequence starting from furfuryl alcohol derivatives 314 furnished naturally 
occurring 6-substituted alkyl-pyrones 2. 
 
Scheme 109. Overview of the sustainable synthesis of 2-pyrones. 
The second chapter focused on further applications and functionalizations of the biobased 
2-pyrone derivatives. Utilizing 6-hydroxyalkyl-2-pyrones 26 that have also been obtained from 
furfuryl alcohol (18) in a previous work of Reiser et al.16, several 3,7-substituted phthalide 
derivatives 342 were synthesized by an intermolecular Diels-Alder reaction with diethyl 
acetylenedicarboxylate (341) (Scheme 110). Likewise, intramolecular [4+2]-cycloaddition 
yielded 3-substituted phthalides 326, including the anti-ischemic stroke drug n-butyl phthalide 
326b (Scheme 110). Moreover, starting from enantioenriched pyrones 26 the stereoselective 






Scheme 110. Synthesis of 3-substituted phthalides 342 and 326 by Diels-Alder reaction. 
In addition, the UV-mediated [4+2]-cycloaddition of 2-pyrone (1), an extremely rare example 
of a photocatalyzed [4+2]-cycloaddition in organic chemistry, was replaced by sustainable 
conditions using visible light-emitting diodes (Scheme 111). By employing the 
[Ir(dtb-bpy)(dF(CF3)ppy)2]PF6 energy transfer catalyst, two structural and stereochemical rich 
regioisomers 367a-b were obtained diastereoselectively in short reaction time and overall 
excellent yield. 
 
Scheme 111. Visible light mediated [4+2]-cycloaddition of 2-pyrone (1). 
Lastly, a transition metal-catalyzed cyclopropanation with donor-acceptor diazoacetate 376 
furnished cyclopropanated pyrone 377a and pyridinone 377b in regioselective and 
diastereoselective fashion. Furthermore, the functionalization of these substrates was achieved 
with high levels of enantioselectivity by applying a chiral rhodium-catalyst – usually 
representing a major challenge in pyrone chemistry (Scheme 112). The scope of further pyrone 
and pyridinone derivatives as well as diazoacetates is currently investigated as a part of the 
Ph.D. thesis of Jiantao Fu, a member of the research group of Professor Huw Davies in Atlanta. 
The high functional group density displayed in these products offers the opportunity for further 
stereoselective follow-up transformations to build-up molecular complexity in future work as 







Scheme 112. Cyclopropanation of pyrone 1 and pyridinone 378 and elaboration towards enol 
411. 
The last chapter was devoted to the atypical reactivity of anthracene derivatives 419b-e. The 
natural 9,10-preference of anthracenes in [4+2]-cycloaddition was successfully circumvented 
by simple yet effective installation of electron-donating substituents at the 1- or 1,5-positions. 
Consequently, a functionally diverse range of 1,4-cycloadducts 431 was obtained in up to 
excellent yields and regioselectivity without any premeditated blocking of the 9,10-positions 
(Scheme 113). However, employment of alkene dienophiles A-C yielded ordinary 9,10-
cycloadducts 430 exclusively (Scheme 113). In cooperation with the working group of Prof. J. 
Rehbein (University of Regensburg), extensive computational studies were conducted 
investigating the influence of substituents and dienophiles on the regioselectivity of the 
[4+2]-cycloaddition. These studies revealed the origin of the atypical selectivity to be of kinetic 
nature, being reflected by the largest orbital coefficient in the HOMO at the 4-position 
(blue sphere, Scheme 113) imposed by the electron-donating ability of the substituents in the 
terminal rings. Moreover, highly asynchronous transition states are leading to the products 431. 
In contrast, computed activation barriers and driving forces of the reaction with alkene 
dienophile B indicated that 1,4-addition is still kinetically favored, but the transformation is 






Scheme 113. Overview of the [4+2]-cycloaddition of anthracenes 419b-e with alkynes D-F and 
alkenes A-C. 
Additionally, electronic manipulation of a terminal ring by installation of a pyrrolidine group 
in 1-position allowed to override the inherent 9,10-preference in aromatic substitution reactions 
with various electrophiles, leading to the exclusive functionalization of the outer ring in all 
cases (Scheme 114).  
 







Das erste Kapitel der vorliegenden Arbeit beschäftigt sich mit der Synthese von 2-Pyronen 
ausgehend von erneuerbaren Rohstoffen (Abbildung 1). Die Synthesesequenzen gingen von 
Furfurylalkohol (18) und dessen Derivaten 314 aus, welche leicht aus kostengünstigem Furfural 
(310) erhältlich sind – einer Plattformchemikalie, die aus landwirtschaftlichen Abfallprodukten 
gewonnen wird. Zunächst wurde die Synthese von unsubstituiertem 2-Pyron (1) in großem 
Maßstab beschrieben. Der Schlüsselschritt war die Entwicklung eines FVT-Aufbaus, der es 
ermöglichte, die thermische Umlagerung von Epoxid 313 im Multigramm-Maßstab 
durchzuführen. Hierbei wurden 20 g (123 mmol) des Epoxids 313 in das gewünschte Pyron 1 
umgesetzt. In ähnlicher Weise lieferte eine Reaktionssequenz ausgehend von 
Furfurylalkoholderivaten 314 natürlich vorkommende 6-substituierte Alkylpyrone 2. 
 
Abbildung 1. Übersicht der nachhaltigen Synthese von 2-Pyronen. 
Das zweite Kapitel befasste sich mit den weiteren Anwendungen und Funktionalisierungen der 
biobasierten 2-Pyron-Derivate. Unter Verwendung von 6-Hydroxyalkyl-2-Pyronen 26, welche 
in vorangegangener Arbeit von Reiser et al. ebenfalls aus Furfurylalkohol (18) erhalten wurden, 
wurden einige 3,7-substituierte Phthalidderivate 342 durch intermolekulare Diels-Alder-
Reaktion mit Diethylacetylendicarboxylat (341) synthetisiert (Abbildung 2). Gleichermaßen 
ergab eine intramolekulare [4+2]-Cycloaddition 3-substituierte Phthalide 326, einschließlich 
des antiischämischen Schlaganfallmedikaments n-Butylphthalid (326b) (Abbildung 2). 
Darüber hinaus wurde ausgehend von enantiomerenangereicherten Pyronen 26 die 






Abbildung 2. Synthese von 3-substituierten Phthaliden 342 und 326 durch Diels-Alder-
Reaktion. 
Des Weiteren konnte die mittels UV-Licht induzierte [4+2]-Cycloaddition von 2-Pyron (1), ein 
äußerst seltenes Beispiel für eine photokatalysierte [4+2]-Cycloaddition in der organischen 
Chemie, durch nachhaltige Bedingungen unter Verwendung von Dioden, die sichtbares Licht 
emittieren, ersetzt werden (Abbildung 3). Durch die Verwendung eines 
[Ir(dtb-bpy)(dF(CF3)ppy)2]PF6 Energieübertragungskatalysators wurden zwei strukturell und 
stereochemisch reiche Regioisomere 367a-b diastereoselektiv in kurzer Reaktionszeit und 
insgesamt ausgezeichneter Ausbeute erhalten.  
 
Abbildung 3. [4+2]-Cycloaddition von 2-Pyron (1) mittels sichtbarem Licht.  
Zuletzt lieferte die übergangsmetallkatalysierte Cyclopropanierung mit Donor-Akzeptor-
Diazoacetat 376 cyclopropaniertes Pyron 377a und Pyridinon 377b auf regioselektive und 
diastereoselektive Weise. Außerdem wurde durch die Anwendung eines chiralen 
Rhodiumkatalysators die Funktionalisierung dieser Substrate mit hoher Enantioselektivität 
erreicht – was gewöhnlich eine große Herausforderung in der Pyronchemie darstellt (Abbildung 
4). Der Anwendungsbereich weiterer Pyron- und Pyridinonderivate sowie Diazoacetate wird 
derzeit im Rahmen der Doktorarbeit von Jiantao Fu, einem Mitglied der Forschungsgruppe von 
Professor Huw Davies in Atlanta, untersucht. Die hohe Dichte an funktionellen Gruppen in 





Aufbau molekularer Komplexität in zukünftigen Arbeiten, wie es bei der Synthese von 
Hydroxymethylcyclopentenolderivat 411 gezeigt wurde (Abbildung 4).  
 
Abbildung 4. Enantioselektive Cyclopropanierung von Pyron 1 und Pyridinon 378 und 
Umwandlung zu Enol 411. 
Das letzte Kapitel widmete sich der atypischen Reaktivität von Anthracenderivaten 419b-e. Die 
natürliche 9,10-Präferenz von Anthracenen in [4+2]-Cycloadditionen wurde erfolgreich durch 
einfache, aber effektive Installation elektronendonierender Substituenten an den 1- oder 
1,5-Positionen umgangen. Infolgedessen wurde eine vielfältige Palette an 1,4-Cycloaddukten 
431 erhalten, ohne dass die 9,10-Positionen vorsätzlich blockiert wurden (Abbildung 5). Die 
Verwendung von Alkendienophilen A-C ergab jedoch ausschließlich gewöhnliche 9,10-
Cycloaddukte 430 (Abbildung 5). In Zusammenarbeit mit der Arbeitsgruppe von Prof. J. 
Rehbein (Universität Regensburg) wurden umfangreiche Computerstudien durchgeführt, in 
denen der Einfluss der Substituenten und Dienophilen auf die Regioselektivität der 
[4+2]-Cycloaddition untersucht wurde. Diese Studien ergaben, dass der Ursprung der 
atypischen Selektivität kinetischer Natur ist, was sich in dem größten Orbitalkoeffizienten im 
HOMO an der 4-Position (blaue Kugel, Abbildung 5) widerspiegelt und durch die 
Elektronendonorfähigkeit der Substituenten im terminalen Ring bedingt ist. Zudem führen stark 
asynchrone Übergangszustände zu den Produkten 431. Im Gegensatz wiesen berechnete 
Aktivierungsbarrieren und Triebkräfte der Reaktion mit Alkendienophil B darauf hin, dass die 
1,4-Addition immer noch kinetisch bevorzugt ist, die Umwandlung jedoch thermodynamisch 






Abbildung 5. Überblick über die [4+2]-Cycloadditionen der Anthracene 419b-e mit Alkinen 
D-F und Alkenen A-C. 
Zusätzlich ermöglichte die elektronische Manipulation eines terminalen Rings durch 
Installation einer Pyrrolidingruppe in 1-Position sich über die inhärente 9,10-Präferenz bei 
aromatischen Substitutionen mit verschiedenen Elektrophilen hinwegzusetzen und in jedem 
Fall eine ausschließliche Funktionalisierung des äußeren Rings zu erreichen (Abbildung 6).  
 






E Experimental Part 
1 General information 
Synthesis 
All chemicals were used as received or purified according to Purification of Laboratory 
Chemicals249 if necessary. Glassware was dried in an oven at 110 °C or flame-dried prior to 
use. Solvents were applied in puriss p. a. grade and absolute solvents were prepared by 
established laboratory procedures. Larger quantities of dried solvents were purchased from a 
MB-SPS solvent purification system. Ethyl acetate, hexanes (40/60) and DCM for 
chromatography were distilled prior to use. Reactions with moisture and oxygen sensitive 
reagents were carried out in flame-dried glassware under an atmosphere of pre-dried nitrogen.  
1H- and 13C-NMR 
1H-NMR spectra were recorded on a BRUKER Avance 400 (400 MHz) and a BRUKER 
Avance 300 (300 MHz) spectrometer at ambient temperature. 13C-NMR spectra were recorded 
on a BRUKER Avance 300 (75 MHz) and BRUKER Avance 400 (101 MHz). Chemical shifts 
are reported in δ [ppm] relative to the signal of the solvent as the internal standard. 
Characterization of signals: s =  singlet, bs =  broad singlet, d = doublet, t = triplet, q = quartet, 
sext = sextet, m = multiplet, dd = doublet of doublet, dt = doublet of triplet, dq = doublet of 
quartet, td = triplet of doublet, ddd = doublet of doublet of doublet. Integration is determined 
as the relative number of atoms, and the coupling constants (J) are given in Hertz [Hz]. In 
addition, DEPT 135 spectra (primary or tertiary carbon (positive signal), secondary carbon 
(negative signal), quaternary carbon (no signal)) were recorded. 
Column Chromatography 
Column Chromatography was performed using Merck Gerduran 60 silica gel (0.063-0.200 mm) 
or Merck flash silica gel (0.040-0.063 mm). 
Gas chromatography 
Gas chromatography was carried out on a Fisons GC 8000 Series with flame ionization detector 
(FID). As stationary phase DB-1 (100% dimethylpolysiloxane, 30 m, ID 0.25 mm, 0.25 µm 





temperature = 300 °C. GC method: starting temperature 80 °C, then temperature ramp 
(5 °C/min) for 24 min to 200 °C followed by an isothermal period at 200 °C for 5 min. 
HPLC 
HPLC was performed on a Varian 920-LC with a photodiode array (PDA) detector. 
Phenomenex Lux Cellulose-1 and 2, Chiracel OD-H and AS served as chiral stationary phase 
and mixtures of n-heptane and i-PrOH were used for elution. 
IR spectroscopy  
IR spectroscopy was carried out on a Cary 630 FTIR Spectrometer (Agilent Technology) with 
ZnSe windows and Diamond Single Reflection Accessory. Solid and liquid compounds were 
measured neatly, and the wavenumbers are reported in cm-1. 
Mass spectrometry 
Mass spectrometry was performed on a Finnigan MAT95, Agilent Q-TOF 6540 UHD, Finnigan 
MAT SSQ 710 A, ThermoQuest Finnigan TSQ 7000 at the Central Analytical Department of 
the University of Regensburg.  
Melting points 
The melting points were measured automatically on a MPA 100 Optimelt (Automated Melting 
Point System, Digital Image Processing Technology). Values thus obtained were not corrected. 
Microwave 
Microwave reactions were carried out on an Anton-Paar Monowave 300 microwave using 
pressure stable sealed 10 mL or 25 mL vessels.  
Optical rotations 
The optical rotation was determined on an Anton Paar MCP 500 polarimeter at 589 nm 






Thin layer chromatography 
Thin layer chromatography was done using Merck silica gel 60 F254 coated with 0.2 mm silica. 
Visualization was accomplished by UV light (254 nm) and staining was performed with vanillin 
or potassium permanganate solutions followed by heating. 
X-ray-crystallography 
X-ray crystallography was done by the crystallography laboratory of the University of 
Regensburg. 
Synthesis of literature known compounds 
The following compounds were synthesized according to literature known procedures and 
spectroscopic data matched well with those reported: 
4-hydroxycyclopent-2-en-1-one (19)160, 4-oxocyclopent-2-en-1-yl acetate (20)16, 
6a-(1-hydroxyethyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one (25a)16, (S)-6-(1-hydroxyethyl)-2H-pyran-2-one ((S)-26a)16, 6-(1-hydroxypentyl)-2H-
pyran-2-one (26b)16, (R)-6-(1-hydroxypentyl)-2H-pyran-2-one ((R)-26b)16, 
6-(hydroxy(phenyl)methyl)-2H-pyran-2-one (26c)16, 6-acetyl-2H-pyran-2-one (361)161, 
[Ir(dtb-bpy)(dF(CF3)ppy)2]PF6
250, Cu(dap)2Cl
251, 1-tosylpyridin-2(1H)-one (350)200, 








1,5-dimethoxyanthracene (419b)231, anthracene-1,5-diamine (429)232, anthracen-1-amine 






2 Sustainable synthesis of 2-pyrones 
3a,4,7,7a-Tetrahydro-1H-4,7-methanoinden-1-one (22)163 
 
In an oven dried round-bottom flask acetate 20 (28.0 g, 200 mmol, 1.0 equiv) was dissolved in 
dry Et2O (650 mL) and the flask was sealed with a drying tube. After stirring the solution for 
30 min at 0 °C in an ice bath, BF3∙OEt2 (2.50 mL, 20.0 mmol, 10 mol%) and freshly distilled 
cyclopentadiene 21 (33.5 mL, 400 mmol, 2.0 equiv) were added. The resulting mixture was 
stirred at 0 °C for 18 h. The reaction mixture was quenched by slow addition of water (50 mL) 
and stirred for 30 min. After phase separation, 3 M NaOH solution (100 mL) was added to the 
organic phase and intensively stirred for 1 h. The phases were separated and the organic phase 
was concentrated to 250 mL under reduced pressure. The aqueous phase was extracted by using 
the previously distilled Et2O (3×) and the combined organic phases were washed with brine 
(1×) and dried over Na2SO4. The solvent was removed under reduced pressure and the crude 
product was dried under a vacuum (20.0 mbar) for 30 min. Afterward, PE (35 mL) and ethyl 
acetate (0.5 mL) were added to the oily residue and the solution was carefully heated to 60 °C 
using a water bath. The solution was allowed to rest at room temperature until crystallization 
was observed and finally stored in the fridge for complete crystallization overnight. The 
resulting solid was filtered off, washed with cold PE (2×) and dried under vacuum to give 22 
as a white solid (23.8 g, 163 mmol, 82%). 
1H NMR (400 MHz, CDCl3) δH = 7.29 (dd, J = 5.7, 2.6 Hz, 1H), 5.86 – 5.78 (m, 2H), 5.67 (dd, 
J = 5.7, 3.0 Hz, 1H), 3.35 – 3.29 (m, 1H), 3.12 – 3.07 (m, 1H), 2.89 – 2.84 (m, 1H), 2.69 (t, J 
= 5.1 Hz, 1H), 1.64 (dt, J = 8.4, 1.9 Hz, 1H), 1.52 (dt, J = 8.4, 1.5 Hz, 1H); 13C NMR (101 MHz, 
CDCl3) δC = 210.5 , 164.5, 136.7, 132.33, 132.31, 52.5, 50.0, 48.1, 44.8, 43.9. 
1a,1b,2,5,5a,6a-Hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one (313)258 
  
In a flask equipped with a reflux condenser enone 22 (24.7 g, 169 mmol, 1.0 equiv) was 
dissolved in DCM:MeOH (1:1, 500 mL) and the resulting solution was cooled by stirring in an 





water, 90.0 mL, 912 mmol, 5.4 equiv) were added and the mixture was stirred at 0 °C for 
15 min before the ice/salt bath was removed and stirred for further 15 min at ambient 
temperature. The reaction mixture was poured into DCM (300 mL) and washed with brine (1×). 
The aqueous phase was extracted with DCM (3×). The combined organic phases were dried 
over MgSO4 and the solvent was removed under reduced pressure to yield pure 313 as a white 
solid (23.1 g, 142 mmol, 84%). 
1H NMR (400 MHz, CDCl3) δH = 6.05 (dd, J = 5.8, 2.6 Hz, 1H), 5.98 (dd, J = 5.8, 2.9 Hz, 1H), 
3.55 (t, J = 1.9 Hz, 1H), 3.23 – 3.16 (m, 1H), 3.17 (d, J = 2.2 Hz, 1H), 3.11 – 3.02 (m, 2H), 2.76 
– 2.68 (m, 1H), 1.58 (dt, J = 8.6, 1.7 Hz, 1H), 1.42 (dt, J = 8.7, 1.4 Hz, 1H); 13C NMR 
(101 MHz, CDCl3) δC = 209.7, 135.4, 133.6, 60.5, 58.3, 51.7, 49.2, 45.7, 44.4, 43.6. 
2H-Pyran-2-one (1)259 
 
A high-quality glass tube (length 90 cm, diameter 1 cm) was fixed horizontally in a tube 
furnace. On one end the tube was connected to a cooling trap filled with ice/water and on the 
other end to a flask containing epoxide 313 (20.0 g, 123 mmol). The cooling trap was connected 
to a high-vacuum line at 2∙10-2 mbar and the tube furnace was heated to 650 °C. Epoxide 313 
was slowly sublimed through the furnace by extern heating at 130 °C using a Kugelrohr 
distillation oven and the product was collected in the cooling trap. The product was washed off 
the cooling trap with MeOH, the solvent was removed under reduced pressure to yield the pure 
pyrone 1 as a brownish liquid (11.3 g, 118 mmol, 96%). 
1H NMR (400 MHz, CDCl3) δH = 7.47 (ddd, J = 5.2, 2.2, 1.2 Hz, 1H), 7.30 (ddd, J = 9.5, 6.4, 
2.2 Hz, 1H), 6.30 (dt, J = 9.5, 1.2 Hz, 1H), 6.20 (ddd, J = 6.3, 5.2, 1.1 Hz, 1H); 13C NMR 
(101 MHz, CDCl3) δC = 161.7, 152.0, 142.9, 116.8, 106.0. 
6-(1-Hydroxyethyl)-2H-pyran-2-one (26a)16 
 
A high-quality glass tube (length 90 cm, diameter 1 cm) was fixed horizontally in a tube 
furnace. On one end the tube was connected to a cooling trap filled with ice/water and on the 





connected to a high-vacuum line at 2∙10-2 mbar and the tube furnace was heated to 650 °C. 
Epoxide 25a was slowly distilled through the furnace by extern heating at 170 °C using a 
Kugelrohr distillation oven and the product was collected in the cooling trap. The product was 
washed off the cooling trap with DCM, the solvent was removed under reduced pressure to 
yield the pure pyrone 26a as a brownish liquid (1.95 g, 13.9 mmol, 96%). 
1H NMR (300 MHz, CDCl3) δH = 7.34 (dd, J = 9.4, 6.6 Hz, 1H), 6.29 (dt, J = 6.5, 0.8 Hz, 1H), 
6.21 (dd, J = 9.3, 0.9 Hz, 1H), 4.60 (q, J = 6.6 Hz, 1H), 1.51 (d, J = 6.6 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) δC = 167.7, 162.3, 144.0, 114.3, 100.6, 66.8, 21.4. 
General procedure A. Grignard reaction of 310 to 314 
In a two necked Schlenk flask magnesium shavings (2.27 g, 93.6 mmol, 1.3 equiv) were 
suspended in dry Et2O (37 mL) and a catalytic amount of iodine was added under nitrogen 
atmosphere. A solution of alkyl bromide (115 mmol, 1.6 equiv) in dry Et2O (92 mL) was added 
dropwise via a dropping funnel. After complete addition, the reaction mixture was heated under 
reflux conditions for 1 h until complete consumption of magnesium was observed. The resulting 
solution was cooled to 0 °C in an ice bath and a solution of furfural 310 (72.0 mmol, 1.0 equiv) 
in dry Et2O (58 mL) was added dropwise. The mixture was stirred for 15 min at 0 °C and finally 
quenched with water and saturated NH4Cl solution. The aqueous phase was extracted with Et2O 
(3×) and the combined organic phases were dried over MgSO4. The solvent was removed under 
reduced pressure and the crude product was purified by flash column chromatography 
(PE:EA = 19:1 to 9:1). 
General procedure B. Piancatelli rearrangement of 314 to 315 
In a microwave vessel furfuryl alcohol 314 (5.0 mmol, 1.0 equiv.) was dissolved in acetone 
(5.0 mL) and water (15 mL). The mixture was stirred under microwave irradiation at 180 °C 
for 15 min. Depending on the employed alcohol 314, this procedure was repeated multiple times 
in order to achieve the desired reaction scale (42.5−65.0 mmol). The reaction mixtures were 
combined and extracted with DCM (3×). The organic phase was dried over MgSO4 and the 
solvent was removed under reduced pressure. The crude product was purified by flash column 
chromatography (PE:EA = 2:1). 
General procedure C. Acetylation of 315 to 316 
5-substituted 4-hydroxy-2-cyclopentenone 315 (1.0 equiv) was dissolved in DCM (0.17 M). 





temperature for 20 h. Water was added and the phases were separated. The aqueous phase was 
extracted with DCM (3×) and the combined organic phases were dried over MgSO4. The crude 
product was purified by flash column chromatography (PE:EA = 9:1). 
General procedure D. Diels-Alder/elimination reaction of 316 to 317 
5-substituted acetate 316 (10 mmol, 1.0 equiv) was dissolved in dry Et2O (30 mL) and the 
solution was cooled to 0 °C in an ice bath. BF3∙OEt2 (0.25 mL, 2.0 mmol, 20 mol%) and freshly 
distilled cyclopentadiene 21 (2.5 mL, 30 mmol, 3.0 equiv) were added at 0 °C. The mixture was 
allowed to warm up to room temperature and stirred for 18 h. The solvent was removed under 
reduced pressure and the residue was dissolved in DCM:MeOH (1:1, 90 mL). 10 M NaOH 
solution (15 mL) was added and stirred for 1 h at room temperature. The mixture was washed 
with brine (1×) and the phases were separated. The aqueous phase was extracted with DCM 
(3×) and the combined organic phases were dried over MgSO4. The solvent was removed under 
reduced pressure and the crude product was purified by flash column chromatography 
(PE:EA =  19:1 to 9:1). 
General procedure E. Epoxidation of 317 to 318 
Enone 317 (3.00 mmol, 1.0 equiv) was dissolved in DCM:MeOH (1:1, 15 mL). 2 M NaOH 
solution (1.80 mL, 3.60 mmol, 1.2 equiv) and H2O2 (34% in water, 1.46 mL, 16.2 mmol, 
5.4 equiv) were added and the reaction mixture was stirred for 24 h at room temperature. The 
reaction mixture was poured into DCM (90 mL) and washed with brine (1x). The organic layer 
was dried over MgSO4 and concentrated under vacuum to yield the pure compound. 
General procedure F. Flash vacuum thermolysis of 318 to 2 
A high-quality glass tube (length 90 cm, diameter 1 cm) was fixed horizontally in a tube 
furnace. On one end the tube was connected to a cooling trap filled with liquid nitrogen and on 
the other end to a flask containing epoxide 318. The cooling trap was connected to a high-
vacuum line at 2∙10-2 mbar and the furnace was heated to 650 °C. Epoxide 318 (500 µmol, 
1.0 equiv) was slowly evaporated through the tube furnace and the product was collected in a 
trap cooled with ice/water. The product was washed off the cooling trap with DCM and the 








Following general procedure A, reaction of magnesium shavings (2.27 g, 93.6 mmol, 
1.3 equiv), 1-bromopropane (10.5 mL, 115 mmol, 1.6 equiv) and furfural 310 (5.96 mL, 
72.0 mmol, 1.0 equiv) afforded 314a as a yellowish liquid (9.28 g, 66.0 mmol, 92%). 
1H NMR (300 MHz, CDCl3) δH = 7.37 (dd, J = 1.9, 0.8 Hz, 1H), 6.32 (dd, J = 3.2, 1.8 Hz, 1H), 
6.22 (dt, J = 3.2, 0.8 Hz, 1H), 4.68 (t, J = 6.9 Hz, 1H), 1.92 (bs, 1H), 1.87 – 1.79 (m, 2H), 1.51 
– 1.28 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 157.0, 142.0, 110.2, 
105.8, 67.6, 37.7, 18.9, 13.9. 
1-(Furan-2-yl)hexan-1-ol (314b)261 
 
Following general procedure A, reaction of magnesium shavings (2.27 g, 93.6 mmol, 
1.3 equiv), 1-bromopentane (14.3 mL, 115 mmol, 1.6 equiv) and furfural 310 (5.96 mL, 
72.0 mmol, 1.0 equiv) afforded 314b as a yellowish liquid (11.9 g, 70.9 mmol, 98%). 
1H NMR (300 MHz, CDCl3) δH = 7.37 (dd, J = 1.8, 0.8 Hz, 1H), 6.33 (dd, J = 3.2, 1.8 Hz, 1H), 
6.22 (dt, J = 3.2, 0.8 Hz, 1H), 4.67 (t, J = 6.8 Hz, 1H), 1.96 – 1.80 (m, 3H), 1.45 – 1.27 (m, 
6H), 0.92 – 0.85 (m, 3H); 13C NMR (75 MHz, CDCl3) δC = 157.0, 142.0, 110.2, 105.9, 67.9, 
35.6, 31.7, 25.3, 22.7, 14.1. 
1-(Furan-2-yl)octan-1-ol (314c)262 
 
Following general procedure A, reaction of magnesium shavings (2.27 g, 93.6 mmol, 
1.3 equiv), 1-bromoheptane (18.1 mL, 115 mmol, 1.6 equiv) and furfural 310 (5.96 mL, 
72.0 mmol, 1.0 equiv) afforded 314c as a yellowish liquid (13.7 g, 69.8 mmol, 97%). 
1H NMR (300 MHz, CDCl3) δH = 7.37 (dd, J = 1.9, 0.9 Hz, 1H), 6.33 (dd, J = 3.2, 1.8 Hz, 1H), 





10H), 0.90 – 0.85 (m, 3H); 13C NMR (75 MHz, CDCl3) δC = 157.0, 141.9, 110.2, 105.8, 67.9, 
35.6, 31.9, 29.5, 29.3, 25.6, 22.7, 14.2. 
4-Hydroxy-5-propylcyclopent-2-en-1-one (315a) 
 
According to general procedure B furfuryl alcohol 314a (5.96 g, 42.5 mmol (8.5 × 5.0 mol)) 
was employed to yield 315a as a yellowish liquid (4.30 g, 30.6 mmol, 72%).  
1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.2 Hz, 1H), 6.17 (dd, J = 5.8, 1.3 Hz, 1H), 
4.70 – 4.65 (m, 1H), 2.61 (bs, 1H), 2.27 – 2.20 (m, 1H), 1.87 – 1.74 (m, 1H), 1.53 – 1.39 (m, 
3H), 0.95 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 208.2, 161.7, 134.4, 76.9, 55.3, 
30.8, 20.7, 14.2. 
4-Hydroxy-5-pentylcyclopent-2-en-1-one (315b)160 
 
According to general procedure B furfuryl alcohol 314b (10.1 g, 60.0 mmol (12 × 5.0 mol)) 
was employed to yield 315b as a yellowish liquid (7.60 g, 45.2 mmol, 75%).  
1H NMR (400 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.2 Hz, 1H), 6.19 (dd, J = 5.8, 1.3 Hz, 1H), 
4.72 – 4.65 (m, 1H), 2.28 – 2.16 (m, 2H), 1.91 – 1.80 (m, 1H), 1.49 – 1.41 (m, 3H), 1.35 – 1.28 
(m, 4H), 0.91 – 0.86 (m, 3H); 13C NMR (75 MHz, CDCl3) δC = 208.2, 161.6, 134.5, 76.9, 55.6, 
32.0, 28.7, 27.1, 22.6, 14.1. 
5-Heptyl-4-hydroxycyclopent-2-en-1-one (315c)262 
 
According to general procedure B furfuryl alcohol 314c (12.8 g, 65.0 mmol (13 × 5.0 mol)) was 
employed to yield 315c as a yellowish liquid (5.08 g, 25.9 mmol, 40%).  
1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.2 Hz, 1H), 6.19 (dd, J = 5.8, 1.3 Hz, 1H), 





(m, 8H), 0.89 – 0.84 (m, 3H); 13C NMR (75 MHz, CDCl3) δC = 208.1, 161.5, 134.5, 77.0, 55.6, 
31.9, 29.7, 29.2, 28.7, 27.5, 22.7, 14.2. 
4-Oxo-5-propylcyclopent-2-en-1-yl acetate (316a) 
 
Following general procedure C, reaction of 5-substituted 4-hydroxycyclopent-2-enone 315a 
(4.29 g, 30.6 mmol, 1.0 equiv), NEt3 (21.3 mL, 153 mmol, 5.0 equiv) and Ac2O (14.5 mL, 
153 mmol, 5.0 equiv) afforded acetate 316a as a yellowish oil (4.96 g, 27.2 mmol, 89%). 
Rf = 0.32 (PE:EA = 9:1); 
1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.3 Hz, 1H), 6.28 
(dd, J = 5.8, 1.2 Hz, 1H), 5.66 – 5.61 (m, 1H), 2.38 (ddd, J = 8.5, 5.0, 2.4 Hz, 1H), 2.10 (s, 3H), 
1.85 – 1.73 (m, 1H), 1.55 – 1.34 (m, 3H), 0.92 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 207.1, 170.6, 157.8, 136.3, 77.6, 51.4, 30.8, 21.1, 20.2, 14.1; IR (ν/cm
-1): 2960, 2937, 
2874, 1715, 1595, 1485, 1372, 1327, 1230, 1170, 1088, 1025, 954, 924, 895, 857, 798, 734; 
HRMS (APCI) m/z calculated for C10H15O3 [MH
+]: 183.1016, found: 183.1026. 
4-Oxo-5-pentylcyclopent-2-en-1-yl acetate (316b) 
 
Following general procedure C, reaction of 5-substituted 4-hydroxycyclopent-2-enone 315b 
(5.99 g, 35.6 mmol, 1.0 equiv), NEt3 (24.8 mL, 178 mmol, 5.0 equiv) and Ac2O (16.8 mL, 
178 mmol, 5.0 equiv) afforded acetate 316b as a yellowish oil (7.02 g, 33.4 mmol, 94%). 
Rf = 0.38 (PE:EA = 9:1); 
1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.3 Hz, 1H), 6.29 
(dd, J = 5.8, 1.2 Hz, 1H), 5.66 – 5.62 (m, 1H), 2.38 (ddd, J = 8.4, 4.9, 2.4 Hz, 1H), 2.10 (s, 3H), 
1.86 – 1.75 (m, 1H), 1.58 – 1.46 (m, 1H), 1.37 – 1.24 (m, 6H), 0.90 – 0.84 (m, 3H); 13C NMR 
(75 MHz, CDCl3) δC = 207.1, 170.7, 157.8, 136.3, 77.6, 51.6, 31.8, 28.6, 26.5, 22.5, 21.1, 14.1; 
IR (ν/cm-1): 2929, 2862, 1714, 1595, 1461, 1371, 1226, 1095, 1021, 924, 868, 793, 726; HRMS 
(APCI) m/z calculated for C12H19O3 [MH






5-Heptyl-4-oxocyclopent-2-en-1-yl acetate (316c) 
 
Following general procedure C, reaction of 5-substituted 4-hydroxycyclopent-2-enone 315c 
(3.14 g, 16.0 mmol, 1.0 equiv), NEt3 (11.2 mL, 80.0 mmol, 5.0 equiv) and Ac2O (7.56 mL, 
80.0 mmol, 5.0 equiv) afforded acetate 316c as a yellowish oil (3.49 g, 14.6 mmol, 91%). 
Rf = 0.42 (PE:EA = 9:1); 
1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.3 Hz, 1H), 6.29 
(dd, J = 5.8, 1.2 Hz, 1H), 5.67 – 5.62 (m, 1H), 2.37 (ddd, J = 8.5, 4.9, 2.4 Hz, 1H), 2.10 (s, 3H), 
1.87 – 1.75 (m, 1H), 1.57 – 1.46 (m, 1H), 1.34 – 1.23 (m, 10H), 0.89 – 0.84 (m, 3H); 13C NMR 
(75 MHz, CDCl3) δC = 207.1, 170.6, 157.8, 136.3, 77.6, 51.6, 31.9, 29.6, 29.1, 28.7, 26.8, 22.7, 
21.1, 14.2; IR (ν/cm-1): 2926, 2855, 1718, 1595, 1581, 1372, 1230, 1170, 1096, 1021, 976, 906, 
794, 723; HRMS (APCI) m/z calculated for C14H23O3 [MH
+]: 239.1642, found: 239.1641. 
2-Propyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one (317a) 
 
According to general procedure D acetate 316a (1.82 g, 10.0 mmol, 1.0 equiv) was employed 
to yield 317a as a colorless liquid (1.77 g, 9.39 mmol, 94%). 
Rf = 0.48 (PE:EA = 9:1); 
1H NMR (300 MHz, CDCl3) δH = 7.02 – 6.94 (m, 1H), 5.86 (dd, J = 
5.6, 2.9 Hz, 1H), 5.74 (dd, J = 5.6, 3.0 Hz, 1H), 3.28 – 3.22 (m, 1H), 3.22 – 3.17 (m, 1H), 2.93 
– 2.89 (m, 1H), 2.83 – 2.79 (m, 1H), 2.08 – 1.92 (m, 2H), 1.73 (dt, J = 8.4, 1.8 Hz, 1H), 1.62 – 
1.57 (m, 1H), 1.39 (sext, J = 7.3 Hz, 2H), 0.85 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 210.3, 157.7, 149.3, 132.6, 132.3, 52.7, 50.9, 45.4, 45.2, 44.1, 26.8, 21.2, 13.9; IR (ν/cm
-
1): 3064, 2960, 2933, 2870, 1692, 1625, 1454, 1338, 1230, 1204, 1126, 1074, 828, 738, 712; 
HRMS (EI) m/z calculated for C13H16O [M








According to general procedure D acetate 316b (2.10 g, 10.0 mmol, 1.0 equiv) was employed 
to yield 317b as a colorless liquid (2.06 g, 9.52 mmol, 95%). 
Rf = 0.51 (PE:EA = 9:1); 
1H NMR (400 MHz, CDCl3) δH = 7.01 – 6.94 (m, 1H), 5.87 (dd, J = 
5.6, 2.9 Hz, 1H), 5.74 (dd, J = 5.6, 3.0 Hz, 1H), 3.27 – 3.22 (m, 1H), 3.22 – 3.17 (m, 1H), 2.93 
– 2.88 (m, 1H), 2.81 (t, J = 5.1 Hz, 1H), 2.08 – 1.95 (m, 2H), 1.73 (dt, J = 8.4, 1.8 Hz, 1H), 
1.60 (dt, J = 8.4, 1.5 Hz, 1H), 1.39 – 1.20 (m, 6H), 0.86 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δC = 210.3, 157.5, 149.6, 132.6, 132.3, 52.7, 50.9, 45.4, 45.2, 44.2, 31.5, 27.6, 24.7, 
22.5, 14.1; IR (ν/cm-1): 3063, 2929, 2862, 1695, 1625, 1457, 1338, 1203, 1125, 909, 738, 711; 
HRMS (APCI) m/z calculated for C15H21O [MH
+]: 217.1587, found: 217.1586. 
2-Heptyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one (317c) 
 
According to general procedure D acetate 316c (2.38 g, 10.0 mmol, 1.0 equiv) was employed 
to yield 317c as a colorless oil (2.29 g, 9.37 mmol, 94%). 
Rf = 0.57 (PE:EA = 9:1); 
1H NMR (300 MHz, CDCl3) δH = 7.02 – 6.92 (m, 1H), 5.86 (dd, J = 
5.6, 2.9 Hz, 1H), 5.74 (dd, J = 5.7, 3.0 Hz, 1H), 3.28 – 3.22 (m, 1H), 3.22 – 3.17 (m, 1H), 2.93 
– 2.88 (m, 1H), 2.81 (t, J = 5.1 Hz, 1H), 2.11 – 1.91 (m, 2H), 1.72 (dt, J = 8.4, 1.8 Hz, 1H), 
1.62 – 1.56 (m, 1H), 1.39 – 1.19 (m, 10H), 0.90 – 0.82 (m, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 210.3, 157.5, 149.6, 132.6, 132.4, 52.7, 50.9, 45.4, 45.2, 44.2, 31.9, 29.3, 29.1, 28.0, 24.7, 
22.7, 14.2; IR (ν/cm-1): 3064, 2926, 2855, 1696, 1625, 1461, 1338, 1293, 1230, 1126, 910, 738, 
716; HRMS (EI) m/z calculated for C17H24O [M









According to general procedure E enone 317a (565 mg, 3.00 mmol, 1.0 equiv) was used to 
afford 318a as a colorless oil (598 mg, 2.93 mmol, 98%). 
Rf = 0.47 (PE:EA = 10:1); 
1H NMR (300 MHz, CDCl3) δH = 6.04 (dd, J = 5.7, 2.8 Hz, 1H), 
5.99 (dd, J = 5.7, 2.8 Hz, 1H), 3.46 (d, J = 1.7 Hz, 1H), 3.25 – 3.19 (m, 1H), 3.09 – 3.04 (m, 
1H), 3.01 – 2.95 (m, 1H), 2.85 – 2.78 (m, 1H), 1.85 – 1.71 (m, 1H), 1.60 (dt, J = 8.5, 1.8 Hz, 
1H), 1.57 – 1.47 (m, 1H), 1.47 – 1.42 (m, 1H), 1.34 – 1.20 (m, 2H), 0.89 (t, J = 7.3 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 210.5, 135.2, 133.8, 67.0, 65.5, 51.9, 50.1, 45.9, 43.6, 43.4, 
27.0, 17.9, 14.5; IR (ν/cm-1): 3064, 2963, 2874, 1733, 1457, 1338, 1200, 1126, 1029, 910, 835, 
775, 723; HRMS (EI) m/z calculated for C13H16O2 [M
+]: 204.1145, found: 204.1145. 
6a-Pentyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one (318b)161 
 
According to general procedure E enone 317b (649 mg, 3.00 mmol, 1.0 equiv) was used to 
afford 318b as a colorless oil (684 mg, 2.94 mmol, 98%). 
Rf = 0.54 (PE:EA = 10:1); 
1H NMR (300 MHz, CDCl3) δH = 6.04 (dd, J = 5.6, 2.8 Hz, 1H), 
5.99 (dd, J = 5.6, 2.8 Hz, 1H), 3.46 (d, J = 1.6 Hz, 1H), 3.26 – 3.17 (m, 1H), 3.10 – 3.04 (m, 
1H), 3.02 – 2.95 (m, 1H), 2.85 – 2.79 (m, 1H), 1.84 – 1.72 (m, 1H), 1.62 – 1.43 (m, 3H), 1.34 
– 1.19 (m, 6H), 0.86 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 210.6, 135.2, 133.8, 
67.1, 65.5, 51.9, 50.1, 45.9, 43.6, 43.4, 32.1, 24.8, 24.1, 22.5, 14.1; IR (ν/cm-1): 3064, 2933, 
2862, 1737, 1461, 1420, 1338, 1252, 1126, 1088, 1044, 910, 842, 775, 723; HRMS (EI) m/z 
calculated for C15H20O2 [M









According to general procedure E enone 317c (733 mg, 4.00 mmol, 1.0 equiv) was used to 
afford 318c as a colorless oil (758 mg, 2.91 mmol, 97%). 
Rf = 0.54 (PE:EA = 10:1); 
1H NMR (300 MHz, CDCl3) δH = 6.04 (dd, J = 5.7, 2.8 Hz, 1H), 
5.99 (dd, J = 5.6, 2.8 Hz, 1H), 3.46 (d, J = 1.7 Hz, 1H), 3.25 – 3.19 (m, 1H), 3.09 – 3.04 (m, 
1H), 3.01 – 2.95 (m, 1H), 2.84 – 2.79 (m, 1H), 1.84 – 1.71 (m, 1H), 1.60 (dt, J = 8.5, 1.8 Hz, 
1H), 1.58 – 1.48 (m, 1H), 1.45 (dt, J = 8.5, 1.6 Hz, 1H), 1.31 – 1.18 (m, 10H), 0.90 – 0.83 (m, 
3H); 13C NMR (75 MHz, CDCl3) δC = 210.6, 135.2, 133.8, 67.1, 65.5, 51.9, 50.1, 45.9, 43.6, 
43.4, 31.8, 29.9, 29.1, 24.8, 24.4, 22.7, 14.2; IR (ν/cm-1): 3064, 2930, 2855, 1737, 1461, 1338, 
1200, 1126, 1088, 1044, 910, 842, 775, 723; HRMS (EI) m/z calculated for C17H24O2 [M
+]: 
260.1771, found: 260.1765. 
6-Propyl-2H-pyran-2-one (2a)161,167 
 
Following general procedure F, epoxide 318a (102 mg, 500 µmol, 1.0 equiv) was employed to 
yield 2a as a colorless oil (68.8 mg, 498 µmol, >99%). 
1H NMR (300 MHz, CDCl3) δH = 7.26 (dd, J = 9.4, 6.5 Hz, 1H), 6.15 (d, J = 9.4 Hz, 1H), 5.97 
(dd, J = 6.6, 0.8 Hz, 1H), 2.46 (t, J = 7.5 Hz, 2H), 1.69 (sext, J = 7.5 Hz, 2H), 0.96 (t, J = 7.4 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 166.6, 163.1, 143.8, 113.2, 102.8, 35.8, 20.3, 13.6. 
6-Pentyl-2H-pyran-2-one (2b)8,161 
 
Following general procedure F, epoxide 318b (116 mg, 500 µmol, 1.0 equiv) was employed to 





1H NMR (300 MHz, CDCl3) δH = 7.25 (dd, J = 9.4, 6.5 Hz, 1H), 6.14 (d, J = 9.4 Hz, 1H), 5.97 
(dd, J = 6.6, 0.7 Hz, 1H), 2.47 (t, J = 7.6 Hz, 2H), 1.69 – 1.60 (m, 2H), 1.36 – 1.27 (m, 4H), 
0.89 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 166.9, 163.1, 143.8, 113.2, 102.7, 
33.9, 31.2, 26.7, 22.4, 14.0. 
6-Heptyl-2H-pyran-2-one (2c)161,167 
 
Following general procedure F, epoxide 318c (130 mg, 500 µmol, 1.0 equiv) was employed to 
yield 2c as a colorless oil (970 mg, 499 µmol, >99%). 
1H NMR (300 MHz, CDCl3) δH = 7.25 (dd, J = 9.4, 6.6 Hz, 1H), 6.15 (d, J = 9.4 Hz, 1H), 5.96 
(dd, J = 6.6, 0.8 Hz, 1H), 2.47 (t, J = 7.5 Hz, 2H), 1.70 – 1.60 (m, 2H), 1.35 – 1.22 (m, 8H), 
0.87 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 166.9, 163.1, 143.8, 113.2, 102.7, 
33.9, 31.7, 29.07, 29.05, 27.0, 22.7, 14.2. 
3 Application of 2-pyrones derived from renewable resources 
General procedure G. Intermolecular Diels-Alder reactions of 26 with alkynes 
A microwave vessel was charged with pyrone 26 (1.0 equiv) and alkyne (1.4 equiv). The 
mixture was heated in the microwave at 150 °C for 7 h. The resulting crude product was purified 
by flash column chromatography (PE:EA). 
Ethyl (S)-1-methyl-3-oxo-1,3-dihydroisobenzofuran-4-carboxylate ((S)-342a) 
 
Following general procedure G, reaction of pyrone (S)-26a (72.6 mg, 518 µmol, 1.0 equiv) and 
diethyl acetylenedicarboxylate (341) (115 µL, 725 µmol, 1.4 equiv) afforded (S)-342a after 
purification by flash column chromatography (PE:EA = 4:1) as a yellowish oil (93.2 mg, 
420 µmol, 81%). 
Rf = 0.16 (PE:EA = 4:1); 
1H NMR (400 MHz, CDCl3) δH = 7.77 – 7.68 (m, 2H), 7.54 (dt, J = 
7.3, 1.0 Hz, 1H), 5.53 (q, J = 6.7 Hz, 1H), 4.47 (q, J = 7.1 Hz, 2H), 1.64 (d, J = 6.7 Hz, 3H), 





129.4, 124.1, 123.5, 76.8, 62.3, 20.5, 14.2; IR (ν/cm-1): 2981, 2937, 1766, 1722, 1595, 1446, 
1371, 1289, 1144, 1025, 946, 745, 700; HRMS (EI) m/z calculated for C12H12O4 [M
+]: 
220.0730, found: 220.0723; Chiral HPLC 99% ee (tR minor, major =  39.9, 43.0 min, 
Chiralpak AS-H 4.6 × 250 mm 10 µm, n-heptane:i-PrOH 90:10, 0.5 mL/min). 
Ethyl 1-butyl-3-oxo-1,3-dihydroisobenzofuran-4-carboxylate (342b) 
 
Following general procedure G, reaction of pyrone 26b (182 mg, 1.00 mmol, 1.0 equiv) and 
diethyl acetylenedicarboxylate (341) (223 µL, 1.40 mmol, 1.4 equiv) afforded 342b after 
purification by flash column chromatography (PE:EA = 7:1) as a yellowish oil (183 mg, 
700 µmol, 70%). 
Rf = 0.17 (PE:EA = 7:1); 
1H NMR (300 MHz, CDCl3) δH = 7.78 – 7.66 (m, 2H), 7.53 (ddd, J 
= 7.3, 1.4, 0.8 Hz, 1H), 5.44 (dd, J = 8.0, 4.0 Hz, 1H), 4.47 (q, J = 7.2 Hz, 2H), 2.10 – 1.97 (m, 
1H), 1.82 – 1.67 (m, 1H), 1.49 – 1.34 (m, 7H), 0.90 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δC = 167.6, 166.1, 151.3, 133.7, 132.3, 129.3, 124.2, 123.8, 80.5, 62.2, 34.5, 27.0, 22.5, 
14.2, 13.9; IR (ν/cm-1): 2983, 2934, 1766, 1722, 1595, 1447, 1370, 1289, 1144, 1025, 946, 700; 
HRMS (ESI) m/z calculated for C15H19O4 [MH
+]: 263.1278, found: 263.1286.  
Ethyl 3-oxo-1-phenyl-1,3-dihydroisobenzofuran-4-carboxylate (342c) 
 
Following general procedure G, reaction of pyrone 26c (202 mg, 1.00 mmol, 1.0 equiv) and 
diethylacetylenedicarboxylate (341) (223 µL, 1.40 mmol, 1.4 equiv) afforded 342c after 
purification by flash column chromatography (PE:EA = 7:1) as a yellowish oil (142 mg, 
500 µmol, 50%). 
Rf = 0.15 (PE:EA = 7:1); 
1H NMR (300 MHz, CDCl3) δH = 7.82 – 7.76 (m, 1H), 7.68 (t, J = 
7.6 Hz, 1H), 7.45 – 7.34 (m, 4H), 7.32 – 7.26 (m, 2H), 6.37 (s, 1H), 4.50 (q, J = 7.1 Hz, 2H), 
1.45 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 167.5, 165.9, 150.9, 136.1, 134.1, 





1766, 1722, 1595, 1447, 1370, 1289, 1144, 1025, 946, 700; HRMS (ESI) m/z calculated for 
C17H15O4 [MH
+]: 283.0965, found: 283.0973.  
Ethyl 3-(1-hydroxyethyl)benzoate (348a)/3-Methylisobenzofuran-1(3H)-one (326a)176 
 
Following general procedure G, reaction of pyrone 26a (280 mg, 2.00 mmol, 1.0 equiv) and 
ethyl propiolate (37) (286 µL, 2.80 mmol, 1.4 equiv) afforded after purification by flash column 
chromatography (PE:EA = 7:1 to 4:1) 348a as a colorless oil (229 mg, 1.18 mmol, 59%) and 
326a as a colorless oil (59.6 mg, 400 µmol, 20%). 
348a: Rf = 0.37 (PE:EA = 2:1); 
1H NMR (400 MHz, CDCl3) δH = 8.02 (t, J = 1.8 Hz, 1H), 7.93 
(dt, J = 7.7, 1.5 Hz, 1H), 7.57 (dt, J = 7.7, 1.5 Hz, 1H), 7.40 (t, J = 7.7 Hz, 1H), 4.94 (q, J = 6.5 
Hz, 1H), 4.36 (q, J = 7.1 Hz, 2H), 2.21 (s, 1H), 1.50 (d, J = 6.5 Hz, 3H), 1.38 (t, J = 7.1 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δC = 166.7, 146.3, 130.7, 129.9, 128.7, 128.6, 126.6, 70.0, 
61.1, 25.4, 14.4; IR (ν/cm-1): 3418, 3071, 2974, 2933, 2903, 1714, 1587, 1446, 1367, 1278, 
1192, 1017, 756, 697; HRMS (EI) m/z calculated for C11H14O3 [M
+]: 194.0937, found: 
194.0931.  
326a: Rf = 0.78 (PE:EA = 2:1); 
1H NMR (400 MHz, CDCl3) δH = 7.90 (d, J = 7.7 Hz, 1H), 
7.68 (td, J = 7.5, 1.1 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.44 (dd, J = 7.6, 0.9 Hz, 1H), 5.57 (q, J 
= 6.7 Hz, 1H), 1.64 (d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δC = 170.6, 151.3, 134.1, 
129.1, 125.9, 125.8, 121.6, 77.8, 20.5. 
General procedure H. Coupling of 6-hydroxyalkyl pyrones 26 with propiolic acid 349 
Under nitrogen atmosphere 6-hydroxyalkyl pyrone 26 (1.0 equiv) and propiolic acid (349) 
(2.0 equiv) were dissolved in dry DCM (2.0 M). The mixture was cooled to −20 °C and a 
solution of DCC (1.1 equiv) and DMAP (7.0 mol%) in dry DCM (0.45 M) was added dropwise. 
After complete addition, the reaction mixture was allowed to warm up to room temperature and 
stirred for 18 h. The solvent was removed under reduced pressure and cold EA was added. The 
dicyclohexylurea solid was filtered off and washed with cold EA. The organic filtrate was 
washed with 1 M HCl (1×) and brine (1×). The organic phase was dried over MgSO4 and the 






General procedure I. Intramolecular Diels-Alder reaction of 350 to 326 
In a microwave vessel pyrone 350 was dissolved in toluene (0.1 M) and the solution was stirred 
under microwave irradiation at 150 °C for 5 h. The crude reaction mixture was filtered through 
a short pad of silica and washed with PE:EA = 1:1. The solvent was removed under reduced 
pressure to yield the pure product. 
1-(2-Oxo-2H-pyran-6-yl)ethyl propiolate (350a) 
 
Following general procedure H, reaction of pyrone 26a (1.05 g, 7.52 mmol, 1.0 equiv), 
propiolic acid (349) (932 µL, 15.0 mmol, 2.0 equiv), DMAP (68.9 mg, 564 µmol, 7.0 mol%) 
and DCC (1.75 g, 8.46 mmol, 1.1 equiv) afforded 350a after purification by flash column 
chromatography (PE:EA = 4:1) as a yellowish oil (807 mg, 4.20 mmol, 56%). 
Rf = 0.17 (PE:EA = 4:1); 
1H NMR (300 MHz, CDCl3) δH = 7.32 (dd, J = 9.4, 6.5 Hz, 1H), 6.31 
– 6.21 (m, 2H), 5.66 (q, J = 6.7 Hz, 1H), 2.97 (s, 1H), 1.61 (d, J = 6.7 Hz, 3H); 13C NMR 
(101 MHz, CDCl3) δC = 161.3, 161.2, 151.4, 143.0, 116.0, 102.6, 76.2, 74.1, 70.1, 18.1; IR 
(ν/cm-1): 3239, 3093, 2993, 2937, 2858, 2117, 1710, 1640, 1561, 1453, 1367, 1207, 1039, 801, 
752; HRMS (ESI) m/z calculated for C10H9O4 [MH
+]: 193.0495, found: 193.0500. 
(R)-1-(2-Oxo-2H-pyran-6-yl)pentyl propiolate) ((R)-350b) 
 
Following general procedure H, reaction of pyrone (R)-26b (434 mg, 2.38 mmol, 1.0 equiv), 
propiolic acid (349) (295 µL, 4.76 mmol, 2.0 equiv), DMAP (21.8 mg, 179 µmol, 7.0 mol%) 
and DCC (552 mg, 2.68 mmol, 1.1 equiv) afforded (R)-350b after purification by flash column 
chromatography (PE:EA = 7:1 to 2:1) as a yellowish oil (345 mg, 1.47 mmol, 62%). 
Rf = 0.18 (PE:EA = 7:1); 
1H NMR (300 MHz, CDCl3) δH = 7.30 (dd, J = 9.4, 6.5 Hz, 1H), 6.26 
(dd, J = 9.4, 1.0 Hz, 1H), 6.21 (dt, J = 6.6, 0.9 Hz, 1H), 5.52 (t, J = 6.7 Hz, 1H), 2.98 (s, 1H), 
2.00 – 1.88 (m, 2H), 1.41 – 1.27 (m, 4H), 0.93 – 0.87 (m, 3H); 13C NMR (101 MHz, CDCl3) 






1): 3235, 3090, 2959, 2933, 2866, 2117, 1714, 1640, 1558, 1464, 1207, 1095, 954, 805, 752; 
HRMS (ESI) m/z calculated for C13H15O4 [MH
+]: 235.0965, found: 235.0970. 
(2-Oxo-2H-pyran-6-yl)(phenyl)methyl propiolate (350c) 
 
Following general procedure H, reaction of pyrone 26c (1.02 g, 5.03 mmol, 1.0 equiv), 
propiolic acid (349) (624 µL, 10.1 mmol, 2.0 equiv), DMAP (46.0 mg, 377 µmol, 7.0 mol%) 
and DCC (1.17 g, 5.66 mmol, 1.1 equiv) afforded 350c after purification by flash column 
chromatography (PE:EA = 4:1 to 2:1) as a yellowish oil (691 mg, 2.72 mmol, 54%). 
Rf = 0.11 (PE:EA = 4:1); 
1H NMR (300 MHz, CDCl3) δH = 7.46 – 7.38 (m, 5H), 7.30 (dd, J = 
9.4, 6.6 Hz, 1H), 6.53 (s, 1H), 6.28 – 6.22 (m, 2H), 3.00 (s, 1H); 13C NMR (75 MHz, CDCl3) 
δC = 161.0, 160.4, 151.1, 142.8, 134.4, 129.7, 129.1, 127.7, 115.9, 103.3, 76.7, 74.9, 74.0; IR 
(ν/cm-1): 3257, 3067, 2937, 2117, 1714, 1640, 1558, 1453, 1207, 1095, 801, 745, 697; HRMS 
(ESI) m/z calculated for C15H11O4 [MH
+]: 255.0652, found: 255.0659. 
3-Methylisobenzofuran-1(3H)-one (326a)176 
 
According to general procedure I pyrone 350a (100 mg, 520 µmol, 1.0 equiv) was used to yield 
phthalide 326a as a colorless oil (76.9 mg, 519 µmol, >99%). 
Rf = 0.78 (PE:EA = 2:1); 
1H NMR (400 MHz, CDCl3) δH = 7.90 (d, J = 7.7 Hz, 1H), 7.68 (td, 
J = 7.5, 1.1 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.44 (dd, J = 7.6, 0.9 Hz, 1H), 5.57 (q, J = 6.7 
Hz, 1H), 1.64 (d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δC = 170.6, 151.3, 134.1, 129.1, 








According to general procedure I pyrone (R)-350b (121 mg, 517 µmol, 1.0 equiv) was used to 
yield phthalide (R)-326b as a colorless oil (97.9 mg, 515 µmol, >99%). 
Rf = 0.78 (PE:EA = 2:1); 
1H NMR (400 MHz, CDCl3) δH = 7.87 (dd, J = 7.6, 0.9 Hz, 1H), 7.66 
(td, J = 7.5, 1.1 Hz, 1H), 7.50 (t, J = 7.5 Hz, 1H), 7.43 (dd, J = 7.7, 0.9 Hz, 1H), 5.46 (dd, J = 
7.9, 4.1 Hz, 1H), 2.08 – 1.99 (m, 1H), 1.79 – 1.70 (m, 1H), 1.49 – 1.32 (m, 4H), 0.89 (t, J = 7.1 
Hz, 3H); 13C NMR (101 MHz, CDCl3) δC = 170.7, 150.2, 134.0, 129.1, 126.2, 125.7, 121.8, 
81.5, 34.5, 26.9, 22.5, 13.9; Chiral HPLC 74% ee (tR minor, major =  14.0, 19.4 min, Chiralcel 
AS-H 4.6 × 250 mm 10 µm, n-heptane:i-PrOH 95:5, 1.0 mL/min). 
3-Phenylisobenzofuran-1(3H)-one (326c)176 
 
According to general procedure I pyrone 350c (127 mg, 500 µmol, 1.0 equiv) was used to yield 
phthalide 326c as a yellowish solid (104 mg, 500 µmol, >99%). 
Rf = 0.32 (PE:EA = 4:1); 
1H NMR (400 MHz, CDCl3) δH = 7.85 (d, J = 7.6 Hz, 1H), 7.54 (td, 
J = 7.5, 1.1 Hz, 1H), 7.44 (t, J = 7.5 Hz, 1H), 7.29 – 7.21 (m, 4H), 7.17 (dd, J = 6.6, 3.0 Hz, 
2H), 6.30 (s, 1H); 13C NMR (101 MHz, CDCl3) δC = 170.6, 149.7, 136.4, 134.4, 129.4, 129.3, 
129.0, 127.0, 125.6, 125.5, 122.9, 82.7. 
1-(2-Oxo-2H-pyran-6-yl)ethyl 3-bromopropiolate (355) 
 
Pyrone propiolate 350a (659 mg, 3.43 mmol, 1.0 equiv) was dissolved in acetone (70 mL) and 
the solution was cooled to 0 °C in an ice bath. Subsequently, AgNO3 (291 mg, 1.72 mmol, 
0.5 equiv) and NBS (917 mg, 5.15 mmol, 1.5 equiv) were added and the mixture was stirred at 





(40 mL). After phase separation, the aqueous phase was extracted with Et2O (3×). The organic 
phase was washed with H2O (1×), brine (1×) and dried over MgSO4. The solvent was 
concentrated under vacuum and the crude product was filtered over a short pad of silica (washed 
with PE:EA = 2:1). The solvent was removed under reduced pressure to yield the pure product 
355 as a yellowish oil (838 mg, 3.09 mmol, 90%). 
Rf = 0.43 (PE:EA = 2:1); 
1H NMR (400 MHz, CDCl3) δH =7.30 (dd, J = 9.4, 6.6 Hz, 1H), 6.24 
(dd, J = 10.2, 8.0 Hz, 2H), 5.61 (q, J = 6.7 Hz, 1H), 1.57 (d, J = 6.7 Hz, 3H); 13C NMR 
(101 MHz, CDCl3) δC = 161.3, 161.1, 151.1, 143.0, 115.9, 102.7, 72.2, 70.2, 54.7, 18.1; IR 
(ν/cm-1): 3090, 2989, 2937, 2191, 1707, 1640, 1558, 1215, 1080, 980, 801, 738; HRMS (ESI) 
m/z calculated for C10H8BrO4 [MH
+]: 270.9600, found: 270.9604. 
7-Bromo-3-methylisobenzofuran-1(3H)-one (354) 
 
According to general procedure I pyrone 355 (195 mg, 720 µmol, 1.0 equiv) was used to yield 
phthalide 354 as a yellowish solid (164 mg, 718 µmol, >99%). 
Rf = 0.59 (PE:EA = 2:1); mp 80 − 81 °C; 
1H NMR (400 MHz, CDCl3) δH = 7.57 (d, J = 7.8 
Hz, 1H), 7.43 (t, J = 7.7 Hz, 1H), 7.32 (d, J = 7.6 Hz, 1H), 5.41 (q, J = 6.7 Hz, 1H), 1.53 (d, J 
= 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δC = 167.7, 153.6, 135.1, 133.7, 126.9, 124.0, 
120.7, 76.0, 20.3; IR (ν/cm-1): 3082, 2993, 2933, 2184, 1707, 1636, 1558, 1215, 1066, 801; 
HRMS (EI) m/z calculated for C9H7BrO2 [M




Under nitrogen atmosphere 2-pyrone (1) (96.1 mg, 1.00 mmol, 1.0 equiv) and 
[Ir(dtb-bpy)(dF((CF3)ppy)2]PF6 (11.2 mg, 10.0 µmol, 1.0 mol%) were dissolved in dry 
degassed DMF (2.0 mL). The reaction mixture was stirred under irradiation with a blue LED 





and the crude product was purified by flash column chromatography (PE:EA = 1:1 to 1:3) to 
afford 367a as a yellow solid (44.5 mg, 230 µmol, 46%) and 367b as a yellow solid 
(43.9 mg, 230 µmol, 46%). 
367a: Rf = 0.36 (PE:EA = 1:3); 
1H NMR (400 MHz, CDCl3) δH = 6.66 – 6.61 (m, 2H), 6.53 
(dd, J = 6.4, 1.8 Hz, 1H), 5.75 – 5.68 (m, 1H), 5.15 (dd, J = 6.4, 3.6 Hz, 1H), 3.60 – 3.56 (m, 
1H), 3.09 (dd, J = 11.3, 1.6 Hz, 1H), 2.82 – 2.76 (m, 1H); 13C NMR (101 MHz, CDCl3) δC = 
170.6, 165.4, 140.6, 132.8, 132.3, 103.8, 77.0, 46.8, 41.5, 31.0. 
367b: Rf = 0.11 (PE:EA = 1:3); 
1H NMR (400 MHz, CDCl3) δH = 6.68 – 6.60 (m, 2H), 6.55 
(ddd, J = 7.7, 5.1, 1.6 Hz, 1H), 6.08 (dd, J = 10.2, 2.1 Hz, 1H), 5.39 (dt, J = 5.2, 1.9 Hz, 1H), 
4.91 (dd, J = 9.9, 1.8 Hz, 1H), 3.61 (dt, J = 6.2, 1.9 Hz, 1H), 2.88 – 2.83 (m, 1H); 13C NMR 
(101 MHz, CDCl3) δC = 169.7, 159.6, 141.8, 133.7, 130.5, 120.8, 78.0, 75.3, 46.2, 29.3. 
General procedure J. Racemic cyclopropanation of pyrone 1 or pyridinone 378 
Under nitrogen atmosphere pyrone 1 or pyridinone 378 (1.0 equiv) and Rh2(OAc)4 (2.5 mol% 
or 1.0 mol%) were dissolved in dry toluene (0.5 M). A solution of methyl 2-diazo-2-
phenylacetate (376) (3.0 equiv or 2.0 equiv) in dry toluene (1.1 M) was added dropwise at room 
temperature for the duration of 1.5 h using a syringe pump. After complete addition, the mixture 
was stirred at room temperature for 30 min. The reaction mixture was filtered through a short 
pad of silica and washed with EA. The solvent was removed under reduced pressure and the 
crude product was purified by flash column chromatography (PE:EA = 4:1 to 2:1). 
Methyl 3-oxo-7-phenyl-2-oxabicyclo[4.1.0]hept-4-ene-7-carboxylate (377a) 
 
Following general procedure J, reaction of 2-pyrone (1) (480 mg, 5.00 mmol, 1.0 equiv), 
Rh2(OAc)4 (55.2 mg, 125 µmol, 2.5 mol%) and methyl 2-diazo-2-phenylacetate (376) (2.64 g, 
15.0 mmol, 3.0 equiv) yielded 377a as a white solid (916 mg, 3.75 mmol, 75%). 
Rf = 0.33 (PE:EA = 2:1); mp 121 − 122 °C; 
1H NMR (400 MHz, CDCl3) δH = 7.35 – 7.27 (m, 
3H), 7.25 – 7.05 (m, 2H), 6.90 (ddd, J = 10.0, 5.5, 1.0 Hz, 1H), 5.60 (d, J = 10.0 Hz, 1H), 4.99 
(dd, J = 7.0, 1.0 Hz, 1H), 3.66 (s, 3H), 2.84 (dd, J = 7.0, 5.6 Hz, 1H); 13C NMR (101 MHz, 





(ν/cm-1): 3030, 2955, 1714, 1435, 1330, 1244, 1136, 1062, 864, 820, 700; HRMS (APCI) m/z 
calculated for C14H13O4 [MH
+]: 245.0808, found: 245.0810. 
Methyl 3-oxo-7-phenyl-2-tosyl-2-azabicyclo[4.1.0]hept-4-ene-7-carboxylate (377b) 
 
Following general procedure J, reaction of 2-pyridinone (378) (1.25 g, 5.00 mmol, 1.0 equiv), 
Rh2(OAc)4 (22.1 mg, 50.0 µmol, 1.0 mol%) and methyl 2-diazo-2-phenylacetate (376) (1.76 g, 
10.0 mmol, 2.0 equiv) yielded 377b as a white solid (1.89 g, 4.76 mmol, 95%). 
Rf = 0.28 (PE:EA = 2:1); mp 178 − 179 °C; 
1H NMR (400 MHz, CDCl3) δH =7.98 (d, J = 8.3 
Hz, 2H), 7.35 – 7.20 (m, 7H), 6.80 (dd, J = 9.9, 5.2 Hz, 1H), 5.52 (d, J = 9.9 Hz, 1H), 4.81 (d, 
J = 9.0 Hz, 1H), 3.69 (s, 3H), 3.00 (dd, J = 9.0, 5.3 Hz, 1H), 2.43 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δC = 172.5, 159.5, 145.4, 139.8, 135.7, 133.7, 129.5, 129.0, 128.5, 128.47, 128.43, 
125.7, 53.4, 46.7, 35.3, 26.9, 21.8; IR (ν/cm-1): 3063, 2955, 1692, 1595, 1435, 1360, 1252, 
1170, 1092, 991, 820, 708; HRMS (ESI) m/z calculated for C21H20NO5S [MH
+]: 398.1057, 
found: 398.1062. 
General procedure K. Enantioselective cyclopropanation of pyrone 1 and pyridinone 378 
Pyrone 1 or pyridinone 378 (500 µmol, 1.0 equiv) and Rh2(R-PTAD)4 (3.90 mg, 2.50 µmol, 
0.5 mol%) were dissolved in dry DCM (1.0 mL) under nitrogen atmosphere. The mixture was 
cooled to 0 °C and a solution of 2,2,2-trichloroethyl 2-(4-bromophenyl)-2-diazoacetate (379) 
(372 mg, 1.00 mmol, 2.0 equiv) in dry DCM (0.9 mL) was added dropwise for the duration of 
1.5 h using a syringe pump. After complete addition, the solvent was removed under reduced 










Following the general procedure K, pyrone 1 (48.0 mg, 500 µmol, 1.0 equiv) was employed to 
afford 380a as a white solid (216 mg, 490 µmol, 98%). 
Rf = 0.39 (PE:EA = 2:1); 
1H NMR (400 MHz, CDCl3) δH =7.50 – 7.41 (m, 2H), 7.08 (d, J = 
8.0 Hz, 2H), 6.92 (ddd, J = 10.0, 5.5, 1.0 Hz, 1H), 5.69 (d, J = 10.0 Hz, 1H), 5.08 (dd, J = 7.1, 
1.0 Hz, 1H), 4.73 (d, J = 11.9 Hz, 1H), 4.66 (d, J = 11.9 Hz, 1H), 2.93 (dd, J = 7.1, 5.5 Hz, 1H); 
13C NMR (101 MHz, CDCl3) δC = 169.2, 158.6, 141.1, 135.4, 132.0, 126.2, 123.2, 121.7, 94.4, 




Following general procedure K, pyridinone 379 (125 mg, 500 µmol, 1.0 equiv) was employed 
to afford 380b as a white solid (294 mg, 495 µmol, 99%). 
Rf = 0.37 (PE:EA = 2:1); 
1H NMR (400 MHz, CDCl3) δH =7.97 (d, J = 8.4 Hz, 2H), 7.47 – 
7.42 (m, 2H), 7.36 – 7.31 (m, 2H), 7.14 (d, J = 8.0 Hz, 2H), 6.82 (ddd, J = 9.9, 5.3, 0.8 Hz, 1H), 
5.61 (d, J = 9.9 Hz, 1H), 4.87 (dd, J = 9.1, 0.7 Hz, 1H), 4.78 (d, J = 11.9 Hz, 1H), 4.72 (d, J = 
11.9 Hz, 1H), 3.10 (dd, J = 9.1, 5.2 Hz, 1H), 2.44 (s, 3H); 13C NMR (101 MHz, CDCl3) δC = 
 
f The complete characterization and HPLC chromatogram of this molecule can be viewed in the Ph.D. thesis of 





170.0, 159.1, 145.7, 139.0, 135.3, 131.9, 129.6, 129.0, 126.7, 126.4, 123.1, 94.5, 74.8, 47.0, 
34.8, 27.0, 21.8; Chiral HPLC 95% ee.g 
(2-Hydroxy-1-phenylcyclopent-4-ene-1,3-diyl)dimethanol (411) 
 
Under nitrogen atmosphere cyclopropanated pyrone 377a (100 mg, 409 µmol, 1.0 equiv) was 
dissolved in dry DCM (8.0 mL) and cooled to −78 °C. DIBAL-H solution (1.2 M in toluene, 
1.19 mL, 1.43 mmol, 3.5 equiv) was added dropwise and the mixture was stirred at −78 °C for 
4 h. The reaction mixture was allowed to warm up to ambient temperature and quenched with 
saturated NaHCO3 solution (4.0 mL). Saturated Rochelle salt solution (6.0 mL) was added and 
the mixture was stirred for 30 min at room temperature. The phases were separated and the 
aqueous phase was extracted with EA (6×). The combined organic phases were dried over 
Na2SO4 and the solvent was removed under reduced pressure. The crude product was purified 
by flash column chromatography (DCM:MeOH = 19:1 to 9:1) to yield 411 as yellowish oil 
(56.6 mg, 257 µmol, 63%).  
Rf = 0.44 (DCM:MeOH = 19:1); 
1H NMR (300 MHz, CDCl3) δH = 7.42 – 7.29 (m, 5H), 6.06 
(dd, J = 6.1, 2.5 Hz, 1H), 5.95 (dd, J = 6.0, 2.0 Hz, 1H), 4.49 (d, J = 6.1 Hz, 1H), 3.85 – 3.65 
(m, 4H), 3.16 – 3.04 (m, 1H), 2.76 (s, 1H), 2.03 (s, 1H), 1.93 (s, 1H); 13C NMR (101 MHz, 
CDCl3) δC = 138.9, 133.5, 133.3, 128.9, 128.3, 127.5, 77.3, 68.7, 64.4, 61.8, 51.8; IR (ν/cm
-1): 
3377, 3056, 2926, 2881, 1703, 1420, 1360, 1222, 1062, 1021, 760, 700; HRMS (APCI) m/z 
calculated for C13H17O3 [MH
+]: 221.1172, found: 221.1171. 
  
 
g The complete characterization and HPLC chromatogram of this molecule can be viewed in the Ph.D. thesis of 





4 Atypical reactivity of anthracene derivatives 
1,5-Dimethoxy-9,10-anthraquinone (427)264 
 
1,5-dihydroxy-9,10-anthraquinone (426) (8.00 g, 33.3 mmol, 1.0 equiv) and K2CO3 (13.4 g, 
96.6 mmol, 2.9 equiv) were dissolved in acetone (42 mL). Dimethyl sulfate (9.24 g, 73.2 mmol, 
2.2 equiv) was added and the mixture was stirred under reflux conditions for 48 h. The solvent 
was removed under reduced pressure and the crude product was purified by flash column 
chromatography (DCM) to afford 427 as a yellow solid (6.26 g, 23.3 mmol, 70%). 
1H NMR (300 MHz, CDCl3) δH = 8.01 – 7.78 (m, 2H), 7.77 – 7.51 (m, 2H), 7.38 – 7.09 (m, 
2H), 4.13 – 3.82 (m, 6H); 13C NMR (75 MHz, CDCl3) δC = 182.8, 159.8, 137.5, 135.1, 120.9, 
119.8, 116.8, 56.6. 
1,5-Bis(N,N-dimethylamino)anthracene (419c) 
 
Under nitrogen atmosphere 1,5-diaminoanthracene (429) (2.00 g, 9.60 mmol, 1.0 equiv) and 
methyl iodide (5.98 mL, 96.0 mmol, 10 equiv) were dissolved in dry THF (100 mL) and the 
resulting solution was cooled to 0 °C. At this temperature NaH (60% dispersion in mineral oil, 
3.84 g, 96.0 mmol, 10 equiv) was added in portions and the reaction mixture was stirred at room 
temperature for 14 h, followed by stirring under reflux conditions for 18 h. The mixture was 
cooled to 0 °C and carefully quenched with water (50 mL). THF was removed under reduced 
pressure and the remaining aqueous phase was extracted with DCM (3×). The combined organic 
phases were washed with brine and dried over MgSO4. The solvent was removed under reduced 
pressure and the crude product was purified by flash column chromatography (PE:DCM = 3:1) 
to yield 419c as a yellow solid (1.52 g, 5.75 mmol, 60%).  
Rf = 0.50 (PE:DCM = 7:3); mp 144 − 145 °C; 
1H NMR (300 MHz, CDCl3) δH =8.78 (d, J = 
3.5 Hz, 2H), 7.75 (d, J = 8.5 Hz, 2H), 7.39 (dd, J = 10.4, 5.2 Hz, 2H), 7.02 (d, J = 7.2 Hz, 2H), 





45.2; IR (ν/cm-1): 3049, 2981, 2944, 2862, 2832, 2788, 1610, 1543, 1453, 1349, 1189, 1140, 
1077, 916, 793, 730; HRMS (ESI) m/z calculated for C18H21N2 [MH




1,5-Diaminoanthracene (429) (2.00 g, 9.60 mmol, 1.0 equiv) and K2CO3 (5.31 g, 38.4 mmol, 
4.0 equiv) were dissolved in dioxane/water (1:1, 40 mL) and 1,4-dibromobutane (3.40 mL, 
28.8 mmol, 3.0 equiv) was added. The reaction mixture was stirred under reflux conditions for 
24 h. Additional 1,4-dibromobutane (3.40 mL,28.8 mmol, 3.0 equiv) was appended and the 
mixture was stirred under reflux conditions for 24 h. The reaction solution was cooled to 
ambient temperature and water (40 mL) was added. The phases were separated and the aqueous 
phase was extracted with DCM (3×). The combined organic phases were dried over MgSO4 
and the solvent was removed under reduced pressure. The crude product was purified by flash 
column chromatography (PE:DCM = 9:1 to 7:3) to afford 419d as a yellow solid (1.49 g, 
4.71 mmol, 49%). 
Rf = 0.58 (PE:DCM = 7:3); mp 194 − 195 °C; 
1H NMR (300 MHz, CDCl3) δH = 8.74 (s, 2H), 
7.65 (d, J = 8.4 Hz, 2H), 7.45 – 7.28 (m, 2H), 6.91 (d, J = 7.3 Hz, 2H), 3.58 – 3.39 (m, 8H), 
2.17 – 2.01 (m, 8H); 13C NMR (75 MHz, CDCl3) δC = 147.3, 132.4, 127.1, 125.1, 123.9, 122.1, 
109.7, 52.8, 25.0; IR (ν/cm-1): 3067, 2948, 2873, 2821, 1610, 1539, 1453, 1353, 1110, 920, 
793, 730; HRMS (ESI) m/z calculated for C22H25N2 [MH
+]: 317.2012, found: 317.2013. 
1-(Pyrrolidine-1-yl)anthracene (419e) 
 
1-Aminoanthracene (433) (9.79 g, 50.7 mmol, 1.0 equiv) and K2CO3 (14.0 g, 101 mmol, 
2.0 equiv) were dissolved in dioxane/water (1:1, 210 mL) and 1,4-dibromobutane (8.97 mL, 
76.0 mmol, 1.5 equiv) was added. The reaction mixture was stirred under reflux conditions for 





mixture was stirred under reflux conditions for 24 h. The reaction solution was cooled to 
ambient temperature and water (100 ml) was added. The phases were separated and the aqueous 
phase was extracted with DCM (6×). The combined organic phases were dried over MgSO4 
and the solvent was removed under reduced pressure. The crude product was purified by flash 
column chromatography (PE:DCM = 9:1 to 7:3 to 1:1) to give rise to 419e as a bright yellow 
solid (7.14 g, 28.9mmol, 57%). 
Rf = 0.24 (PE:DCM = 7:3); mp 60 − 61 °C; 
1H NMR (400 MHz, CDCl3) δH = 8.85 (s, 1H), 
8.41 (s, 1H), 8.13 – 7.96 (m, 2H), 7.66 (d, J = 8.4 Hz, 1H), 7.54 – 7.45 (m, 2H), 7.39 (dd, J = 
8.4, 7.3 Hz, 1H), 6.95 (d, J = 7.3 Hz, 1H), 3.56 – 3.44 (m, 4H), 2.17 – 2.06 (m, 4H); 13C NMR 
(101 MHz, CDCl3) δC = 147.5, 133.3, 131.4, 130.8, 128.8, 127.7, 127.4, 126.3, 125.5, 125.0, 
123.7, 121.7, 109.9, 52.9, 24.9; IR (ν/cm-1): 3049, 2996, 2967, 2870, 2810, 1613, 1535, 1453, 
1394, 1349, 1230, 1129, 887, 749; HRMS (EI) m/z calculated for C18H17N [M
+]: 247.1355, 
found: 247.1350. 
General procedure L. [4+2]-Cycloaddition of anthracenes 
In a pressure tube anthracene 419 (1.0 equiv) and dienophile A-E (1.1 equiv) were dissolved in 
toluene (0.5 M) and the reaction mixture was stirred at 150 °C until complete conversion of 
starting material was observed (monitored by TLC). The solvent was removed under reduced 




Following general procedure L, reaction of anthracene 419b (80.0 mg, 335 µmol, 1.0 equiv) 
and dimethyl fumarate (A) (53.0 mg, 369 µmol, 1.1 equiv) for 24 h afforded 430bA after 
purification by flash column chromatography (DCM to DCM:EA = 99:1) as a white solid 
(122 mg, 318 µmol, 95%). 
Rf = 0.52 (DCM:EA = 99:1); mp 162 − 163 °C; 
1H NMR (400 MHz, CDCl3) δH = 7.10 – 6.99 
(m, 3H), 6.91 (d, J = 7.3 Hz, 1H), 6.68 (d, J = 8.2 Hz, 2H), 5.22 – 5.17 (m, 2H), 3.85 (s, 3H), 
3.82 (s, 3H), 3.64 (s, 3H), 3.63 (s, 3H), 3.37 (dt, J = 5.5, 1.3 Hz, 2H); 13C NMR (101 MHz, 





116.6, 109.1, 108.9, 55.7, 55.5, 52.2, 52.1, 47.5, 47.4, 40.0, 39.5; IR (ν/cm-1): 3000, 2952, 2840, 
1729, 1587, 1483, 1438, 1263, 1200, 1095, 1021, 909, 782, 730; HRMS (ESI) m/z calculated 
for C22H23O6 [MH
+]: 383.1489, found: 383.1490. 
1,5-Dimethoxy-9,10-dihydro-9,10-[3,4]furanoanthracene-12,14-dione (430bB) 
 
Following general procedure L, reaction of anthracene 419b (80.0 mg, 335 µmol, 1.0 equiv) 
and maleic anhydride (B) (36.0 mg, 369 µmol, 1.1 equiv) for 2 h afforded 430bB after 
recrystallization from DCM as a white solid (109 mg, 324 µmol, 97%). 
Rf = 0.69 (DCM:EA = 99:1); mp 263 − 264 °C; 
1H NMR (400 MHz, CDCl3) δH = 7.14 (ddd, 
J = 8.3, 7.4, 4.2 Hz, 2H), 7.03 (d, J = 7.4 Hz, 1H), 6.98 (d, J = 7.4 Hz, 1H), 6.75 (ddd, J = 8.4, 
5.7, 0.9 Hz, 2H), 5.33 (dd, J = 17.1, 3.0 Hz, 2H), 3.86 (s, 3H), 3.84 (s, 3H), 3.50 – 3.41 (m, 
2H); 13C NMR (101 MHz, CDCl3) δC = 170.7, 170.6, 155.0, 154.6, 142.8, 140.2, 128.6, 128.5, 
127.8, 126.4, 117.9, 117.0, 110.2, 109.5, 55.9, 55.6, 47.8, 47.7, 38.5, 38.4; IR (ν/cm-1): 3011, 
2959, 2922, 2840, 1863, 1781, 1587, 1483, 1267, 1215, 1099, 939, 786, 726; HRMS (EI) m/z 
calculated for C20H16O5 [M




Following general procedure L, reaction of anthracene 419b (80.0 mg, 335 µmol, 1.0 equiv) 
and N-phenylmaleimide (C) (64.0 mg, 369 µmol, 1.1 equiv) for 2 h afforded 430bC after 
recrystallization from DCM as a white solid (137 mg, 333 µmol, 99%). 
Rf = 0.41 (DCM:EA = 99:1); mp 274 − 275 °C; 
1H NMR (400 MHz, CDCl3) δH = 7.35 – 7.27 
(m, 3H), 7.16 (ddd, J = 8.1, 7.3, 4.6 Hz, 2H), 7.08 (d, J = 7.3 Hz, 1H), 7.01 (d, J = 7.3 Hz, 1H), 
6.77 (ddd, J = 8.2, 5.8, 0.9 Hz, 2H), 6.60 – 6.52 (m, 2H), 5.42 (d, J = 3.3 Hz, 1H), 5.38 (d, J = 





CDCl3) δC = 176.3, 176.1, 155.1, 154.6, 143.5, 140.8, 131.7, 129.3, 129.1, 128.7, 127.8, 127.5, 
127.1, 126.6, 118.0, 117.0, 109.8, 109.2, 56.1, 55.6, 46.9, 46.7, 38.8; IR (ν/cm-1): 3067, 2996, 
2937, 2899, 2836, 2255, 1777, 1707, 1584, 1479, 1382, 1263, 1095, 909, 723; HRMS (ESI) 
m/z calculated for C26H22NO4 [MH




Following general procedure L, reaction of anthracene 419c (132 mg, 500 µmol, 1.0 equiv) and 
N-phenylmaleimide (C) (95.0 mg, 550 µmol, 1.1 equiv) for 30 min afforded 430cC after 
purification by flash column chromatography (DCM:EA = 99:1 to 1:1) as a white solid 
(215 mg, 492 µmol, 98%). 
Rf = 0.46 (DCM:EA = 99:1); mp 209 − 210 °C; 
1H NMR (400 MHz, CDCl3) δH = 7.43 – 7.37 
(m, 3H), 7.28 – 7.22 (m, 3H), 7.17 (dd, J = 7.3, 1.1 Hz, 1H), 7.07 (dd, J = 8.1, 1.1 Hz, 1H), 7.03 
(dd, J = 6.4, 2.8 Hz, 1H), 6.68 – 6.60 (m, 2H), 5.54 (d, J = 3.1 Hz, 1H), 5.41 (d, J = 3.0 Hz, 
1H), 3.45 – 3.37 (m, 2H), 2.90 (s, 6H), 2.84 (s, 6H); 13C NMR (101 MHz, CDCl3) δC = 176.3, 
175.9, 150.6, 150.1, 142.6, 139.6, 135.2, 133.5, 131.7, 129.0, 128.6, 127.3, 126.9, 126.6, 119.8, 
118.6, 117.2, 116.5, 47.0, 46.8, 45.1, 44.9, 41.5, 41.2; IR (ν/cm-1): 3063, 2985, 2944, 2862, 
2784, 2251, 1777, 1710, 1584, 1483, 1382, 1319, 1189, 909, 790, 726; HRMS (ESI) m/z 
calculated for C28H28N3O2 [MH




Following general procedure L, reaction of anthracene 419d (158 mg, 500 µmol, 1.0 equiv) and 





purification by flash column chromatography (DCM:EA = 99:1 to 1:1) as a white solid 
(223 mg, 460 µmol, 92%). 
Rf = 0.52 (DCM:EA = 99:1); mp 225 − 226 °C; 
1H NMR (400 MHz, CDCl3) δH =7.31 – 7.22 
(m, 3H), 7.08 – 6.98 (m, 2H), 6.94 (d, J = 7.2 Hz, 1H), 6.79 (d, J = 7.2 Hz, 1H), 6.71 (d, J = 8.2 
Hz, 1H), 6.64 (d, J = 8.3 Hz, 1H), 6.60 – 6.51 (m, 2H), 5.44 (d, J = 2.7 Hz, 1H), 5.22 (d, J = 
2.3 Hz, 1H), 3.58 – 3.46 (m, 2H), 3.46 – 3.38 (m, 2H), 3.31 – 3.17 (m, 6H), 2.03 – 1.90 (m, 
6H), 1.90 – 1.77 (m, 2H); 13C NMR (101 MHz, CDCl3) δC = 176.6, 176.4, 146.7, 146.4, 143.7, 
140.5, 131.8, 130.4, 129.0, 128.5, 127.2, 126.8, 126.69, 126.65, 115.8, 115.6, 113.94, 113.91, 
52.0, 51.8, 47.1, 47.0, 43.2, 42.8, 25.6, 25.4; IR (ν/cm-1): 3063, 2967, 2870, 2825, 2251, 1774, 
1710, 1580, 1476, 1382, 1356, 1185, 909, 726; HRMS (ESI) m/z calculated for C32H32N3O2 
[MH+]: 490.2489, found: 490.2496. 
Methyl 1,5-di(pyrrolidin-1-yl)-9,10-dihydro-9,10-ethenoanthracene-11-carboxylate 
(430dE) 
Methyl 1,5-di(pyrrolidin-1-yl)-1,4-dihydro-1,4-ethenoanthracene-2-carboxylate (431dE) 
 
Following general procedure L, reaction of anthracene 419d (200 mg, 632 µmol, 1.0 equiv) and 
methyl propiolate (E) (62.0 µL, 695 µmol, 1.1 equiv) for 24 h afforded after purification by 
flash column chromatography (DCM:EA = 19:1 to 3:2) 430dE as a white solid (34.9 mg, 
87.0 µmol, 14%) and 431dE as a white solid (142 mg, 355 µmol, 56%). 
430dE: Rf = 0.56 (DCM:EA = 19:1); mp 118 − 119 °C; 
1H NMR (400 MHz, CDCl3) δH =7.87 
(dd, J = 6.3, 1.9 Hz, 1H), 6.98 (d, J = 7.2 Hz, 1H), 6.91 – 6.83 (m, 3H), 6.55 (dd, J = 8.3, 1.0 
Hz, 1H), 6.51 (d, J = 8.2 Hz, 1H), 6.20 (d, J = 1.9 Hz, 1H), 5.69 (d, J = 6.4 Hz, 1H), 3.70 (s, 
3H), 3.49 – 3.38 (m, 6H), 3.31 – 3.24 (m, 2H), 2.03 – 1.95 (m, 8H); 13C NMR (101 MHz, 
CDCl3) δC = 165.5, 150.5, 147.7, 146.6, 146.2, 146.0, 144.9, 133.5, 132.9, 125.4, 125.3, 116.0, 
114.9, 112.7, 112.5, 52.2, 51.9, 51.7, 49.1, 47.8, 25.8, 25.5.; IR (ν/cm-1): 3034, 2944, 2866, 
1710, 1625, 1580, 1461, 1330, 1237, 1092, 730; HRMS (ESI) m/z calculated for C26H29N2O2 





431dE: Rf = 0.18 (DCM:EA = 3:2); mp 201 − 202 °C; 
1H NMR (400 MHz, CDCl3) δH =7.89 
(s, 2H), 7.43 (d, J = 6.3 Hz, 1H), 7.39 (d, J = 8.1 Hz, 1H), 7.29 (t, J = 7.8 Hz, 1H), 7.00 (d, J = 
3.8 Hz, 2H), 6.96 (d, J = 7.5 Hz, 1H), 4.95 – 4.85 (m, 1H), 3.70 (s, 3H), 3.37 – 3.21 (m, 8H), 
2.08 – 1.98 (m, 8H); 13C NMR (101 MHz, CDCl3) δC = 166.7, 148.7, 147.4, 146.0, 143.8, 
141.2, 139.6, 138.5, 132.5, 125.7, 125.4, 122.2, 121.7, 117.5, 112.5, 52.8, 52.0, 51.3, 48.0, 26.0, 
24.7; IR (ν/cm-1): 3052, 2948, 2866, 2817, 1714, 1621, 1580, 1457, 1364, 1289, 1230, 1073, 
894, 738; HRMS (ESI) m/z calculated for C26H29N2O2 [MH






Following general procedure L, reaction of anthracene 419e (200 mg, 809 µmol, 1.0 equiv) and 
dimethyl fumarate (A) (128 mg, 889 µmol, 1.1 equiv) for 24 h afforded after purification by 
flash column chromatography (DCM to DCM:EA = 19:1) syn-430eA as a white solid (147 mg, 
370 µmol, 46%) and anti-430eA as a white solid (157 mg, 400 µmol, 50%). 
syn-430eA: Rf = 0.77 (DCM:EA = 19:1); mp 138 − 139 °C; 
1H NMR (400 MHz, CDCl3) δH = 
7.52 – 7.47 (m, 1H), 7.42 – 7.39 (m, 1H), 7.31 – 7.22 (m, 2H), 7.16 (dd, J = 8.2, 7.2 Hz, 1H), 
7.03 (d, J = 7.1 Hz, 1H), 6.78 (dd, J = 8.3, 1.0 Hz, 1H), 5.46 (d, J = 2.9 Hz, 1H), 4.84 (d, J = 
2.8 Hz, 1H), 3.76 (s, 3H), 3.74 (s, 3H), 3.69 – 3.60 (m, 3H), 3.51 (dd, J = 4.7, 2.9 Hz, 1H), 3.36 
– 3.28 (m, 2H), 2.25 – 2.13 (m, 2H), 2.10 – 1.98 (m, 2H); 13C NMR (101 MHz, CDCl3) δC = 
173.1, 173.0, 146.3, 143.7, 142.5, 140.8, 128.6, 126.9, 126.3, 126.2, 124.7, 123.2, 115.5, 113.7, 
52.2, 51.9, 51.8, 47.8, 47.6, 47.4, 43.5, 25.7; IR (ν/cm-1): 3052, 3022, 2952, 2870, 1729, 1580, 
1479, 1435, 1356, 1259, 1192, 1006, 868, 771; HRMS (ESI) m/z calculated for C24H26NO4 
[MH+]: 392.1856, found: 392.1858. 
anti-430eA: Rf = 0.59 (DCM:EA = 19:1); mp 106 − 107 °C; 
1H NMR (400 MHz, CDCl3) δH 
= 7.51 – 7.46 (m, 1H), 7.44 – 7.41 (m, 1H), 7.30 – 7.22 (m, 2H), 7.13 (dd, J = 8.2, 7.2 Hz, 1H), 
6.96 (d, J = 7.1 Hz, 1H), 6.84 (dd, J = 8.3, 1.0 Hz, 1H), 5.37 (d, J = 2.6 Hz, 1H), 4.85 (d, J = 





– 2.09 (m, 4H); 13C NMR (101 MHz, CDCl3) δC = 173.0, 172.9, 146.0, 142.6, 141.8, 140.7, 
130.9, 126.4, 126.2, 126.1, 124.3, 123.6, 116.8, 113.8, 52.2, 52.0, 47.9, 47.6, 47.3, 42.9, 25.4; 
IR (ν/cm-1): 3019, 2955, 2577, 2814, 1729, 1587, 1476, 1435, 1304, 1177, 1010, 872, 782, 738; 
HRMS (ESI) m/z calculated for C24H26NO4 [MH






Following general procedure L, reaction of anthracene 419e (200 mg, 809 µmol, 1.0 equiv) and 
maleic anhydride (B) (87.0 mg, 889 µmol, 1.1 equiv) for 30 min afforded a crude mixture of 
exo-430eB and endo-430eB (NMR yield > 99%, ratio endo-430eB/exo-430eB = 67:33) as a 
white solid. During purification by flash column chromatography (DCM to DCM:EA = 19:1) 
decomposition of both products was observed and only endo-430eB could be isolated as a white 
solid (94.0 mg, 272 µmol, 34%). 
endo-430eB: Rf = 0.63 (DCM:EA = 19:1); mp 218 − 219 °C; 
1H NMR (400 MHz, CDCl3) δH 
= 7.40 – 7.30 (m, 2H), 7.24 – 7.15 (m, 2H), 7.06 (t, J = 7.7 Hz, 1H), 6.93 (d, J = 7.2 Hz, 1H), 
6.74 (d, J = 8.2 Hz, 1H), 5.29 (d, J = 3.1 Hz, 1H), 4.77 (d, J = 3.2 Hz, 1H), 3.57 – 3.37 (m, 4H), 
3.33 – 3.18 (m, 2H), 2.08 – 1.92 (m, 4H); 13C NMR (101 MHz, CDCl3) δC = 170.9, 170.8, 
146.7, 142.4, 138.6, 129.3, 127.6, 127.4, 125.2, 124.8, 116.3, 114.6, 52.2, 48.1, 48.0, 46.1, 42.1, 
25.5; IR (ν/cm-1): 3026, 2970, 2825, 1859, 1774, 1580, 1476, 1356, 1222, 1077, 928, 756; 
HRMS (EI) m/z calculated for C22H19NO3 [M











Following general procedure L, reaction of anthracene 419e (200 mg, 809 µmol, 1.0 equiv) and 
N-phenylmaleimide (C) (154 mg, 889 µmol, 1.1 equiv) for 30 min afforded an inseparable 
mixture of exo-430eC and endo-430eC (ratio endo-430eC/exo-430eC = 67:33) as a white solid 
(324 mg, 771 µmol, 95%). 
Characteristic signals of minor compound exo-430eC are marked in the proton NMR. 
exo-430eC and endo-430eC: mp 177 − 178 °C; 1H NMR (400 MHz, CDCl3) δH =7.50 – 7.13 
(m, 13H), 7.05 (q, J = 7.5 Hz, 2H), 6.96 (d, J = 7.2 Hz, 1H), 6.81minor (t, J = 3.7 Hz, 2H), 6.74 
(d, J = 8.2 Hz, 1H), 6.67minor (d, J = 8.3 Hz, 1H), 6.64 – 6.54 (m, 1H), 6.49 (dd, J = 7.0, 2.7 Hz, 
2H), 5.51minor (d, J = 3.2 Hz, 1H), 5.32 (d, J = 3.1 Hz, 1H), 4.82 (d, J = 3.3 Hz, 1H), 4.80minor 
(d, J = 3.1 Hz, 1H), 3.54 (q, J = 7.8 Hz, 1H), 3.44 (q, J = 6.9 Hz, 2H), 3.40 – 3.15 (m, 6H), 2.06 
– 1.92 (m, 5H), 1.92 – 1.81 (m, 1H); 13C NMR (101 MHz, CDCl3) δC = 176.47, 176.42, 176.3, 
176.1, 146.7, 146.5, 143.1, 141.9, 140.0, 139.1, 134.2, 131.7, 131.5, 130.0, 129.1, 129.09, 
129.05, 128.7, 128.6, 127.9, 127.3, 127.05, 127.00, 126.66, 126.60, 126.5, 126.4, 126.0, 125.1, 
124.7, 124.3, 123.6, 116.3, 116.2, 114.2, 114.1, 52.1, 51.8, 47.2, 47.1, 47.0, 46.5, 46.4, 42.4, 
42.1, 25.6, 25.4; IR (ν/cm-1): 3067, 2967, 2870, 2825, 2251, 1774, 1707, 1587, 1498, 1382, 
1185, 909, 723; HRMS (ESI) m/z calculated for C28H25N2O2 [MH
+]: 421.1911, found 421.1913 









Following general procedure L, reaction of anthracene 419e (282 mg, 1.14 mmol, 1.0 equiv) 
and DMAD (D) (154 µL, 1.25 mmol, 1.1 equiv) for 24 h afforded 431eD after purification by 
flash column chromatography (DCM:EA = 19:1) as a white solid (403 mg, 1.03 mmol, 90%). 
Rf = 0.33 (DCM:EA = 19:1); mp 159 − 160 °C; 
1H NMR (400 MHz, CDCl3) δH = 7.89 (s, 1H), 
7.77 – 7.68 (m, 2H), 7.63 (s, 1H), 7.45 – 7.39 (m, 2H), 7.07 – 6.99 (m, 2H), 5.38 (dd, J = 5.9, 
1.9 Hz, 1H), 3.80 (s, 3H), 3.74 (s, 3H), 3.45 – 3.34 (m, 4H), 2.06 – 1.98 (m, 4H); 13C NMR 
(101 MHz, CDCl3) δC = 168.1, 163.8, 155.2, 142.6, 142.0, 141.8, 139.5, 139.0, 131.05, 131.02, 
128.3, 127.2, 126.2, 125.9, 122.0, 121.1, 79.1, 52.7, 52.5, 51.4, 47.3, 26.4; IR (ν/cm-1): 3034, 
2952, 2870, 2836, 1722, 1628, 1595, 1427, 1312, 1237, 1203, 1110, 1051, 883, 749; HRMS 
(ESI) m/z calculated for C24H24NO4 [MH





Methyl 1-(pyrrolidin-1-yl)-1,4-dihydro-1,4-ethenoanthracene-2-carboxylate (431eE) 
 
Following general procedure L, reaction of anthracene 419e (200 mg, 809 µmmol, 1.0 equiv) 
and methyl propiolate (E) (79.0 µL, 889 µmol, 1.1 equiv) for 24 h afforded after purification 
by flash column chromatography (DCM:EA = 19:1 to 3:2) an inseparable mixture of syn-430eE 
and anti-430eE (ratio: syn-430eE/anti-430eE = 55:45) as a white solid (67.0 mg, 203 µmol, 
25%) and pure 431eE as a white solid (193 mg, 582 µmol, 72%). 





syn-430eE and anti-430eE: Rf = 0.71 (DCM:EA = 19:1); mp 64 − 65 °C; 
1H NMR (400 MHz, 
CDCl3) δH = 7.91 (dd, J = 6.2, 1.8 Hz, 1H), 7.87
minor (dd, J = 6.3, 1.8 Hz, 1H), 7.42 – 7.31 (m, 
4H), 7.05 – 6.95 (m, 5H), 6.94 – 6.86 (m, 3H), 6.60minor (d, J = 8.1 Hz, 1H), 6.57 – 6.51 (m, 
1H), 6.27 (d, J = 1.8 Hz, 1H), 5.77minor (d, J = 6.3 Hz, 1H), 5.66minor (d, J = 1.9 Hz, 1H), 5.21 
(d, J = 6.2 Hz, 1H), 3.74 (s, 6H), 3.51 – 3.46 (m, 4H), 3.45 – 3.38minor (m, 2H), 3.33 – 3.25minor 
(m, 2H), 2.07 – 1.93 (m, 8H); 13C NMR (101 MHz, CDCl3) δC = 165.5, 165.3, 150.4, 149.7, 
147.2, 146.4, 146.3, 146.04, 146.02, 145.7, 145.14, 145.13, 144.5, 144.3, 134.7, 133.0, 132.4, 
131.3, 125.58, 125.51, 124.95, 124.94, 124.8, 124.7, 123.7, 123.4, 123.3, 123.1, 116.4, 115.3, 
112.9, 112.7, 52.7, 52.6, 52.1, 51.9, 51.84, 51.82, 51.1, 48.1, 47.1, 25.7, 25.4; IR (ν/cm-1): 3063, 
2948, 2870, 1707, 1617, 1587, 1435, 1330, 1244, 1214, 1066, 946, 745; HRMS (ESI) m/z 
calculated for C22H22NO2 [MH
+]: 332.1645, found: 332.1651 (rt 2.485 min) and 332.1649 (rt 
2.555 min). 
431eE: Rf = 0.24 (DCM:EA = 3:2); mp 84 − 85 °C; 
1H NMR (400 MHz, CDCl3) δH = 7.93 (s, 
1H), 7.78 – 7.73 (m, 1H), 7.69 – 7.64 (m, 1H), 7.52 (s, 1H), 7.44 – 7.38 (m, 3H), 7.03 – 6.97 
(m, 2H), 4.93 – 4.83 (m, 1H), 3.71 (s, 3H), 3.38 – 3.23 (m, 4H), 2.11 – 1.99 (m, 4H); 13C NMR 
(101 MHz, CDCl3) δC = 166.7, 148.4, 146.1, 144.1, 142.2, 139.6, 138.4, 131.1, 130.8, 128.2, 
127.1, 125.9, 125.8, 121.2, 120.5, 52.0, 51.4, 47.5, 26.0; IR (ν/cm-1): 3056, 2948, 2866, 1714, 
1621, 1580, 1431, 1289, 1226, 1196, 1077, 883, 745; HRMS (ESI) m/z calculated for 
C22H22NO2 [MH
+]: 332.1645, found: 332.1650. 
1-Phenyl-3-(4-(pyrrolidin-1-yl)anthracen-1-yl)pyrrolidine-2,5-dione (434) 
 
A sealed tube was charged with anthracene 419e (100 mg, 400 µmol, 1.0 equiv), 
N-phenylmaleimide (C) (77.0 mg, 440 µmol, 1.1 equiv), AlCl3 (162 mg, 1.21 mmol, 3.0 equiv) 
and CHCl3 (5.0 mL). The mixture was dispersed in an ultrasonic bath for 1 min and afterwards 
stirred at room temperature for 3 h. The reaction was quenched with water (10 mL) and the 
aqueous phase was extracted with DCM (3×). The combined organic phases were washed with 





After purification by flash column chromatography (PE:DCM = 1:2 to DCM), pure 434 was 
obtained as a brownish solid (106 mg, 250 µmol, 62%). 
Rf = 0.63 (DCM); mp 94 − 95 °C; 
1H NMR (400 MHz, CDCl3) δH = 8.88 (s, 1H), 8.33 (s, 1H), 
8.06 – 7.96 (m, 2H), 7.56 – 7.44 (m, 7H), 7.28 (d, J = 7.7 Hz, 1H), 6.84 (d, J = 7.7 Hz, 1H), 
4.95 (dd, J = 9.7, 4.8 Hz, 1H), 3.59 (dd, J = 18.5, 9.7 Hz, 1H), 3.51 – 3.41 (m, 4H), 3.04 (dd, J 
= 18.5, 4.9 Hz, 1H), 2.11 – 2.05 (m, 4H); 13C NMR (101 MHz, CDCl3) δC = 177.6, 175.4, 
148.6, 132.2, 131.6, 130.9, 130.5, 129.4, 128.8, 128.6, 128.0, 127.9, 126.6, 126.2, 125.9, 125.5, 
125.3, 121.4, 108.7, 52.9, 43.5, 37.9, 25.0; IR (ν/cm-1): 3049, 2963, 2870, 2817, 1777, 1707, 
1561, 1498, 1375, 1170, 745, 693; HRMS (ESI) m/z calculated for C28H25N2O2 [MH
+]: 
421.1911, found: 421.1918. 
1-(2,4-Dibromoanthracen-1-yl)pyrrolidine (436) 
 
Anthracene 419e (200 mg, 810 µmol, 1.0 equiv) and NEt3 (676 µL, 4.85 mmol, 6.0 equiv) were 
dissolved in DCM (10 mL) and the resulting solution was cooled to 0 °C. NBS (864 mg, 
4.85 mmol, 6.0 equiv) was added in portions over a period of 15 min and the reaction mixture 
was stirred at 0 °C for 5 h. The mixture was washed with saturated K2CO3 solution (1×) and 
the aqueous phase was extracted with DCM (3×). The combined organic phases were dried over 
anhydrous K2CO3 and the solvent was removed under reduced pressure. The crude product was 
purified by flash column chromatography (PE) to yield 436 as a bright yellow solid (191 mg, 
0.47 mmol, 58%). 
Rf = 0.52 (PE); mp 138 − 139 °C; 
1H NMR (400 MHz, CDCl3) δH = 8.80 (s, 1H), 8.73 (s, 1H), 
8.09 – 8.03 (m, 2H), 7.92 (s, 1H), 7.57 – 7.50 (m, 2H), 3.53 – 3.48 (m, 4H), 2.23 – 2.18 (m, 
4H); 13C NMR (101 MHz, CDCl3) δC = 143.9, 133.6, 133.4, 132.4, 132.3, 130.1, 128.6, 128.5, 
127.1, 126.6, 126.4, 124.2, 120.2, 119.0, 50.8, 27.0; IR (ν/cm-1): 3052, 2967, 2862, 2814, 2668, 
1677, 1595, 1558, 1442, 1293, 1140, 939, 838, 872, 715; HRMS (EI) m/z calculated for 
C18H15NBr2 [M








Under nitrogen atmosphere anthracene 419e (247 mg, 1.00 mmol, 2.0 equiv), NEt3 (279 µL, 
2.00 mmol, 4.0 equiv) and MTAD 437 (57.0 mg, 500 µmol, 1.0 equiv) were dissolved in 
degassed acetone (5.0 mL) and stirred under irradiation with a green LED (λ = 530 nm) at –
78 °C for 5 h. The solvent was removed under reduced pressure and the crude product was 
purified by flash column chromatography (DCM to DCM:MeOH = 19:1) to afford 438 as a 
brownish solid (107 mg, 300 µmol, 60%). 
Rf = 0.28 (DCM:MeOH = 19:1); mp 191 − 192 °C; 
1H NMR (400 MHz, CD2Cl2) δH =8.79 (s, 
1H), 8.24 (s, 1H), 8.00 – 7.98 (m, 1H), 7.92 – 7.88 (m, 1H), 7.48 – 7.43 (m, 2H), 7.21 (d, J = 
8.0 Hz, 1H), 6.57 (d, J = 8.0 Hz, 1H), 3.51 – 3.45 (m, 4H), 3.12 (s, 3H), 2.07 – 2.01 (m, 4H); 
13C NMR (101 MHz, CD2Cl2) δC = 155.3, 153.3, 149.9, 132.1, 130.9, 130.0, 129.1, 128.3, 
127.1, 126.9, 126.6, 126.0, 125.6, 123.8, 121.3, 107.1, 53.4, 25.79, 25.78; IR (ν/cm-1): 3049, 
2952, 2866, 1766, 1692, 1617, 1453, 1386, 1323, 1148, 1021, 875, 741; HRMS (ESI) m/z 
calculated for C21H21N4O2 [MH






5 Computational details 
All calculations have been conducted with the Gaussian09 E.01 suite of programs265. The 
calculations were carried out at the B3LYP-D3/6-31G**266 level of theory with Grimme’s D3 
dispersion correction267 accounting for long-range dispersion interactions. Stationary points 
were confirmed as ground or transition states with the computation of the harmonic vibrational 
frequencies and evaluating the number of imaginary frequencies (0 for ground state, 1 for 
transition state). IRC calculations were conducted to classify the transition states as the correct 
ones and moreover, to find potential hints of stepwise processes by analyzing the RMS gradient. 
Population analyses according to Mulliken268 and NBO269 were employed to derive FMO 





5.1 Thermodynamic data 





[a] ΔG≠[a] ΔH≠[a] ΔRG
[a] ΔRH
[a] 
419a 25.7 13.5 ‒24.6 ‒39.6 31.9 19.5 ‒12.4 ‒27.2 
419b 26.7 13.6 ‒22.7 ‒38.0 28.1 14.3 ‒6.9 ‒22.7 
419c 25.0 11.9 ‒25.6 ‒41.4 25.0 10.2 ‒5.1 ‒21.7 
419d 24.4 8.2 ‒26.8 ‒42.9 21.6 5.4 ‒5.0 ‒21.0 
419e[b] 29.1 14.8 ‒24.8 ‒40.9 23.1 7.0 ‒19.7 ‒2.3 
[a] values in [kcal/mol]; [b] values in [kcal/mol] for 5,8-addition: ΔG≠ = 36.1 ; ΔH≠ = 22.0 ; ΔRG = −10.8 ; ΔRH = 
−42.3. 
Table S2. Thermodynamic data for the reaction of anthracenes 419a-e with maleic anhydride 
(B). 
anthracene 
9,10-addition 1,4-addition (endo) 
ΔG≠[a] ΔH≠[a] ΔRG
[a] ΔRH
[a] ΔG≠[a] ΔH≠[a] ΔRG
[a] ΔRH
[a] 
419a 23.2 9.8 ‒8.6 ‒22.6 31.0 17.5 4.1 ‒9.9 
419b 22.8 8.9 ‒7.4 ‒21.9 33.4 19.5 11.4 ‒3.4 
419c 22.1 8.0 ‒8.5 ‒23.4 24.8 10.6 14.3 ‒0.8 
419d 19.8 6.1 ‒10.1 ‒24.5 17.1 1.2 8.1 ‒7.5 
419e[b,c] 28.5 14.1 ‒7.3 ‒21.9 19.5 4.3 7.9 ‒7.5 
[a] values in [kcal/mol]; [b] values in [kcal/mol] for 5,8-addition: ΔG≠ = 31.0 ; ΔH≠ = 17.0 ; ΔRG = 4.4 ; ΔRH = 






Table S3. Thermodynamic data for the reaction of anthracenes 419a-e with maleic anhydride 
(B). 
anthracene 
9,10-addition 1,4-addition (exo) 
ΔG≠[a] ΔH≠[a] ΔRG
[a] ΔRH
[a] ΔG≠[a] ΔH≠[a] ΔRG
[a] ΔRH
[a] 
419a 23.2 9.8 ‒8.6 ‒22.6 30.6 17.3 3.9 ‒10.0 
419b 22.8 8.9 ‒7.4 ‒21.9 29.9 16.2 10.1 ‒4.8 
419c 22.1 8.0 ‒8.5 ‒23.4 22.6 7.8 12.7 ‒2.5 
419d 19.8 6.1 ‒10.1 ‒24.5 17.9 2.5 11.5 ‒3.6 
419e[b,c] 22.7 9.0 ‒7.3 ‒22.6 17.4 2.3 10.9 ‒3.5 
[a] values in [kcal/mol]; [b] values in [kcal/mol] for 5,8-addition: ΔG≠ = 30.4 ; ΔH≠ = 16.6 ; ΔRG = 4.2 ; ΔRH = 






5.2 Bond orders 
The bond orders have been calculated with Pauling’s equation (equation 1) with 0.6 as a fitting 
factor for transition states.270 As reference, the according product structures were used. 
BO = n0 × e
r0-rx
c              (1) 
With n0 representing the reference bond order, r0 representing the reference bond length in Å, 
rx representing the examined bond length in Å and c representing a factor with 0.3 for ground 
states and 0.6 for transition states. 
Table S4. Bond lengths in the product structures for 430a-eB and 431a-eB. 
anthracene 
1,4-addition (exo) 1,4-addition (endo) 9,10-Addition 
C1 – CA 
(Å) 
C4 – CB 
(Å) 
C1 – CA 
(Å) 






419a 1.57 1.57 1.57 1.57 1.57 1.57 
419b 1.58 1.58 1.59 1.57 1.57 1.57 
419c 1.59 1.58 1.63 1.56 1.56 1.57 
419d 1.59 1.57 1.59 1.57 1.57 1.57 
419e[a,b,c] 1.60 1.57 1.59 1.57 1.57 1.57 
[a] for 5,8-addition endo product: C5 – CA = 1.57, C8 – CB = 1.57; [b] for 5,8-addition exo product: C5 – CA = 
1.57, C8 – CB = 1.57; [c] values in table for exo 9,10-addition product. Values for endo 9,10-product: C9 – CA = 






Table S5. Bond lengths in the transition state structures for 430a-eB and 431a-eB. 
anthracene 
1,4-addition (exo) 1,4-addition (endo) 9,10-Addition 
C1 – CA 
(Å) 
C4 – CB 
(Å) 
C1 – CA 
(Å) 






419a 2.13 2.13 2.14 2.14 2.19 2.19 
419b 2.46 1.86 2.42 1.93 2.17 2.18 
419c 2.66 1.85 2.73 1.83 2.15 2.25 
419d 2.76 1.86 2.79 1.85 2.16 2.18 
419e[a,b,c] 2.75 1.86 2.78 1.86 2.20 2.16 
[a] for 5,8-addition endo product: C5 – CA = 2.13, C8 – CB = 2.13; [b] for 5,8-addition exo product: C5 – CA = 
2.14, C8 – CB = 2.14; [c] values in table for exo 9,10-addition transition state. Values for endo 9,10-transition 
state: C9 – CA = 2.28, C10 – CB = 2.12. 
Table S6. Bond orders after Pauling, calculated after equation 1 for structures 430a-eB and 
431a-eB. 
anthracene 
1,4-addition (exo) 1,4-addition (endo) 9,10-Addition 
C1 – CA 
(Å) 
C4 – CB 
(Å) 
C1 – CA 
(Å) 






419a 0.39 0.39 0.39 0.39 0.36 0.36 
419b 0.23 0.63 0.25 0.55 0.37 0.36 
419c 0.17 0.64 0.16 0.64 0.37 0.32 
419d 0.14 0.62 0.14 0.63 0.37 0.36 
419e[a,b,c] 0.15 0.62 0.14 0.62 0.35 0.37 
[a] for 5,8-addition endo product: C5 – CA = 0.39, C8 – CB = 0.39; [b] for 5,8-addition exo product: C5 – CA = 
0.39, C8 – CB = 0.39 ; c values in table for exo 9,10-addition transition state. Values for endo 9,10-transition state: 






Figure S1. Assignment of the carbon atoms for the calculation of the bond orders. 
Table S7. Computed bond lengths in product structures for 430a-eD and 431a-eD. 
anthracene 
1,4-Addition 9,10-Addition 
C1 – CA (Å) C4 – CB (Å) C9-CA (Å) C10-CB (Å) 
419a 1.54 1.53 1.54 1.54 
419b 1.56 1.56 1.53 1.53 
419c 1.55 1.53 1.54 1.54 
419d 1.56 1.55 1.53 1.53 
419e[a] 1.56 1.53 1.54 1.53 




















Table S8. Computed bond lengths in transition state structures for 430a-eD and 431a-eD. 
anthracene 
1,4-Addition 9,10-Addition 
C1 – CA (Å) C4 – CB (Å) C9-CA (Å) C10-CB (Å) 
419a 2.40 2.04 2.50 2.05 
419b 2.76 1.91 2.61 2.03 
419c 3.08 1.96 2.26 2.15 
419d 3.35 1.94 3.50 1.86 
419e[a] 3.18 1.95 2.20 2.31 
[a] for 5,8-addition, values are: C5-CA = 2.20, C8 – CB = 2.20. 
Table S9. Calculated bond orders in transition state structures for 430a-eD and 431a-eD. 
anthracene 
1,4-Addition 9,10-Addition 
C1 – CA (Å) C4 – CB (Å) C9-CA (Å) C10-CB (Å) 
419a 0.24 0.43 0.20 0.42 
419b 0.13 0.56 0.17 0.44 
419c 0.08 0.51 0.30 0.36 
419d 0.05 0.52 0.04 0.58 
419e[a] 0.07 0.50 0.33 0.28 






5.3 Marcus Analysis 











              (2) 
With ∆G≠ representing the activation barrier, ∆G≠° representing the intrinsic barrier and ∆RG 
representing the driving force. 









419a 25.7 ‒24.6 37.0 31.9 ‒12.4 37.9 
419b 26.7 ‒22.7 37.2 28.1 ‒6.9 31.5 
419c 25.0 ‒25.6 35.7 25.0 ‒5.1 27.5 
419d 23.1 ‒26.8 36.6 21.6 ‒5.0 24.0 
419e[b] 29.1 ‒24.8 40.6 23.1 ‒2.3 24.2 
[a]values in [kcal/mol]; [b] values in [kcal/mol] for 5,8-position: ΔG≠5,8 = 36.1 ; ΔRG5,8 = ‒10.8, ΔG≠°5,8 = 41.3. 
Table S11. Calculated intrinsic barriers for the reaction of anthracenes 419a-e with maleic 








419a 23.2 −8.6 27.3 31.0 4.1 28.9 
419b 22.8 −7.4 26.4 33.4 11.4 27.4 
419c 22.1 −8.5 26.2 24.8 14.3 16.9 
419d 19.8 −10.1 24.6 17.1 8.1 12.7 
419e[b] 28.5 −7.3 33.0 19.5 7.9 15.3 






Table S12. Calculated intrinsic barriers for the reaction of anthracenes 419a-e with maleic 








419a 23.2 −8.6 27.3 30.6 3.9 28.6 
419b 22.8 −7.4 26.4 29.9 10.1 24.6 
419c 22.1 −8.5 26.2 22.6 12.7 15.6 
419d 19.8 −10.1 24.6 17.9 11.5 11.4 
419e[b] 22.7 −7.3 26.2 17.4 10.9 11.3 






5.4 FMO Analysis 
The computed orbital energies from the Mulliken analysis were used for the calculation of the 
HOMO-LUMO gap. 
Table S13. FMO Analysis for anthracenes 419a-e with DMAD (D). 
anthracene 


















419b −4.82 3.33 −1.27 6.62 
419c −4.81 3.32 −1.40 6.49 
419d −4.37 2.88 −1.12 6.77 
419e −4.68 3.19 −1.38 6.51 
 
Table S14. FMO Analsis for anthracenes 419a-e with maleic anhydride (B). 
anthracene 


















419b −4.82 1.63 −1.27 6.87 
419c −4.81 1.62 −1.40 6.74 
419d −4.37 1.18 −1.12 7.02 







5.5 NBO Analysis  
The partial charges were taken from the NBO analysis. In all cases, the charge from the 
neighbouring hydrogen atom was added to the charge of the carbon center. 




CA CB C1 C4 CA CB C9 C10 
419a −0.023 −0.130 0.049 0.076 −0.132 −0.013 0.074 0.102 
419b −0.025 −0.153 0.410 0.005 −0.130 −0.022 0.083 0.119 
419c −0.060 −0.131 0.269 −0.012 −0.103 −0.052 0.077 0.091 
419d −0.058 −0.148 0.283 −0.022 −0.173 −0.047 0.019 0.125 
419e[a] −0.103 −0.138 0.282 −0.032 −0.123 −0.086 0.068 0.096 
[a]  Values for 5,8-addition: CA = −0.106, CB = −0.110, C5 = 0.074, C8 = 0.056. 
Table S16. Partial charges at the reaction centers for the reaction of anthracenes 419a-e with 
maleic anhydride (B). 
anthr. 
1,4-addition (endo) 9,10-addition 
CA CB C1 C4 CA CB C9 C10 
419a −0.086 −0.086 0.075 0.075 −0.083 −0.083 0.102 0.102 
419b −0.150 −0.076 0.403 0.030 −0.087 −0.087 0.118 0.117 
419c −0.201 −0.070 0.273 0.004 −0.083 −0.096 0.107 0.112 
419d −0.222 −0.057 0.293 −0.003 −0.084 −0.084 0.106 0.101 
419e[a,b] −0.214 −0.065 0.287 −0.004 −0.094 −0.078 0.104 0.093 
[a]  Values for 5,8-addition endo: CA = −0.089, CB = −0.087, C5 = 0.074, C8 = 0.074; [b] Values for 9,10-






Table S17. Partial charges at the reaction centers for the reaction of anthracenes 419a-e with 
maleic anhydride (B). 
anthracene 
1,4-addition (exo) 
CA CB C1 C4 
419a −0.079 −0.079 0.074 0.074 
419b −0.142 −0.066 0.414 0.020 
419c −0.185 −0.060 0.272 0.005 
419d −0.201 −0.059 0.284 −0.003 
419e[a] −0.200 −0.057 0.282 −0.002 
[a]  Values for 5,8-addition exo: CA = −0.079, CB = −0.080, C5 = 0.073, C8 = 0.074. 
 
 




















5.6 IRC plots with DMAD as dienophile 
The SCF energy was plotted against the longer critical bond length in the transition state. 
IRCs for R1 = R2 = H 419a 









































Bond length C1-CA (Å)

























































419a + D 
431aD 
TS 






IRCs for R1 = R2 = OMe 419b 

































































































419b + D 
431bD 
TS 






IRCs for R1 = R2 = NMe2 419c 










































































































419c + D 
430cD 
TS 







5.7 IRC plots with maleic anhydride as dienophile 
Plots for R1 = R2 = H 419a 




















































































































419a + B 
430aB 






Plots for R1 = R2 = OMe 419b 
















































































































419b + B 
430bB 
TS 






Plots for R1 = R2 = NMe2 419c 












































































































419c + B 
430cB 
TS 






Plots for R1 = R2 = Pyrrolidine 419d 
































































Plots for R1 = H ; R2 = Pyrrolidine 419e 


















































































































419e + B 
430eB 
TS 







































































1H NMR spectra   upper image 
 
13C NMR spectra   lower image 
 






1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 







1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 






1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 







4-Oxo-5-propylcyclopent-2-en-1-yl acetate (316a) 
1H NMR (300 MHz, CDCl3) 
 







4-Oxo-5-pentylcyclopent-2-en-1-yl acetate (316b) 
1H NMR (300 MHz, CDCl3) 
 







5-Heptyl-4-oxocyclopent-2-en-1-yl acetate (316c) 
1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 







Ethyl (S)-1-methyl-3-oxo-1,3-dihydroisobenzofuran-4-carboxylate ((S)-342a) 
1H NMR (400 MHz, CDCl3) 
 







Ethyl 1-butyl-3-oxo-1,3-dihydroisobenzofuran-4-carboxylate (342b) 
1H NMR (300 MHz, CDCl3) 
 







Ethyl 3-oxo-1-phenyl-1,3-dihydroisobenzofuran-4-carboxylate (342c) 
1H NMR (300 MHz, CDCl3) 
 







Ethyl 3-(1-hydroxyethyl)benzoate (348a) 
1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 







1-(2-Oxo-2H-pyran-6-yl)ethyl propiolate (350a) 
1H NMR (300 MHz, CDCl3) 
 







(R)-1-(2-Oxo-2H-pyran-6-yl)pentyl propiolate) ((R)-350b) 
1H NMR (300 MHz, CDCl3) 
 







(2-Oxo-2H-pyran-6-yl)(phenyl)methyl propiolate (350c) 
1H NMR (300 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 







1-(2-Oxo-2H-pyran-6-yl)ethyl 3-bromopropiolate (355) 
1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 







Methyl 3-oxo-7-phenyl-2-oxabicyclo[4.1.0]hept-4-ene-7-carboxylate (377a) 
1H NMR (400 MHz, CDCl3) 
 






Methyl 3-oxo-7-phenyl-2-tosyl-2-azabicyclo[4.1.0]hept-4-ene-7-carboxylate (377a) 
1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 







1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (300 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 







Methyl 1,5-di(pyrrolidin-1-yl)-1,4-dihydro-1,4-ethenoanthracene-2-carboxylate (431dE) 
1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 









1H NMR (400 MHz, CDCl3) 
 







Methyl 1-(pyrrolidin-1-yl)-1,4-dihydro-1,4-ethenoanthracene-2-carboxylate (431eE) 
1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CDCl3) 
 








1H NMR (400 MHz, CD2Cl2) 
 















Peak RT Area %Ar Height 
1 3.304 311.528 99.63 133.688 
2 11.192 1.157 0.37 0.118 
 





3 Chiral HPLC data 
Ethyl-1-methyl-3-oxo-1,3-dihydroisobenzofuran-4-carboxylate (342a) 
 






















4 X-ray data 
X-ray crystallography structure of 367a (the ellipsoid contour percent probability level is 50%). 
Compound  Q174  
    
Formula  C10H8O4  
Dcalc./ g cm-3  1.546  
m/mm-1  1.027  
Formula Weight  192.16  
Colour  clear colourless  
Shape  prism  
Max Size/mm  0.33  
Mid Size/mm  0.26  
Min Size/mm  0.13  
T/K  122.99(10)  
Crystal System  orthorhombic  
Flack Parameter  0.00(6)  
Hooft Parameter  -0.01(4)  
Space Group  Pna21  
a/Å  12.9535(3)  
b/Å  6.90480(10)  
c/Å  9.2292(2)  
a/°  90  
b/°  90  
g/°  90  
V/Å3  825.47(3)  
Z  4  
Z'  1  
Qmin/°  6.836  
Qmax/°  75.981  
Measured Refl.  13889  
Independent Refl.  1732  
Reflections Used  1726  
Rint  0.0345  
Parameters  127  
Restraints  1  
Largest Peak  0.161  
Deepest Hole  -0.151  
GooF  1.072  
wR2 (all data)  0.0646  
wR2  0.0646  
R1 (all data)  0.0244  





X-ray crystallography structure of 367b (the ellipsoid contour percent probability level is 50%). 
Compound  Q176  
    
Formula  C10H8O4  
Dcalc./ g cm-3  1.520  
m/mm-1  1.010  
Formula Weight  192.16  
Colour  clear colourless  
Shape  prism  
Size/mm3  0.27×0.17×0.06  
T/K  296.9(7)  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  6.4822(2)  
b/Å  12.2757(4)  
c/Å  10.5683(3)  
a/°  90  
b/°  93.126(2)  
g/°  90  
V/Å3  839.71(4)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  CuKa  
Qmin/°  5.528  
Qmax/°  73.685  
Measured Refl.  17038  
Independent Refl.  1675  
Reflections Used  1481  
Rint  0.0408  
Parameters  127  
Restraints  0  
Largest Peak  0.190  
Deepest Hole  -0.231  
GooF  1.066  
wR2 (all data)  0.1010  
wR2  0.0958  
R1 (all data)  0.0419  





X-ray crystallography structure of 377a (the ellipsoid contour percent probability level is 
50%). 
Compound  S144  
    
Formula  C14H12O4  
Dcalc./ g cm-3  1.417  
/mm-1  0.867  
Formula Weight  244.24  
Colour  clear colourless  
Shape  prism  
Size/mm3  0.14×0.08×0.04  
T/K  122.93(18)  
Crystal System  monoclinic  
Flack Parameter  -0.02(10)  
Hooft Parameter  -0.01(8)  
Space Group  P21  
a/Å  8.5849(2)  
b/Å  7.83773(17)  
c/Å  8.61592(16)  
/°  90  
/°  99.086(2)  
/°  90  
V/Å3  572.46(2)  
Z  2  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  Cu K   
min/°  5.199  
max/°  74.315  
Measured Refl's.  7123  
Ind't Refl's  2283  
Refl's with I > 2(I)  2203  
Rint  0.0296  
Parameters  164  
Restraints  1  
Largest Peak  0.187  
Deepest Hole  -0.142  
GooF  1.065  
wR2 (all data)  0.0735  
wR2  0.0725  
R1 (all data)  0.0297  






X-ray crystallography structure of 377b (the ellipsoid contour percent probability level is 
50%). 
Compound  S143  
    
Formula  C21H19NO5S  
Dcalc./ g cm-3  1.409  
/mm-1  1.828  
Formula Weight  397.43  
Colour  clear colourless  
Shape  irregular  
Size/mm3  0.17×0.13×0.06  
T/K  123.01(10)  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  16.9878(3)  
b/Å  15.4001(3)  
c/Å  7.23590(15)  
/°  90  
/°  98.2042(19)  
/°  90  
V/Å3  1873.64(6)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  Cu K   
min/°  3.892  
max/°  76.011  
Measured Refl's.  18181  
Ind't Refl's  3861  
Refl's with I > 2(I)  3510  
Rint  0.0218  
Parameters  256  
Restraints  0  
Largest Peak  0.328  
Deepest Hole  -0.336  
GooF  1.057  
wR2 (all data)  0.0809  
wR2  0.0782  
R1 (all data)  0.0328  






X-ray crystallography structure of 431eD (the ellipsoid contour percent probability level is 
50%). 
Compound  R040  
    
Formula  C24H23NO4  
Dcalc./ g cm-3  1.347  
/mm-1  0.742  
Formula Weight  389.43  
Colour  clear yellow  
Shape  block  
Size/mm3  0.30×0.27×0.20  
T/K  122.9(2)  
Crystal System  orthorhombic  
Flack Parameter  -0.06(5)  
Hooft Parameter  -0.05(5)  
Space Group  P212121  
a/Å  6.74420(10)  
b/Å  7.90290(10)  
c/Å  36.0260(3)  
/°  90  
/°  90  
/°  90  
V/Å3  1920.14(4)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  CuK   
min/°  4.910  
max/°  74.780  
Measured Refl.  22748  
Independent Refl.  3901  
Reflections Used  3824  
Rint  0.0300  
Parameters  264  
Restraints  0  
Largest Peak  0.155  
Deepest Hole  -0.245  
GooF  1.049  
wR2 (all data)  0.0771  
wR2  0.0765  
R1 (all data)  0.0291  







5 Curriculum Vitae 
 
Name Michael Leitner 





Since 11/2016 Ph.D. thesis in the group of Prof. Dr. O. Reiser at the University of 
Regensburg, Germany 
09/2016 Master of Science in chemistry 
1/2016-09/2016 Master thesis in the group of Prof. Dr. O. Reiser at the University of 
Regensburg, Germany 
10/2014 – 09/2016 Advanced studies in chemistry, University of Regensburg, Germany 
09/2014 Bachelor of science in chemistry 
10/2011 – 09/2014 Studies in chemistry, University of Regensburg, Germany 
09/2002 – 05/2011 Allgemeine Hochschulreife (A-levels), Ludwig-Thoma-Gymnasium 
(secondary school), Prien am Chiemsee, Germany 
 
Prof. Dr. Oliver Reiser 
Institut für Organische Chemie 
Universität Regensburg, Universitätsstr. 31 
93053 Regensburg, Germany 







7th EuCheMS Chemistry Congress (26.-30.08.2018), Liverpool, United Kingdom 
‘‘Sustainable synthesis of 3-substituted phthalides’’ (Poster) 
GDCh-Wissenschaftsforum 2017 (10.-14.09.2017), Berlin, Germany 
‘‘Synthesis of 3H-isobenzofuran-1-ones starting from renewable resources’’ (Poster) 
26th ISHC-congress (03.-08.09.2017), Regensburg, Germany 
‘‘Sustainable synthesis of 3-substituted phthalides from pyrones’’ (Poster) 







(1)   Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2020, 83, 770–803. 
(2)   Dickinson, J. M. Nat. Prod. Rep. 1993, 10, 71–98. 
(3)   McGlacken, G. P.; Fairlamb, I. J. S. Nat. Prod. Rep. 2005, 22, 369–385. 
(4)   Lee, J. S. Marine drugs 2015, 13, 1581–1620. 
(5)   Schäberle, T. F. Beilstein J. Org. Chem. 2016, 12, 571–588. 
(6)   Goel, A.; Ram, V. J. Tetrahedron 2009, 65, 7865–7913. 
(7)   Pratap, R.; Ram, V. J. Tetrahedron 2017, 73, 2529–2590. 
(8)   Wickel, S. M.; Citron, C. A.; Dickschat, J. S. Eur. J. Org. Chem. 2013, 2013, 2906–2913. 
(9)   (a) Michinobu, T.; Bito, M.; Yamada, Y.; Tanimura, M.; Katayama, Y.; Masai, E.; 
Nakamura, M.; Otsuka, Y.; Ohara, S.; Shigehara, K. Polym. J. 2009, 41, 1111–1116; (b) 
Kraus, G. A.; Pollock III, G. R.; Beck, C. L.; Palmer, K.; Winter, A. H. RSC Adv. 2013, 
3, 12721. 
(10)   Baumann, M.; Baxendale, I. R. Beilstein J. Org. Chem. 2013, 9, 2265–2319. 
(11)   Sharma, C. P.; Gupta, N. M.; Singh, J.; Yadav, R. A. K.; Dubey, D. K.; Rawat, K. S.; Jha, 
A. K.; Jou, J.-H.; Goel, A. J. Org. Chem. 2019, 84, 7674–7684. 
(12)   Pechmann, H. von. Liebigs Ann. 1891, 264, 261–309. 
(13)   Wiley, R. H.; Smith, N. R. Org. Synth. 1951, 31, 23. 
(14)   Smith, L. K.; Baxendale, I. R. React. Chem. Eng. 2018, 3, 722–732. 
(15)   Leonardi, G.; Li, J.; Righetti, G. I. C.; Truscello, A. M.; Gambarotti, C.; Terraneo, G.; 
Citterio, A.; Sebastiano, R. Eur. J. Org. Chem. 2020, 2020, 241–251. 
(16)   Dobler, D.; Reiser, O. J. Org. Chem. 2016, 81, 10357–10365. 
(17)   Tsuda, T.; Morikawa, S.; Sumiya, R.; Saegusa, T. J. Org. Chem. 1988, 53, 3140–3145. 
(18)   Louie, J.; Gibby, J. E.; Farnworth, M. V.; Tekavec, T. N. J. Am. Chem. Soc. 2002, 124, 
15188–15189. 
(19)   Ishii, M.; Mori, F.; Tanaka, K. Chem. Eur. J. 2014, 20, 2169–2174. 
(20)   Hou, J.; Ee, A.; Feng, W.; Xu, J.-H.; Zhao, Y.; Wu, J. J. Am. Chem. Soc. 2018, 140, 5257–
5263. 
(21)   Manikandan, R.; Jeganmohan, M. Org. Lett. 2014, 16, 652–655. 
(22)   Larock, R. C.; Doty, M. J.; Han, X. J. Org. Chem. 1999, 64, 8770–8779. 
(23)   Mochida, S.; Hirano, K.; Satoh, T.; Miura, M. J. Org. Chem. 2009, 74, 6295–6298. 
(24)   Yu, Y.; Huang, L.; Wu, W.; Jiang, H. Org. Lett. 2014, 16, 2146–2149. 





(26)   Yang, Q.-L.; Xing, Y.-K.; Wang, X.-Y.; Ma, H.-X.; Weng, X.-J.; Yang, X.; Guo, H.-M.; 
Mei, T.-S. J. Am. Chem. Soc. 2019, 141, 18970–18976. 
(27)   Kumar, A.; Prabhu, K. R. J. Org. Chem. 2020, 85, 3548–3559. 
(28)   Kajita, Y.; Kurahashi, T.; Matsubara, S. J. Am. Chem. Soc. 2008, 130, 17226–17227. 
(29)   Matsuda, T.; Suzuki, K. RSC Adv. 2014, 4, 37138–37141. 
(30)   Prakash, R.; Shekarrao, K.; Gogoi, S.; Boruah, R. C. Chem. Commun. 2015, 51, 9972–
9974. 
(31)   Itoh, M.; Shimizu, M.; Hirano, K.; Satoh, T.; Miura, M. J. Org. Chem. 2013, 78, 11427–
11432. 
(32)   Wu, J.; Wang, D.; Wan, Y.; Ma, C. Chem. Commun. 2016, 52, 1661–1664. 
(33)   Zhou, P.; Yang, W.-T.; Rahman, A. U.; Li, G.; Jiang, B. J. Org. Chem. 2020, 85, 360–
366. 
(34)   Dombray, T.; Blanc, A.; Weibel, J.-M.; Pale, P. Org. Lett. 2010, 12, 5362–5365. 
(35)   Chaładaj, W.; Corbet, M.; Fürstner, A. Angew. Chem. Int. Ed. 2012, 51, 6929–6933. 
(36)   Luo, T.; Schreiber, S. L. Angew. Chem. Int. Ed. 2007, 46, 8250–8253. 
(37)   Sánchez-Larios, E.; Giacometti, R. D.; Hanessian, S. Eur. J. Org. Chem. 2014, 2014, 
5664–5669. 
(38)   Luo, T.; Dai, M.; Zheng, S.-L.; Schreiber, S. L. Org. Lett. 2011, 13, 2834–2836. 
(39)   Wang, Y.; Burton, D. J. J. Org. Chem. 2006, 71, 3859–3862. 
(40)   Cherry, K.; Parrain, J.-L.; Thibonnet, J.; Duchêne, A.; Abarbri, M. J. Org. Chem. 2005, 
70, 6669–6675. 
(41)   Tian, P.-P.; Cai, S.-H.; Liang, Q.-J.; Zhou, X.-Y.; Xu, Y.-H.; Loh, T.-P. Org. Lett. 2015, 
17, 1636–1639. 
(42)   Ahmad, T.; Qiu, S.-Q.; Xu, Y.-H.; Loh, T.-P. J. Org. Chem. 2018, 83, 13414–13426. 
(43)   Qiu, S.-Q.; Ahmad, T.; Xu, Y.-H.; Loh, T.-P. J. Org. Chem. 2019, 84, 6729–6736. 
(44)   Fukuyama, T.; Higashibeppu, Y.; Yamaura, R.; Ryu, I. Organic letters 2007, 9, 587–589. 
(45)   Kuninobu, Y.; Kawata, A.; Nishi, M.; Takata, H.; Takai, K. Chem. Commun. 2008, 6360–
6362. 
(46)   Grigalunas, M.; Wiest, O.; Helquist, P. Org. Lett. 2016, 18, 5724–5727. 
(47)   Huang, J.; Li, L.; Chen, H.; Xiao, T.; He, Y.; Zhou, L. J. Org. Chem. 2017, 82, 9204–
9209. 
(48)   Bellina, F.; Biagetti, M.; Carpita, A.; Rossi, R. Tetrahedron 2001, 57, 2857–2870. 





(50)   Faizi, D. J.; Issaian, A.; Davis, A. J.; Blum, S. A. J. Am. Chem. Soc. 2016, 138, 2126–
2129. 
(51)   Yata, T.; Kita, Y.; Nishimoto, Y.; Yasuda, M. J. Org. Chem. 2019, 84, 14330–14341. 
(52)   Zhu, X.-F.; Schaffner, A.-P.; Li, R. C.; Kwon, O. Org. Lett. 2005, 7, 2977–2980. 
(53)   Yeh, P.-P.; Daniels, D. S. B.; Cordes, D. B.; Slawin, A. M. Z.; Smith, A. D. Org. Lett. 
2014, 16, 964–967. 
(54)   (a) Kong, X.; Zhang, G.; Yang, S.; Liu, X.; Fang, X. Adv. Synth. Catal. 2017, 359, 2729–
2734; (b) Zheng, P.; Li, C.; Mou, C.; Pan, D.; Wu, S.; Xue, W.; Jin, Z.; Chi, Y. R. Asian 
J. Org. Chem. 2019, 8, 1067–1070; (c) Bera, S.; Studer, A. Synthesis 2016, 49, 121–
126; (d) Lang, M.; Jia, Q.; Wang, J. Chem. Asian. J. 2018, 13, 2427–2430. 
(55)   Wang, G.; Chen, X.; Miao, G.; Yao, W.; Ma, C. J. Org. Chem. 2013, 78, 6223–6232. 
(56)   Xu, L.-C.; Zhou, P.; Li, J.-Z.; Hao, W.-J.; Tu, S.-J.; Jiang, B. Org. Chem. Front. 2018, 5, 
753–759. 
(57)   Sathishkannan, G.; Srinivasan, K. Adv. Synth. Catal. 2014, 356, 729–735. 
(58)   Zhu, Y.; Gong, Y. J. Org. Chem. 2015, 80, 490–498. 
(59)   Kim, H. Y.; Oh, K. Org. Lett. 2017, 19, 4904–4907. 
(60)   Zhang, W.-Z.; Yang, M.-W.; Lu, X.-B. Green Chem. 2016, 18, 4181–4184. 
(61)   Zhou, Y.; Chen, X.; Ling, X.; Rao, W. Green Chem. 2019, 21, 5611–5615. 
(62)   Joule, J. A.; Mills, K. Heterocyclic Chemistry; A John Wiley & Sons, Ltd., Publication, 
United Kingdom, 2010. 
(63)   Vogel, G. J. Org. Chem. 1965, 30, 203–207. 
(64)   Sun, C.-L.; Fürstner, A. Angew. Chem. Int. Ed. 2013, 52, 13071–13075. 
(65)   Zhuo, C.-X.; Fürstner, A. Angew. Chem. Int. Ed. 2016, 55, 6051–6056. 
(66)   Zhuo, C.-X.; Fürstner, A. J. Am. Chem. Soc. 2018, 140, 10514–10523. 
(67)   Agarwal, J.; Bayounes, O.; Thorimbert, S.; Dechoux, L. RSC Adv 2014, 4, 2772–2775. 
(68)   Plevová, K.; Chang, L.; Martin, E.; Llopis, Q.; Dechoux, L.; Thorimbert, S. Adv. Synth. 
Catal. 2016, 358, 3293–3297. 
(69)   Maji, T.; Tunge, J. A. Org. Lett. 2015, 17, 4766–4769. 
(70)   (a) Shimo, T.; Somekawa, K.; Wakikawa, Y.; Uemura, H.; Tsuge, O.; Imada, K.; Tanabe, 
K. Bull. Chem. Soc. Jpn. 1987, 60, 621–626; (b) Shimo, T.; Yasuda, M.; Tajima, J.; 
Somekawa, K. Heterocycl. Chem. 1991, 28, 745–748. 
(71)   Corey, E. J.; Streith, J. J. Am. Chem. Soc. 1964, 86, 950–951. 
(72)   Williams, J. D.; Otake, Y.; Coussanes, G.; Saridakis, I.; Maulide, N.; Kappe, C. O. 





(73)   Frébault, F.; Luparia, M.; Oliveira, M. T.; Goddard, R.; Maulide, N. Angew. Chem. Int. 
Ed. 2010, 49, 5672–5676. 
(74)   Luparia, M.; Oliveira, M. T.; Audisio, D.; Frébault, F.; Goddard, R.; Maulide, N. Angew. 
Chem. Int. Ed. 2011, 50, 12631–12635. 
(75)   Niyomchon, S.; Audisio, D.; Luparia, M.; Maulide, N. Org. Lett. 2013, 15, 2318–2321. 
(76)   Souris, C.; Misale, A.; Chen, Y.; Luparia, M.; Maulide, N. Org. Lett. 2015, 17, 4486–
4489. 
(77)   Souris, C.; Frébault, F.; Patel, A.; Audisio, D.; Houk, K. N.; Maulide, N. Org. Lett. 2013, 
15, 3242–3245. 
(78)   Chen, Y.; Coussanes, G.; Souris, C.; Aillard, P.; Kaldre, D.; Runggatscher, K.; Kubicek, 
S.; Di Mauro, G.; Maryasin, B.; Maulide, N. J. Am. Chem. Soc. 2019, 141, 13772–13777. 
(79)   (a) Nistanaki, S. K.; Boralsky, L. A.; Pan, R. D.; Nelson, H. M. Angew. Chem. Int. Ed. 
2019, 58, 1724–1726; (b) Gutekunst, W. R.; Baran, P. S. J. Am. Chem. Soc. 2011, 133, 
19076–19079; (c) Gutekunst, W. R.; Gianatassio, R.; Baran, P. S. Angew. Chem. Int. Ed. 
2012, 51, 7507–7510. 
(80)   Colvin, E. W.; Thom, I. G. Tetrahedron 1986, 42, 3137–3146. 
(81)   Imagawa, T.; Sueda, N.; Kawanisi, M. J. Chem. Soc., Chem. Commun. 1972, 388. 
(82)   Afarinkia, K.; Vinader, V.; Nelson, T. D.; Posner, G. H. Tetrahedron 1992, 48, 9111–
9171. 
(83)   Diels, O.; Alder, K. Ann. 1931, 490, 257–266. 
(84)   Shah, T. K.; Medina, J. M.; Garg, N. K. J. Am. Chem. Soc. 2016, 138, 4948–4954. 
(85)   Bronner, S. M.; Bahnck, K. B.; Garg, N. K. Org. Lett. 2009, 11, 1007–1010. 
(86)   Kirkham, J. D.; Butlin, R. J.; Harrity, J. P. A. Angew. Chem. Int. Ed. 2012, 51, 6402–
6405. 
(87)   Habicht, M. H.; Wossidlo, F.; Bens, T.; Pidko, E. A.; Müller, C. Chem. Eur. J. 2018, 24, 
944–952. 
(88)   Habicht, M. H.; Wossidlo, F.; Weber, M.; Müller, C. Chem. Eur. J. 2016, 22, 12877–
12883. 
(89)   Wang, Y.; Li, H.; Wang, Y.-Q.; Liu, Y.; Foxman, B. M.; Deng, L. J. Am. Chem. Soc. 
2007, 129, 6364–6365. 
(90)   Shi, L.-M.; Dong, W.-W.; Tao, H.-Y.; Dong, X.-Q.; Wang, C.-J. Org. Lett. 2017, 19, 
4532–4535. 
(91)   Zhao, P.; Beaudry, C. M. Angew. Chem. Int. Ed. 2014, 53, 10500–10503. 





(93)   (a) Markó, I. E.; Chellé-Regnaut, I.; Leroy, B.; Warriner, S. L. Tetrahedron Lett. 1997, 
38, 4269–4272; (b) Markó, I. E.; Evans, G. R. Tetrahedron Lett. 1994, 35, 2771–2774; 
(c) Markó, I. E.; Evans, G. R.; Declercq, J.-P. Tetrahedron 1994, 50, 4557–4574; (d) 
Posner, G. H.; Carry, J.-C.; Kyoo Lee, J.; Bull, D.S.; Dai, H. Tetrahedron Lett. 1994, 
35, 1321–1324; (e) Posner, G. H.; Dai, H.; Bull, D. S.; Lee, J.-K.; Eydoux, F.; Ishihara, 
Y.; Welsh, W.; Pryor, N.; Petr, S. J. Org. Chem. 1996, 61, 671–676; (f) Posner, G. H.; 
Eydoux, F.; Lee, J. K.; Bull, D.S. Tetrahedron Lett. 1994, 35, 7541–7544. 
(94)   Liang, X.-W.; Zhao, Y.; Si, X.-G.; Xu, M.-M.; Tan, J.-H.; Zhang, Z.-M.; Zheng, C.-G.; 
Zheng, C.; Cai, Q. Angew. Chem. Int. Ed. 2019, 58, 14562–14567. 
(95)   (a) Watanabe, S.; Nishikawa, T.; Nakazaki, A. Org. Lett. 2019, 21, 7410–7414; (b) Wang, 
N.; Du, S.; Li, D.; Jiang, X. Org. Lett. 2017, 19, 3167–3170; (c) Liang, X.; Zhou, L.; 
Min, L.; Ye, W.; Bao, W.; Ma, W.; Yang, Q.; Qiao, F.; Zhang, X.; Lee, C.-S. J. Org. 
Chem. 2017, 82, 3463–3481. 
(96)   Lee, J.-H.; Cho, C.-G. Org. Lett. 2018, 20, 7312–7316. 
(97)   Gan, P.; Smith, M. W.; Braffman, N. R.; Snyder, S. A. Angew. Chem. Int. Ed. 2016, 55, 
3625–3630. 
(98)   Trost, B. M.; Wang, Y. Angew. Chem. Int. Ed. 2018, 57, 11025–11029. 
(99)   (a) Trost, B. M.; Schneider, S. Angew. Chem. Int. Ed. Engl. 1989, 28, 213–215; (b) Zheng, 
S.; Lu, X. Org. Lett. 2009, 11, 3978–3981. 
(100)   Gao, X.; Xia, M.; Yuan, C.; Zhou, L.; Sun, W.; Li, C.; Wu, B.; Zhu, D.; Zhang, C.; 
Zheng, B.; Wang, D.; Guo, H. ACS Catal. 2019, 9, 1645–1654. 
(101)   Liu, K.; Teng, H.-L.; Wang, C.-J. Org. Lett. 2014, 16, 4508–4511. 
(102)   Giardinetti, M.; Jessen, N. I.; Christensen, M. L.; Jørgensen, K. A. Chem. Commun. 
2018, 55, 202–205. 
(103)   Jessen, H. J.; Gademann, K. Nat. Prod. Rep. 2010, 27, 1168–1185. 
(104)   Liu, Y.; Zhang, Q.; Chen, L.-H.; Yang, H.; Lu, W.; Xie, X.; Nan, F.-J. ACS Med. Chem. 
Lett. 2016, 7, 579–583. 
(105)   Hu, L.; Feng, H.; Zhang, H.; Yu, S.; Zhao, Q.; Wang, W.; Bao, F.; Ding, X.; Hu, J.; 
Wang, M.; Xu, Y.; Wu, Z.; Li, X.; Tang, Y.; Mao, F.; Chen, X.; Zhang, H.; Li, J. J. Med. 
Chem. 2020, 63, 1051–1067. 
(106)   Lv, Z.; Sheng, C.; Wang, T.; Zhang, Y.; Liu, J.; Feng, J.; Sun, H.; Zhong, H.; Niu, C.; 





(107)   Vincetti, P.; Caporuscio, F.; Kaptein, S.; Gioiello, A.; Mancino, V.; Suzuki, Y.; 
Yamamoto, N.; Crespan, E.; Lossani, A.; Maga, G.; Rastelli, G.; Castagnolo, D.; Neyts, 
J.; Leyssen, P.; Costantino, G.; Radi, M. J. Med. Chem. 2015, 58, 4964–4975. 
(108)   Liu, Z.; Yao, Y.; Kogiso, M.; Zheng, B.; Deng, L.; Qiu, J. J.; Dong, S.; Lv, H.; Gallo, J. 
M.; Li, X.-N.; Song, Y. J. Med. Chem. 2014, 57, 8307–8318. 
(109)   Gorobets, N. Y.; Yousefi, B. H.; Belaj, F.; Kappe, C.O. Tetrahedron 2004, 60, 8633–
8644. 
(110)   Hammes, G. G.; Lillford, P. J. J. Am. Chem. Soc. 1970, 92, 7578–7585. 
(111)   Rawson, J. M.; Winpenny, R. E.P. Coord. Chem. Rev. 1995, 139, 313–374. 
(112)   Dimroth, K. Angew. Chem. Int. Ed. 1960, 72, 331–342. 
(113)   Moloney, H.; Magnus, N. A.; Buser, J. Y.; Embry, M. C. J. Org. Chem. 2017, 82, 6279–
6288. 
(114)   Disadee, W.; Lekky, A.; Ruchirawat, S. J. Org. Chem. 2020, 85, 1802–1822. 
(115)   Kume, T.; Kojima, T.; Iwasaki, H.; Yamamoto, Y.; Akiba, K. J. Org. Chem. 1989, 54, 
1931–1935. 
(116)   Mao, B.; Fañanás-Mastral, M.; Feringa, B. L. Org. Lett. 2013, 15, 286–289. 
(117)   Ireland, R. E.; McGarvey, G. J.; Anderson, R. C.; Badoud, R.; Fitzsimmons, B. J. Am. 
Chem. Soc. 1980, 102, 6178–6180. 
(118)   Yanai, H.; Kobayashi, O.; Takada, K.; Isono, T.; Satoh, T.; Matsumoto, T. Chem. 
Commun. 2016, 52, 3280–3283. 
(119)   Liu, Q.; Zu, L. Angew. Chem. 2018, 130, 9649–9653. 
(120)   Chang, L.; Thorimbert, S.; Dechoux, L. Org. Biomol. Chem. 2019, 17, 2784–2791. 
(121)   Palani, V.; Hugelshofer, C. L.; Sarpong, R. J. Am. Chem. Soc. 2019, 141, 14421–14432. 
(122)   Kurasawa, K.; Kwon, E.; Kuwahara, S.; Enomoto, M. Org. Lett. 2018, 20, 4645–4648. 
(123)   Ohyoshi, T.; Mitsugi, K.; Higuma, T.; Ichimura, F.; Yoshida, M.; Kigoshi, H. RSC Adv. 
2019, 9, 7321–7323. 
(124)   Liu, Z.; Meinwald, J. J. Org. Chem. 1996, 61, 6693–6699. 
(125)   Lee, J.-H.; Kim, W.-S.; Lee, Y. Y.; Cho, C.-G. Tetrahedron Lett. 2002, 43, 5779–5782. 
(126)   Gravett, E. C.; Hilton, P. J.; Jones, K.; Péron, J.-M. Synlett 2003, 253–255. 
(127)   Bellina, F.; Biagetti, M.; Carpita, A.; Rossi, R. Tetrahedron Lett. 2001, 42, 2859–2863. 
(128)   Lee, J.-H.; Park, J.-S.; Cho, C.-G. Org. Lett. 2002, 4, 1171–1173. 
(129)   Kim, W.-S.; Kim, H.-J.; Cho, C.-G. J. Am. Chem. Soc. 2003, 125, 14288–14289. 
(130)   (a) Frébault, F.; Oliveira, M. T.; Wöstefeld, E.; Maulide, N. J. Org. Chem. 2010, 75, 





2009, 2251–2261; (c) Shah, P.; Santana, M. D.; García, J.; Serrano, J. L.; Naik, M.; 
Pednekar, S.; Kapdi, A. R. Tetrahedron 2013, 69, 1446–1453. 
(131)   Nolan, M.-T.; Pardo, L. M.; Prendergast, A. M.; McGlacken, G. P. J. Org. Chem. 2015, 
80, 10904–10913. 
(132)   Burns, M. J.; Thatcher, R. J.; Taylor, R. J. K.; Fairlamb, I. J. S. Dalton Trans. 2010, 39, 
10391–10400. 
(133)   Nolan, M.-T.; Bray, J. T.W.; Eccles, K.; Cheung, M. S.; Lin, Z.; Lawrence, S. E.; 
Whitwood, A. C.; Fairlamb, I. J.S.; McGlacken, G. P. Tetrahedron 2014, 70, 7120–
7127. 
(134)   Pardo, L. M.; Prendergast, A. M.; Nolan, M.-T.; Ó Muimhneacháin, E.; McGlacken, G. 
P. Eur. J. Org. Chem. 2015, 3540–3550. 
(135)   Prendergast, A. M.; Pardo, L. M.; Fairlamb, I. J. S.; McGlacken, G. P. Eur. J. Org. 
Chem. 2017, 2017, 5119–5124. 
(136)   Mackey, K.; Pardo, L. M.; Prendergast, A. M.; Nolan, M.-T.; Bateman, L. M.; 
McGlacken, G. P. Org. Lett. 2016, 18, 2540–2543. 
(137)   Cheng, C.; Chen, W.-W.; Xu, B.; Xu, M.-H. J. Org. Chem. 2016, 81, 11501–11507. 
(138)   Zhang, J.; Zhuang, Y.; Ma, Y.; Yang, X.; Szostak, M. Adv. Synth. Catal. 2019, 361, 
5709–5714. 
(139)   Lah, H. U.; Rasool, F.; Yousuf, S. K. RSC Adv. 2015, 5, 78958–78961. 
(140)   Rosenblum, M.; Gatsonis, C. J. Am. Chem. Soc. 1967, 89, 5074–5075. 
(141)   Fairlamb, I. J.; Syvänne, S. M.; Whitwood, A. C. Synlett 2003, 1693–1697. 
(142)   Lin, Q.; Leong, W. K. Organometallics 2003, 22, 3639–3648. 
(143)   Rosenblum, M.; North, B.; Wells, D.; Giering, W. P. J. Am. Chem. Soc. 1972, 94, 1239–
1246. 
(144)   Saura-Llamas, I.; Dalton, D. M.; Arif, A. M.; Gladysz, J. A. Organometallics 1992, 11, 
683–693. 
(145)   Fairlamb, I. J. S.; Lynam, J. M.; Taylor, I. E.; Whitwood, A. C. Organometallics 2004, 
23, 4964–4969. 
(146)   Fairlamb, I. J. S.; Lynam, J. M.; Moulton, B. E.; Taylor, I. E.; Duhme-Klair, A. K.; 
Sawle, P.; Motterlini, R. Dalton Trans. 2007, 3603–3605. 
(147)   Fairlamb, I. J. S.; Duhme-Klair, A.-K.; Lynam, J. M.; Moulton, B. E.; O'Brien, C. T.; 





(148)   Sawle, P.; Hammad, J.; Fairlamb, I. J. S.; Moulton, B.; O'Brien, C. T.; Lynam, J. M.; 
Duhme-Klair, A. K.; Foresti, R.; Motterlini, R. J. Pharm. Exp. Ther. 2006, 318, 403–
410. 
(149)   Diercks, R.; Arndt, J.-D.; Freyer, S.; Geier, R.; Machhammer, O.; Schwartze, J.; 
Volland, M. Chem. Eng. Technol. 2008, 31, 631–637. 
(150)   (a) Ragauskas, A. J.; Williams, C. K.; Davison, B. H.; Britovsek, G.; Cairney, J.; Eckert, 
C. A.; Frederick, W. J.; Hallett, J. P.; Leak, D. J.; Liotta, C. L.; Mielenz, J. R.; Murphy, 
R.; Templer, R.; Tschaplinski, T. Science 2006, 311, 484–489; (b) Binder, J. B.; Raines, 
R. T. J. Am. Chem. Soc. 2009, 131, 1979–1985. 
(151)   Zhou, C.-H.; Xia, X.; Lin, C.-X.; Tong, D.-S.; Beltramini, J. Chem. Soc. Rev. 2011, 40, 
5588–5617. 
(152)   Verband der chemischen Industrie e.V. Energiestatistik in Daten und Fakten. 
(153)   (a) Chapman, O. L.; Hess, T. C. J. Org. Chem. 1979, 44, 962–964; (b) Morris, M. R.; 
Waring, A. J. J. Chem. Commun. 1969, 526–527; (c) Klunder, A. J. H.; Bos, W.; 
Verlaak, J. M. M.; Zwanenburg, B. Tetrahedron Lett. 1981, 22, 4553–4556; (d) 
Houwen-Claassen, A. A. M.; Klunder, A. J. H.; Zwanenburg, B. Tetrahedron 1989, 45, 
7134–7148. 
(154)   (a) Klunder, A. J. H.; Bos, W.; Zwanenburg, B. Tetrahedron Lett. 1981, 22, 4557–4560; 
(b) Zhu, J.; Klunder, A. J. H.; Zwanenburg, B. Tetrahedron 1994, 50, 10597–10610; (c) 
Zhu, J.; Yang, J.-Y.; Klunder, A. J. H.; Liu, Z.-Y.; Zwanenburg, B. Tetrahedron 1995, 
51, 5847–5870. 
(155)   Corma, A.; Iborra, S.; Velty, A. Chem. Rev. 2007, 107, 2411–2502. 
(156)   Dutta, S.; De, S.; Saha, B.; Alam, M. I. Catal. Sci. Technol. 2012, 2, 2025. 
(157)   Mamman, A. S.; Lee, J.-M.; Kim, Y.-C.; Hwang, I. T.; Park, N.-J.; Hwang, Y. K.; Chang, 
J.-S.; Hwang, J.-S. Biofuels, Bioprod. Bioref. 2008, 2, 438–454. 
(158)   Achmatowicz, O.; Bielski, R. Carbohydrate Research 1977, 55, 165–176. 
(159)   Piancatelli, G.; Scettri, A.; Barbadoro, S. Tetrahedron Lett. 1976, 17, 3555–3558. 
(160)   Ulbrich, K.; Kreitmeier, P.; Reiser, O. Synlett 2010, 2010, 2037–2040. 
(161)   Dobler, D. Conversion of 4-hydroxy-2-cyclopentenone derivatives into valuable fine 
chemicals. Dissertation, Universität Regensburg, Regensburg, 2017. 
(162)   (a) Zimmermann, H. E.; Grunewald, G. L.; Paufler, R. M. Org. Synth. 1966, 46, 101–
104; (b) Nakagawa, M.; Saegusa, J.; Tonozuka, M.; Obi, M.; Kiuchi, M.; Hino, T.; Ban, 





48, 1673–1674; (d) Chidambaram, N.; Satyanarayana, K.; Chandrasekaran, S. 
Tetrahedron Lett. 1989, 30, 2429–2432. 
(163)   Dols, P. P. M.; Klunder, A. J. H.; Zwanenburg, B. Tetrahedron 1994, 50, 8515–8538. 
(164)   (a) Eddolls, J. P.; Iqbal, M.; Roberts, S. M.; Santoro, M. G. Tetrahedron 2004, 60, 2539–
2550; (b) Mander, L. N.; Thomson, R. J. J. Org. Chem. 2005, 70, 1654–1670; (c) 
Sugahara, T.; Fukuda, H.; Iwabuchi, Y. J. Org. Chem. 2004, 69, 1744–1747; (d) Takano, 
S.; Kamikubo, T.; Moriya, M.; Ogasawara, K. Synthesis 1994, 1994, 601–604; (e) 
Tanaka, K.; Nakashima, H.; Taniguchi, T.; Ogasawara, K. Org. Lett. 2000, 2, 1915–
1917. 
(165)   Karpf, M. Angew. Chem. Int. Ed. 1986, 25, 414–430. 
(166)   Seybold, G. Angew. Chem. Int. Ed. 1977, 16, 365–373. 
(167)   Moss, M. O.; Jackson, R. M.; Rogers, D. Phytochemistry 1975, 14, 2706–2708. 
(168)   Amaral, P. A.; Gouault, N.; Le Roch, M.; Eifler-Lima, V. L.; David, M. Tetrahedron 
Lett. 2008, 49, 6607–6609. 
(169)   Soldi, C.; Moro, A. V.; Pizzolatti, M. G.; Correia, C. R. D. Eur. J. Org. Chem. 2012, 
3607–3616. 
(170)   Zhu, J.; Klunder, A. J.H.; Zwanenburg, B. Tetrahedron 1995, 51, 5099–5116. 
(171)   Karmakar, R.; Pahari, P.; Mal, D. Chem. Rev. 2014, 114, 6213–6284. 
(172)   (a) Beck, J. J.; Chou, S.-C. J. Nat. Prod. 2007, 70, 891–900; (b) Zhang, H.; Zhang, S.; 
Liu, L.; Luo, G.; Duan, W.; Wang, W. J. Org. Chem. 2010, 75, 368–374. 
(173)   Diao, X.; Deng, P.; Xie, C.; Li, X.; Zhong, D.; Zhang, Y.; Chen, X. Drug Metab. Dispos. 
2013, 41, 430–444. 
(174)   Zhang, B.; Xu, M.-H.; Lin, G.-Q. Org. Lett. 2009, 11, 4712–4715. 
(175)   (a) Kitamura, M.; Ohkuma, T.; Inoue, S.; Sayo, N.; Kumobayashi, H.; Akutagawa, S.; 
Ohta, T.; Takaya, H.; Noyori, R. J. Am. Chem. Soc. 1988, 110, 629–631; (b) Everaere, 
K.; Scheffler, J.-L.; Mortreux, A.; Carpentier, J.-F. Tetrahedron Lett. 2001, 42, 1899–
1901. 
(176)   Lu, B.; Zhao, M.; Ding, G.; Xie, X.; Jiang, L.; Ratovelomanana-Vidal, V.; Zhang, Z. 
ChemCatChem 2017, 9, 3989–3996. 
(177)   Phan, D. H. T.; Kim, B.; Dong, V. M. J. Am. Chem. Soc. 2009, 131, 15608–15609. 
(178)   Tanaka, K.; Osaka, T.; Noguchi, K.; Hirano, M. Org. Lett. 2007, 9, 1307–1310. 






(180)   Afarinkia, K.; Vinader, V.; Nelson, T. D.; Posner, G. H. Tetrahedron 1992, 48, 9111–
9171. 
(181)   Loupy, A.; Maurel, F.; Sabatié-Gogová, A. Tetrahedron 2004, 60, 1683–1691. 
(182)   Kappe, C. O. Angew. Chem. Int. Ed. 2004, 43, 6250–6284. 
(183)   Ward, D. E.; Souweha, M. S. Org. Lett. 2005, 7, 3533–3536. 
(184)   Birkett, S.; Ganame, D.; Hawkins, B. C.; Meiries, S.; Quach, T.; Rizzacasa, M. A. Org. 
Lett. 2011, 13, 1964–1967. 
(185)   Billingsley, K. L.; Buchwald, S. L. J. Org. Chem. 2008, 73, 5589–5591. 
(186)   (a) Vijgen, S.; Nauwelaerts, K.; Wang, J.; van Aerschot, A.; Lagoja, I.; Herdewijn, P. J. 
Org. Chem. 2005, 70, 4591–4597; (b) Jung, Y.-G.; Lee, S.-C.; Cho, H.-K.; Darvatkar, 
N. B.; Song, J.-Y.; Cho, C.-G. Org. Lett. 2013, 15, 132–135; (c) Pfennig, T.; 
Chemburkar, A.; Johnson, R. L.; Ryan, M. J.; Rossini, A. J.; Neurock, M.; Shanks, B. 
H. ACS Catal. 2018, 8, 2450–2463. 
(187)   Pirkle, W. H.; McKendry, L. H. Tetrahedron Lett. 1968, 9, 5279–5282. 
(188)   Kerres, S.; Plut, E.; Malcherek, S.; Rehbein, J.; Reiser, O. Adv. Synth. Catal. 2019, 361, 
1400–1407. 
(189)   (a) Fehr, M. J.; Consiglio, G.; Scalone, M.; Schmid, R. J. Org. Chem. 1999, 64, 5768–
5776; (b) Huck, W.-R.; Bürgi, T.; Mallat, T.; Baiker, A. J. Catal. 2003, 219, 41–51. 
(190)   (a) Hale, K. J.; Hummersone, M. G.; Bhatia, G. S. Org. Lett. 2000, 2, 2189–2192; (b) 
Huang, H.; Panek, J. S. Org. Lett. 2003, 5, 1991–1993; (c) Tarver, J. E.; Joullié, M. M. 
J. Org. Chem. 2004, 69, 815–820. 
(191)   Davies, H. M. L.; Hedley, S. J. Chem. Soc. Rev. 2007, 36, 1109–1119. 
(192)   Davies, H. M. L.; Denton, J. R. Chem. Soc. Rev. 2009, 38, 3061–3071. 
(193)   Lehner, V.; Davies, H. M. L.; Reiser, O. Org. Lett. 2017, 19, 4722–4725. 
(194)   Fu, J.; Wurzer, N.; Lehner, V.; Reiser, O.; Davies, H. M. L. Org. Lett. 2019, 21, 6102–
6106. 
(195)   Davies, H.; Babal, T.; Liu, W.; Röther, A.; Reiser, O. Chem. Eur. J. 2019. 
(196)   Pilsl, L. K. A.; Ertl, T.; Reiser, O. Org. Lett. 2017, 19, 2754–2757. 
(197)   Schneider, T. F.; Kaschel, J.; Werz, D. B. Angew. Chem. Int. Ed. 2014, 53, 5504–5523. 
(198)   Reddy, R. P.; Davies, H. M. L. J. Am. Chem. Soc. 2007, 129, 10312–10313. 
(199)   Jurberg, I. D.; Davies, H. M. L. Chem. Sci. 2018, 9, 5112–5118. 






(201)   Davies, H. M. L.; Bruzinski, P. R.; Lake, D. H.; Kong, N.; Fall, M. J. J. Am. Chem. Soc. 
1996, 118, 6897–6907. 
(202)   Davies, H. M.L.; Bruzinski, P. R.; Fall, M. J. Tetrahedron Lett. 1996, 37, 4133–4136. 
(203)   (a) Chhor, R. B.; Nosse, B.; Sörgel, S.; Böhm, C.; Seitz, M.; Reiser, O. Chem. Eur. J. 
2003, 9, 260–270; (b) Gharpure, S. J.; Shukla, M. K.; Vijayasree, U. Org. Lett. 2009, 
11, 5466–5469. 
(204)   (a) Liu, Z.; Lin, X.; Yang, N.; Su, Z.; Hu, C.; Xiao, P.; He, Y.; Song, Z. J. Am. Chem. 
Soc. 2016, 138, 1877–1883; (b) Saito, A.; Yanai, H.; Taguchi, T. Tetrahedron Lett. 2004, 
45, 9439–9442; (c) Yanai, H.; Takahashi, A.; Taguchi, T. Tetrahedron 2007, 63, 12149–
12159. 
(205)   (a) Brown, M. K.; Degrado, S. J.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2005, 44, 
5306–5310; (b) Fan, X.-Z.; Rong, J.-W.; Wu, H.-L.; Zhou, Q.; Deng, H.-P.; Tan, J. D.; 
Xue, C.-W.; Wu, L.-Z.; Tao, H.-R.; Wu, J. Angew. Chem. Int. Ed. 2018, 57, 8514–8518; 
(c) Khiar, N.; Valdivia, V.; Salvador, Á.; Chelouan, A.; Alcudia, A.; Fernández, I. Adv. 
Synth. Catal. 2013, 355, 1303–1307; (d) Le Nôtre, J.; Allen, J. C.; Frost, C. G. Chem. 
Commun. 2008, 3795–3797; (e) Liang, L.; Su, L.; Li, X.; Chan, A. S.C. Tetrahedron 
Lett. 2003, 44, 7217–7220; (f) Liang, L.; Yan, M.; Li, Y.-M.; Chan, A. S.C. 
Tetrahedron: Asymmetry 2004, 15, 2575–2578; (g) Maciver, E. E.; Maksymowicz, R. 
M.; Wilkinson, N.; Roth, P. M. C.; Fletcher, S. P. Org. Lett. 2014, 16, 3288–3291; (h) 
Walter, C.; Auer, G.; Oestreich, M. Angew. Chem. Int. Ed. 2006, 45, 5675–5677. 
(206)   (a) Aggarwal, V. K.; Emme, I.; Fulford, S. Y. J. Org. Chem. 2003, 68, 692–700; (b) 
Bugarin, A.; Connell, B. T. J. Org. Chem. 2009, 74, 4638–4641; (c) Karur, S.; Hardin, 
J.; Headley, A.; Li, G. Tetrahedron Lett. 2003, 44, 2991–2994. 
(207)   (a) Kitanosono, T.; Xu, P.; Kobayashi, S. Chem. Asian. J. 2014, 9, 179–188; (b) Ebel, 
H.; Zeitler, K.; Steglich, W. Synthesis 2003, 101–106; (c) Martínez-Fructuoso, L.; 
Pereda-Miranda, R.; Rosas-Ramírez, D.; Fragoso-Serrano, M.; Cerda-García-Rojas, C. 
M.; da Silva, A. S.; Leitão, G. G.; Leitão, S. G. J. Nat. Prod. 2019, 82, 520–531; (d) 
Sawant, K. B.; Jennings, M. P. J. Org. Chem. 2006, 71, 7911–7914. 
(208)   Wolberg, M.; Dassen, B. H. N.; Schürmann, M.; Jennewein, S.; Wubbolts, M. G.; 
Schoemaker, H. E.; Mink, D. Adv. Synth. Catal. 2008, 350, 1751–1759. 
(209)   Yadav, V. K.; Kapoor, K. K. Tetrahedron 1995, 51, 8573–8584. 
(210)   (a) Weisser, R.; Yue, W.; Reiser, O. Org. Lett. 2005, 7, 5353–5356; (b) Roy, S.; Reiser, 





Jones, P. G.; Werz, D. B. Org. Lett. 2014, 16, 5804–5807; (d) Kreft, A.; Jones, P. G.; 
Werz, D. B. Org. Lett. 2018, 20, 2059–2062. 
(211)   Yedoyan, J.; Wurzer, N.; Klimczak, U.; Ertl, T.; Reiser, O. Angew. Chem. Int. Ed. 2019, 
58, 3594–3598. 
(212)   (a) Yet, L. Chem. Rev. 2000, 100, 2963–3008; (b) Wei, Y.; Liu, S.; Li, M.-M.; Li, Y.; 
Lan, Y.; Lu, L.-Q.; Xiao, W.-J. J. Am. Chem. Soc. 2019, 141, 133–137. 
(213)   Li, M.; Lin, S.; Dong, Z.; Zhang, X.; Liang, F.; Zhang, J. Org. Lett. 2013, 15, 3978–
3981. 
(214)   Reissig, H.-U.; Zimmer, R. Chem. Rev. 2003, 103, 1151–1196. 
(215)   (a) Danheiser, R. L.; Martinez-Davila, C.; Morin, J. M. J. Org. Chem. 1980, 45, 1340–
1341; (b) Danheiser, R. L.; Bronson, J. J.; Okano, K. J. Am. Chem. Soc. 1985, 107, 
4579–4581; (c) Davies, H. M.L.; Hu, B. Tetrahedron Lett. 1992, 33, 455–456; (d) 
McGaffin, G.; Grimm, B.; Heinecke, U.; Michaelsen, H.; Meijere, A. d.; Walsh, R. Eur. 
J. Org. Chem. 2001, 2001, 3559–3573; (e) Murray, C. K.; Yang, D. C.; Wulff, W. D. J. 
Am. Chem. Soc. 1990, 112. 
(216)   Davies, H. M. L.; Hu, B. J. Org. Chem. 1992, 57, 3186–3190. 
(217)   Bisacchi, G. S.; Chao, S. T.; Bachard, C.; Daris, J. P.; Innaimo, S.; Jacobs, G. A.; Kocy, 
O.; Lapointe, P.; Martel, A.; Merchant, Z.; Slusarchyk, W. A.; Sundeen, J. E.; Young, 
M. G.; Colonno, R.; Zahler, R. Bioorg. Med. Chem. Lett. 1997, 7, 127–132. 
(218)   (a) Wang, S.-c.; Zhang, X.-q.; Gu, H.-m.; Zhu, X.-y.; Guo, Y.-j. Org. Prep. Proced. Int. 
2017, 49, 568–574; (b) La Clair, J. J. Angew. Chem. Int. Ed. 2006, 45, 2769–2773; (c) 
Tsuna, K.; Noguchi, N.; Nakada, M. Angew. Chem. Int. Ed. 2011, 50, 9452–9455; (d) 
Tsuna, K.; Noguchi, N.; Nakada, M. Chem. Eur. J. 2013, 19, 5476–5486. 
(219)   Schaudt, M.; Blechert, S. J. Org. Chem. 2003, 68, 2913–2920. 
(220)   Kress, S.; Weckesser, J.; Schulz, S. R.; Blechert, S. Eur. J. Org. Chem. 2013, 2013, 
1346–1355. 
(221)   (a) Fringuelli, F.; Taticchi, A. The Diels Alder reaction: Selected practical methods; 
Wiley, Chichester, New York, 2002; (b) Atherton, J.C.C.; Jones, S. Tetrahedron 2003, 
59, 9039–9057. 
(222)   Wiberg, K. B. J. Org. Chem. 1997, 62, 5720–5727. 
(223)   Klanderman, B. H. J. Am. Chem. Soc. 1965, 87, 4649–4651. 
(224)   Godinez, C. E.; Zepeda, G.; Mortko, C. J.; Dang, H.; Garcia-Garibay, M. A. J. Org. 
Chem. 2004, 69, 1652–1662. 





(226)   Nikitin, K.; Müller-Bunz, H.; McGlinchey, M. J. Organometallics 2013, 32, 6118–6129. 
(227)   Chen, H.; Yao, E.; Xu, C.; Meng, X.; Ma, Y. Org. Biomol. Chem. 2014, 12, 5102–5107. 
(228)   Chen, Q.; Chen, H.; Meng, X.; Ma, Y. Org. Lett. 2015, 17, 5016–5019. 
(229)   Yoshizawa, M.; Tamura, M.; Fujita, M. Science 2006, 312, 251–254. 
(230)   Taylor, R. G. D.; Carta, M.; Bezzu, C. G.; Walker, J.; Msayib, K. J.; Kariuki, B. M.; 
McKeown, N. B. Org. Lett. 2014, 16, 1848–1851. 
(231)   Tius, M. A.; Gomez-Galeno, J.; Zaidi, J. H. Tetrahedron Lett. 1988, 29, 6909–6912. 
(232)   Kendall, J. K.; Shechter, H. J. Org. Chem. 2001, 66, 6643–6649. 
(233)   Ngoc, V. N. 1,4-Cycloaddition of anthracenes and practical method for the synthesis of 
chiral diamino alcohols. Dissertation, Universität Regensburg, Regensburg, 2017. 
(234)   Bouffard, J.; Eaton, R. F.; Müller, P.; Swager, T. M. J. Org. Chem. 2007, 72, 10166–
10180. 
(235)   (a) Heinrich, M. R.; Klisa, H. S.; Mayr, H.; Steglich, W.; Zipse, H. Angew. Chem. Int. 
Ed. 2003, 42, 4826–4828; (b) Held, I.; Villinger, A.; Zipse, H. Synthesis 2005, 2005, 
1425–1430. 
(236)   Verma, S. M.; Singh, M. D. J. Org. Chem. 1977, 42, 3736–3740. 
(237)   Pauling, L. J. Am. Chem. Soc. 1947, 69, 542–553. 
(238)   Marcus, R. A. J. Phys. Chem. 1968, 72, 891–899. 
(239)   Streitwieser, A.; Heathcock, C. H. Introduction to Organic Chemistry; Macmillan, New 
York, 1981. 
(240)   (a) Duan, S.; Turk, J.; Speigle, J.; Corbin, J.; Masnovi, J.; Baker, R. J. J. Org. Chem. 
2000, 65, 3005–3009; (b) Cakmak, O.; Erenler, R.; Tutar, A.; Celik, N. J. Org. Chem. 
2006, 71, 1795–1801. 
(241)   Das, B.; Venkateswarlu, K.; Majhi, A.; Siddaiah, V.; Reddy, K. R. J. Mol. Catal. A: 
Chem. 2007, 267, 30–33. 
(242)   Breton, G. Adv. Chem. Lett. 2013, 1, 68–73. 
(243)   Tang, R.-J.; Milcent, T.; Crousse, B. Eur. J. Org. Chem. 2017, 4753–4757. 
(244)   Southgate, E. H.; Pospech, J.; Fu, J.; Holycross, D. R.; Sarlah, D. Nat. Chem. 2016, 8, 
922–928. 
(245)   Bouas-Laurent, H.; Desvergne, J.-P.; Castellan, A.; Lapouyade, R. Chem. Soc. Rev. 
2001, 30, 248–263. 
(246)   Bailey, D.; Williams, V. E. J. Org. Chem. 2006, 71, 5778–5780. 
(247)   Bouas-Laurent, H.; Desvergne, J.-P.; Castellan, A.; Lapouyade, R. Chem. Soc. Rev. 





(248)   Becker, H.-D.; Becker, H.-C.; Langer, V. J. Photochem. Photobiol. A 1996, 97, 25–32. 
(249)   Armarego, W. L. F.; Chai, C. L. L. Purification of Laboratory Chemicals, 6th ed.; 
Elsevier/BH, Oxford, 2009. 
(250)   Lee, M.; Neukirchen, S.; Cabrele, C.; Reiser, O. J. Pept. Sci. 2017, 23, 556–562. 
(251)   Pirtsch, M.; Paria, S.; Matsuno, T.; Isobe, H.; Reiser, O. Chem. Eur. J. 2012, 18, 7336–
7340. 
(252)   Zheng, Y.; Bian, R.; Zhang, X.; Yao, R.; Qiu, L.; Bao, X.; Xu, X. Eur. J. Org. Chem. 
2016, 2016, 3872–3877. 
(253)   Fu, L.; Mighion, J. D.; Voight, E. A.; Davies, H. M. L. Chem. Eur. J. 2017, 23, 3272–
3275. 
(254)   Yamawaki, M.; Tsutsui, H.; Kitagaki, S.; Anada, M.; Hashimoto, S. Tetrahedron Lett. 
2002, 43, 9561–9564. 
(255)   Qin, C.; Boyarskikh, V.; Hansen, J. H.; Hardcastle, K. I.; Musaev, D. G.; Davies, H. M. 
L. J. Am. Chem. Soc. 2011, 133, 19198–19204. 
(256)   Reddy, R. P.; Lee, G. H.; Davies, H. M. L. Org. Lett. 2006, 8, 3437–3440. 
(257)   (a) Breton, G. W.; Turlington, M. Tetrahedron Lett. 2014, 55, 4661–4663; (b) Cookson, 
R. C.; Gupte, S. S.; Stevens, I. D. R.; Watts, C. T. Org. Synth. 1971, 51, 121. 
(258)   Zhu, J.; Yang, J.-Y.; Klunder, A. J. H.; Liu, Z.-Y.; Zwanenburg, B. Tetrahedron 1995, 
51, 5847–5870. 
(259)   Pirkle, W. H.; Dines, M. J. Heterocycl. Chem. 1969, 6, 1–3. 
(260)   Wang, H.-Y. L.; Qi, Z.; Wu, B.; Kang, S.-W.; Rojanasakul, Y.; O'Doherty, G. A. ACS 
Med. Chem. Lett. 2011, 2, 259–263. 
(261)   Ma, Y.; O’Doherty, G. A. Org. Lett. 2015, 17, 5280–5283. 
(262)   Otero, M. P.; Santín, E. P.; Rodríguez-Barrios, F.; Vaz, B.; Lera, Á. R. de. Bioorg. Med. 
Chem. Lett. 2009, 19, 1883–1886. 
(263)   Billington, D. C.; Helps, I. M.; Pauson, P. L.; Thomson, W.; Willison, D. J. Organomet. 
Chem. 1988, 354, 233–242. 
(264)   Carreno, M. C.; Ruano, J. L.; Urbanoy, A. J. Org. Chem. 1992, 57, 6870–6876. 
(265)   M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, 
G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. 
Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, 
M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. 
Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, 





Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, 
N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. 
Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. 
Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, 
P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. 
V. Ortiz, J. Cioslowski, and D. J. Fox. Gaussian 09, Revision E.01; Gaussian, Inc., 
Wallingford CT, 2013. 
(266)   (a) Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B 1988, 37, 785–789; (b) Krishnan, R.; 
Binkley, J. S.; Seeger, R.; Pople, J. A. J. Chern. Phys. 1980, 72, 650–654; (c) Becke, A. 
D. J. Chem. Phys. 1993, 98, 5648–5652. 
(267)   Grimme, S.; Antony, J.; Ehrlich, S.; Krieg, H. J. Phys. Chem. 2010, 132, 154104. 
(268)   Mulliken, R. S. J. Chem. Phys. 1955, 23, 1833–1840. 
(269)   (a) NBO Version 3.1, E. D. Glendening, A. E. Reed, J. E. Carpenter, and F. Weinhold 
as implemented in Gaussian09.E01; (b) Foster, J. P.; Weinhold, F. J. Am. Chem. Soc. 
1980, 102, 7211–7218; (c) Reed, A. E.; Weinstock, R. B.; Weinhold, F. J. Chem. Phys. 
1985, 83, 735–746; (d) Reed, A. E.; Weinhold, F. J. Chem. Phys. 1985, 83, 1736–1740; 
(e) Reed, A. E.; Curtiss, L. A.; Weinhold, F. Chem. Rev. 1988, 88, 899–926. 
(270)   (a) Pauling, L. J. Am. Chem. Soc. 1947, 69, 543–553; (b) Houk, K. N.; Gustafson, S. 
M.; Black, K. A. J. Am. Chem. Soc. 1992, 114, 8565–8572. 
(271)   (a) Marcus, R. A. J. Phys. Chem. 1968, 72, 891–899; (b) Follet, E.; Mayer, P.; Mayr, H. 







Ich bedanke mich bei Prof. Oliver Reiser für die Überlassung des äußerst interessanten Themas 
und seine beständige Unterstützung während der gesamten Arbeit. 
Ebenfalls großer Dank gebührt Dr. Peter Kreitmeier für seine Hilfe bei technischen und 
chemischen Problemen sowie für die unzähligen fachlichen, aber besonders auch für die nicht 
fachlichen Diskussionen. Außerdem bedanke ich mich bei Klaus Döring, Johanes Floß, Roxane 
Harteis, Helena Konkel und Brigitte Eichenseher für die Unterstützung im Laboralltag.  
Vielen Dank an Prof. Julia Rehbein und Patrick Sakrausky für die Durchführung der 
theoretischen Berechnungen zu den Diels-Alder Reaktionen der Anthracene. Vielen Dank auch 
an Jiantao Fu (AK Prof. Davies, Atlanta) für seine Kollaboration bei der enantioselektiven 
Cyclopropanierung der Pyrone und Pyridinone. 
Bei allen Mitarbeitern der zentralen Analytik möchte ich mich bedanken. Besonders bedanke 
ich mich bei den Mitarbeitern der Röntgenstrukturanalyse Dr. Michael Bodensteiner, Dr. 
Stefanie Gärtner, Sabine Stempfhuber und Birgit Hirscha für die Messung der 
Kristallstrukturen, sowie Josef Kiermaier und Wolfgang Söllner für die Messung der 
Massenspektren. Des Weiteren bei den Mitarbeitern der NMR Abteilung Dr. Ilya Shenderovich, 
Fritz Kastner, Veronica Scheidler, Annette Schramm und Georgine Stühler. 
Ein herzliches Dankeschön an unsere Sekretärinnen, Antje Weigert und Michaela Schüle, für 
aller Hilfe organisatorischer Art.  
Herzlichen Dank an alle aktuellen und ehemaligen Mitarbeiter des AK Reisers für die gute 
Atmosphäre, die schönen Aktivitäten am und außerhalb des Arbeitskreises. Besonders danken 
möchte ich Verena Lehner, Thomas Ertl, Daniel Dobler, Corina Neumeister, Matthias Gnahn, 
Benjamin Kastl, Martin Hofman, Saerom Park, Sabine Kerres, Thomas Föll, Simon Budde, 
Aditya Bhattacharyya, Tobias Babl, Robert Eckl, Peter Ehrnsberger, Christian Eichinger, 
Sebastian Engl, Sebastian Fischer, Andreas Hartl, Tomislav Krolo, Natalija Moor, Eva Plut, 
Roxane Harteis, Carina Sonnleitner, Lisa Stadler, Lukas Traub, Andreas Ratzenböck und 
Thomas Weinbender.  
Für das gewissenhafte Korrekturlesen bedanke ich mich herzlichst bei Sebastian Fischer, 





Außerdem danke ich meinen ehemaligen Bachelorstudenten und Forschungspraktikanten 
Andreas Ratzenböck, Sebastian Hauer, Simon Scheuerer und Fabian Schabenberger. 
Vielen lieben Dank an meine Laborkollegen, Sabine Kerres, Thomas Ertl, Robert Eckl, Eva 
Plut, Tomislav Krolo und Aditya Bhattacharyya für die gute Zusammenarbeit und lustige Zeit 
im Labor 33.1.19, aber auch dafür, dass ihr meine laute Musik täglich ertragen habt. Mein 
besonderer Dank gilt hierbei Tom und Sabine, die mich gleich als neues Mitglied im Labor 
aufgenommen haben und mir eine extreme Hilfe waren. Danke auch für unsere Laborabende 
und die schöne Zeit außerhalb der Universität. 
Liebe Sabine, ich kann dir gar nicht genug danken für deine Unterstützung jeglicher Art und 
vor allem für deine Freundschaft. Es war ja schon fast Laborehe auf dem ersten Blick. Du hast 
sehr großen Anteil daran, dass diese Zeit immer unvergessen bleibt.  
Tomislav moje sunce, brate moje, hvala. ću uvijek ću biti tvoj heroj. Ich vermisse jetzt schon 
unsere Tanz- und Gesangseinlagen. Wir sind so richtige Tschucksl. Kad se sjetim, suza krene. 
Lijepa li si.  
An meine Leidgenossen Lisa Stadler, Christian Eichinger, Andreas Hartl, Lukas Traub, Thomas 
Weinbender und Peter Ehrnsberger ein herzliches Dankeschön. Wir waren ein super Jahrgang 
und keine Spreu. 
Für die schönen Ausflüge, die Konferenzen, die Küchenpartys, die morgendlichen 
Kaffeepausen, für diese unvergessliche Zeit möchte ich mich herzlich bei Benjamin Kastl, 
Matthias Gnahn, Lisa Stadler, Sabine Kerres, Peter Ehrnsberger, Thomas Föll, Sebastian 
Fischer, Sebastian Engl, Carina Sonnleitner und Tomislav Krolo bedanken.  
Vielen Dank an die Regensburg Familie Flori, Messut, Resi, Nini, Sebi, Otzi, Schäffer, Luca, 
Basti, Lisa und Julia für diese Wahnsinnszeit in Regensburg. Egal ob Sport, Grillen oder 
Fortgehen, es war immer super lustig. Ihr habt die Zeit hier zu was Besonderem gemacht. 
Tobi, Kalle, Hias, Michi, Pol, Felix und Nuschey herzliches Merce für alles. Ohne euch wäre 
alles deutlich schwieriger gewesen und das Leben ganz schön langweilig. Dr. Sepp und Tino 
auch an euch ein großes Dankeschön. Egal ob Skiausflug oder Raguse-Dachterrasse es ist 
immer eine super Zeit mit euch. Natürliche bedanke ich mich auch bei allen Biergls und 
Proseccls. Ihr seid der Wahnsinn. Danke auch an den TuS Prien und seinen Spielern, dass trotz 
Trainingsmangel immer ein Platz für mich im Team war. Besonders möchte ich mich hier bei 





Mein größter Dank geht an meine ganze Familie für ihre unerschütterliche Unterstützung. Ohne 
euch wäre alles nicht möglich gewesen und dafür bin ich euch unendlich dankbar. Danke Baba, 
Dedo, Oma, Tetkas und Ojkos. Markus und Thomas danke für alles. Ihr seid die besten Brüder, 
die man sich nur wünschen kann. Mama und Papa, ohne euch wäre ich nie so weit gekommen. 







Herewith I declare that this present thesis is a presentation of my original work prepared 
single-handed. Wherever contributions from others are involved, all of them are marked clearly, 
with reference to the literature, license, and acknowledgment of collaborative research. 
 
Regensburg, July 02, 2020 
 
 
     
Michael Leitner 
